 EX-2.1  



Exhibit 2.1



EXECUTION VERSION





| | 
---|---|--- 

AGREEMENT AND PLAN OF MERGER

by and among

Hewlett Packard Enterprise Company,

a Delaware corporation,

Santorini Merger Sub, Inc.,

a Delaware corporation,

Silver Peak Systems, Inc.,

a Delaware corporation,

Fortis Advisors LLC as the Stockholders' Agent,

and

David Hughes, as the Holdback Participant

___________________________

Dated as of July 11, 2020

___________________________

| | 
---|---|--- 

 



US3653629/60 166756-0017 TABLE OF CONTENTS

| | | | | 
---|---|---|---|---|--- 
| Page 
ARTICLE I The Merger | 2 
1.1. The Merger | 2 
1.2. Closing Deliveries. | 3 
1.3. Effect on Capital Stock, Options, Warrants and RSUs. | 5 
1.4. Payment Procedures. | 9 
1.5. No Further Ownership Rights in the Company Capital Stock, Company
Options, | 
Company Warrants, Company RSUs or Retention RSUs. | 12 
1.6. Holdback Consideration. | 13 
1.7. Tax Consequences. | 13 
1.8. Certain Taxes. | 13 
1.9. Withholding Rights. | 13 
1.10. Taking of Necessary Action; Further Action. | 13 
ARTICLE II Representations and Warranties of the Company. | 13 
2.1. Organization, Standing, Power and Subsidiaries. | 14 
2.2. Capital Structure. | 14 
2.3. Authority; Non-contravention. | 17 
2.4. Financial Statements; No Undisclosed Liabilities. | 18 
2.5. Absence of Changes. | 20 
2.6. Litigation; DandO Indemnification Claims. | 21 
2.7. Compliance with Laws; Governmental Permits. | 21 
2.8. Title to, Condition and Sufficiency of Assets; Real Property. | 22 
2.9. Intellectual Property. | 22 
2.10. Information Technology. | 27 
2.11. Privacy and Personal Data. | 28 
2.12. Taxes. | 30 
2.13. Employee Benefit Plans. | 34 
2.14. Employment Matters. | 37 
2.15. Interested-Party Transactions | 40 
2.16. Insurance. | 40 
2.17. Books and Records. | 40 
2.18. Material Contracts. | 41 
2.19. Transaction Fees. | 44 
2.20. Antitrust Laws. | 44 
2.21. Anti-Corruption Law.. | 44 
2.22. Environmental, Health and Safety Matters. | 45 
2.23. Import, Export Control and Sanctions Laws. | 46 
2.24. Government Contracts. | 47 
2.25. Customers and Suppliers. | 49 

US3653629/60 166756-0017

* * *



| | | | | 
---|---|---|---|---|--- 
2.26. Stockholder Notice. | 50 
ARTICLE III Representations and Warranties of Acquirer and Merger Sub. | 50 
3.1. Organization and Standing. | 50 
3.2. Authority; Non-contravention. | 50 
3.3. No Prior Merger Sub Operations | 51 
3.4. Sufficiency of Funds. | 51 
ARTICLE IV Conduct Prior to the Effective Time. | 51 
4.1. Conduct of the Business; Notices. | 51 
4.2. Restrictions on Conduct of the Business | 52 
4.3. Certain Limitations | 56 
ARTICLE V Additional Agreements. | 56 
5.1. Board Recommendation, Stockholder Approval and Stockholder Notice. | 56 
5.2. No Solicitation. | 57 
5.3. Confidentiality; Public Disclosure. | 58 
5.4. Reasonable Best Efforts; Regulatory Approvals. | 59 
5.5. Third-Party Consents; Notices | 60 
5.6. Litigation. | 60 
5.7. Access to Information. | 60 
5.8. Expenses; Company Debt | 61 
5.9. Employees. | 62 
5.10. Termination of Benefit Plans. | 65 
5.11. Company Closing Financial Certificate. | 65 
5.12. Tax Matters. | 65 
5.13. 280G Stockholder Approval | 67 
5.14. Joinder Agreements, Option Cancellation Agreements and Warrantholder | 
Agreements. | 67 
5.15. Prohibited and Restricted Parties. | 67 
5.16. Directors' and Officers' Indemnification and Insurance. | 67 
5.17. Termination of Agreements. | 68 
5.18. Spreadsheet | 68 
5.19. Audited Interim Financials. | 69 
5.20. Specified Actions. | 69 
ARTICLE VI Conditions to the Merger | 69 
6.1. Conditions to Obligations of Each Party to Effect the Merger | 69 
6.2. Additional Conditions to Obligations of the Company. | 70 
6.3. Additional Conditions to the Obligations of Acquirer | 70 
ARTICLE VII Termination. | 71 
7.1. Termination. | 71 
7.2. Effect of Termination. | 72 
ARTICLE VIII Escrow Fund and Indemnification. | 72 
8.1. Escrow Fund and Release of Escrow Fund. | 72 

2

US3653629/60 166756-0017 | | | | | 
---|---|---|---|---|--- 
8.2. Indemnification. | 73 
8.3. Indemnifiable Damage Threshold; Other Limitations | 75 
8.4. Period for Claims | 77 
8.5. Claims. | 77 
8.6. Resolution of Objections to Claims. | 78 
8.7. Stockholders' Agent | 78 
8.8. Third-Party Claims. | 81 
8.9. Treatment of Indemnification Payments. | 81 
8.10. Sole and Exclusive Remedy. | 81 
ARTICLE IX General Provisions. | 82 
9.1. Survival of Representations, Warranties and Covenants. | 82 
9.2. Notices. | 82 
9.3. Interpretation. | 83 
9.4. Amendment | 84 
9.5. Extension; Waiver | 84 
9.6. Counterparts. | 85 
9.7. Entire Agreement; Parties in Interest. | 85 
9.8. Assignment | 85 
9.9. Severability. | 86 
9.10. Remedies Cumulative; Specific Performance. | 86 
9.11. Governing Law.. | 86 
9.12. Jurisdiction and Venue; Consent to Service of Process | 86 
9.13. WAIVER OF JURY TRIAL. | 86 
9.14. Rules of Construction. | 87 
9.15. Waiver of Conflicts; Privilege. | 87 

 

3

US3653629/60 166756-0017 Exhibits

Exhibit A - Definitions

Exhibit B - Form of Written Consent

Exhibit C - Form of Certificate of Merger

Exhibit D - Form of Joinder Agreement

Exhibit E - Form of Option Cancellation Agreement

Exhibit F - Form of Warrantholder Agreement

Exhibit G-1 - Form of FIRPTA Notice

Exhibit G-2 - Form of FIRPTA Notification Letter

Exhibit H - Form of Letter of Transmittal

Exhibit I - Form of Parachute Payment Waiver

Exhibit J - Form of Escrow Agreement

Exhibit K - Form of Restricted Stock Unit Agreement



Schedules

Company Disclosure Letter

Schedule I-1 - Key Employees

Schedule I-2 - Specified Individuals

Schedule I-3 - Knowledge Persons

Schedule 1.6 - Holdback Terms

Schedule 5.5 - Third-Party Consents and Notices

Schedule 5.17(a) - Contracts with Related Parties to be Terminated

Schedule 5.19 - Audited Interim Financials

Schedule 5.20 - Specified Actions

Schedule 6.1(c) - Governmental Approvals

Schedule A-1 - Acquirer Authorized Representatives

Schedule A-2 - Additional Company Debt

Schedule A-3 - Aggregate Retention Award Amount

| | 
---|---|--- 

4

US3653629/60 166756-0017 Agreement and Plan of Merger

This Agreement and Plan of Merger (this "Agreement") is made and entered into
as of July 11, 2020 (the "Agreement Date"), by and among Hewlett Packard
Enterprise Company, a Delaware corporation ("Acquirer"), Santorini Merger Sub,
Inc., a Delaware corporation and a wholly owned subsidiary of Acquirer
("Merger Sub"), Silver Peak Systems, Inc., a Delaware corporation (the
"Company"), Fortis Advisors LLC, a Delaware limited liability company, as the
stockholders' agent (the "Stockholders' Agent") and, solely for purposes of
Sections 1.6, 5.9 and 5.20, Article IX, and related provisions, David Hughes
(the "Holdback Participant"). Certain other capitalized terms used herein are
defined in Exhibit A.

Recitals

A.Acquirer, Merger Sub and the Company intend to effect a merger of Merger Sub
with and into the Company in accordance with this Agreement and DGCL (the
"Merger"). Upon consummation of the Merger, Merger Sub will cease to exist,
and the Company will become a wholly owned subsidiary of Acquirer.

B.The board of directors of the Company (the "Board") has carefully considered
the terms of this Agreement and has unanimously (1) declared this Agreement
and the transactions contemplated by this Agreement and the documents
referenced herein to be entered into in connection with this Agreement and the
Merger (collectively, the "Transactions"), including the Merger, upon the
terms and subject to the conditions set forth herein, advisable, fair to and
in the best interests of the Company and the Company Stockholders, (2)
approved this Agreement and the Transactions (including the Merger) in
accordance with Applicable Law and (3) adopted a resolution directing that the
adoption of this Agreement and approval of the Merger be submitted to the
Company Stockholders for consideration and recommending that all of the
Company Stockholders adopt this Agreement and approve the Merger.

C.The board of directors of Merger Sub has (1) declared this Agreement and the
Transactions, including the Merger, upon the terms and subject to the
conditions set forth herein, advisable, fair to and in the best interests of
Merger Sub and the stockholder of Merger Sub, (2) approved this Agreement and
the Transactions (including the Merger) in accordance with Applicable Law and
(3) adopted a resolution recommending that Acquirer, as the sole stockholder
of Merger Sub, adopt this Agreement and approve the Merger.

D.Concurrently with the execution of this Agreement, and as a condition and
inducement to Acquirer's and Merger Sub's willingness to enter into this
Agreement, certain employees of the Company identified on Schedule I-1 (each,
a "Key Employee") have each executed Acquirer's customary form of employment
offer letter, together with a confidential information and invention
assignment agreement (together, an "Offer Letter"), to become effective upon
the Closing.

E.As an inducement to Acquirer's and Merger Sub's willingness to enter into
this Agreement (but not pursuant to any prior agreement with Acquirer or the
Company), (i) holders of at least 70% of the outstanding shares of Company
Capital Stock voting together as a single class and on an as-converted basis,
(ii) holders of at least 90% of the outstanding shares of Company Preferred
Stock, voting together as a single class and on an as-converted basis and
(iii) holders of at least 50% of the outstanding shares of Company Common
Stock voting together as a single class (collectively, the "Consenting
Stockholders"), have indicated that they expect to deliver,

US3653629/60 166756-0017

* * *



following the approval and adoption of this Agreement by the Board and
immediately following the execution and delivery of this Agreement, their
written consent and agreement to (a) the irrevocable approval and adoption of
this Agreement, the Company Transaction Documents, the Merger and the other
Transactions, and (b) specified undertakings, representations, warranties,
releases and waivers, in each case pursuant to a written consent, joinder,
release and waiver, in the form attached hereto as Exhibit B, signed and dated
as of the date hereof by such Company Stockholders, pursuant to and in
accordance with the applicable provisions of the DGCL, the Certificate of
Incorporation and the Bylaws (such consents of such Company Stockholders in
the form of Exhibit B, collectively, the "Written Consent").

Now, Therefore, in consideration of the representations, warranties,
covenants, agreements and obligations contained herein, and for other good and
valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties hereto agree as follows:

ARTICLE I.

The Merger

1.1The Merger

(a)Merger of Merger Sub into the Company. Upon the terms and subject to the
conditions set forth herein, at the Effective Time, Merger Sub shall be merged
with and into the Company, and the separate existence of Merger Sub shall
cease. The Company will continue as the surviving corporation in the Merger
(sometimes referred to herein as the "Surviving Corporation") and as a wholly
owned subsidiary of Acquirer.

(b)Effects of the Merger. The Merger shall have the effects set forth herein
and in the applicable provisions of the DGCL.

(c)Closing. Upon the terms and subject to the conditions set forth herein, the
closing of the Transactions (the "Closing") shall take place remotely via the
exchange of documents and signatures at (i) 10:00 a.m. Pacific time on a date
to be agreed by Acquirer and the Company, which date shall be no later than
the fourth Business Day following the date on which all of the conditions set
forth in Article VI have been satisfied or waived (other than those conditions
that, by their terms, are intended to be satisfied at the Closing, but subject
to the satisfaction or waiver of those conditions); provided that if such
Business Day would otherwise occur anytime during the final 10 days of a
fiscal quarter of Acquirer, then Acquirer may, in its discretion, and by
providing advance written notice to the Company at least three (3) days prior
to such proposed delay, delay the Closing until the first Business Day of the
next succeeding fiscal quarter of Acquirer (it being understood that if such a
written notice is delivered then the references to the Closing Date in clause
(iii) of Section 6.3(a) shall be modified to the date of the delivery of such
written notice except in the case of any breaches or inaccuracies in the
representations and warranties that are the result of a willful breach by or
on behalf of the Company) or (ii) such other time as Acquirer and the Company
agree. The date on which the Closing occurs is sometimes referred to herein as
the "Closing Date."

(d)Effective Time. A certificate of merger satisfying the applicable
requirements of the DGCL in substantially the form attached hereto as Exhibit
C (the "Certificate of Merger") shall be duly executed by the Company and,
concurrently with or as soon as practicable following the Closing, delivered
to the Secretary of State of the State of Delaware for filing. The Merger
shall become effective upon the filing of the Certificate of Merger with the Secretary of State of
the State of Delaware or at such later time as Acquirer and the Company agree
and specify in the Certificate of Merger (the "Effective Time").

(e)Certificate of Incorporation and Bylaws; Directors and Officers. Unless
otherwise determined by Acquirer prior to the Effective Time and subject to
Section 5.16:

(i)the certificate of incorporation of the Surviving Corporation shall be
amended and restated as of the Effective Time to read as set forth in the
Certificate of Merger, until thereafter amended as provided by the DGCL;

(ii)the Company shall take all actions necessary to cause the Bylaws to be
amended and restated as of the Effective Time to be identical (other than as
to name) to the bylaws of Merger Sub as in effect immediately prior to the
Effective Time; and

(iii)the Company shall take all actions necessary to cause the directors of
Merger Sub immediately prior to the Effective Time to be the only directors of
the Surviving Corporation immediately after the Effective Time until their
respective successors are duly elected or appointed and qualified or until
their earlier death, resignation or removal in accordance with the certificate
of incorporation and bylaws of the Surviving Corporation.

1.2Closing Deliveries

(a)Acquirer Deliveries. Acquirer shall deliver to the Company, at or prior to
the Closing:

(i)a certificate, dated as of the Closing Date, executed on behalf of Acquirer
by a duly authorized officer of Acquirer to the effect that each of the
conditions set forth in Section 6.2(a) has been satisfied; and

(ii)the Escrow Agreement, executed by Acquirer and the Escrow Agent.

(b)Company Deliveries. The Company shall deliver to Acquirer, at or prior to
the Closing:

(i)a certificate, dated as of the Closing Date and executed on behalf of the
Company by its Chief Executive Officer, to the effect that each of the
conditions set forth in Sections 6.3(a) and (e) has been satisfied;

(ii)a certificate, dated as of the Closing Date and executed on behalf of the
Company by its Secretary, certifying (A) the certificate of incorporation of
the Company (the "Certificate of Incorporation") in effect as of the Closing,
(B) the bylaws of the Company (the "Bylaws") in effect as of the Closing, (C)
the resolutions of the Board (I) declaring this Agreement and the
Transactions, including the Merger, upon the terms and subject to the
conditions set forth herein, advisable, fair to and in the best interests of
the Company and the Company Stockholders, (II) approving this Agreement and
the Transactions (including the Merger) in accordance with Applicable Law and
(III) directing that the adoption of this Agreement and approval of the Merger
be submitted to the Company Stockholders for consideration and recommending
that all of the Company Stockholders adopt this Agreement and approve the
Merger, and (D) the valid adoption of this Agreement and approval of the
Merger, the Company Transaction Documents and the other Transactions, in each
case, by the Written Consent whereby all requisite approvals of this Agreement, the Company Transaction Documents, the
Merger and the other Transactions were obtained;

(iii)the Escrow Agreement, executed by the Stockholders' Agent;

(iv) (A) a stockholder joinder agreement (including a release of claims) in
substantially the form attached hereto as Exhibit D (the "Joinder Agreement")
executed by Company Stockholders (that have not already executed the Written
Consent), (B) option cancellation agreements, in substantially the form
attached hereto as Exhibit E (each, an "Option Cancellation Agreement")
executed by the Company Optionholders holding Vested Company Options, and (C)
the warrantholder agreement in substantially the form attached hereto as
Exhibit F by and between the Company and Company Warrantholders (a
"Warrantholder Agreement"), such that the aggregate Pro Rata Share covered by
such executed documents, together with the Pro Rata Share covered by the
Written Consent, collectively represents a fraction that, when expressed as a
percentage, shall equal at least 90%;

(v)Offer Letters, effective as of the Closing, executed by each of the Key
Employees, which shall continue to be in full force and effect, and no action
shall have been taken by any such individual to rescind such Offer Letter;

(vi)the Spreadsheet;

(vii)a letter of resignation, duly executed by each director of the Company in
office immediately prior to the Closing as a director of the Company,
confirming their resignation as a director of the Company effective as of, and
contingent upon, the Effective Time;

(viii) (A) a true, correct and complete copy of resolutions adopted by the
Board or any applicable committee thereof, certified by the Secretary of the
Company, terminating any Company Employee Plans intended to include a Code
Section 401(k) arrangement (the "401(k) Plan"), with such termination to be
effective as of the date immediately preceding the Closing Date and contingent
upon the Closing (unless and to the extent that Acquirer provides written
notice to the Company no later than three Business Days prior to the Closing
Date that such plans shall not be terminated), (B) a true, correct and
complete copy of resolutions adopted by the Board approving an amendment to
Company's 2014 Equity Incentive Plan increasing the share reserve thereunder
in a number sufficient to grant the Retention RSUs and Excess Promised Option
RSUs, if any (the "2014 Plan Amendment"), the grant of the Retention RSUs and
Excess Promised Option RSUs, if any, pursuant to this Agreement and the
treatment of the Company Options, the Company RSUs, the Retention RSUs and
Company Capital Stock as provided under this Agreement and (C) true, correct
and complete copies of all executed agreements and documents relating to the
the Retention RSUs and Excess Promised Option RSUs (if any);

(ix)a certificate from the Secretary of State of Delaware dated within five
Business Days of the Closing certifying that the Company is in good standing;

(x)a funds flow memorandum (including all amounts, payees, and wiring
information) setting forth all payments to be made by or on behalf of Acquirer
in respect of Unpaid Transaction Expenses, Company Debt and Expense Fund (the
"Funds Flow");

(xi)FIRPTA documentation, consisting of (A) a notice to the IRS, in accordance
with the requirements of Treasury Regulation Section 1.897-2(h)(2), in
substantially the form attached hereto as Exhibit G-1, dated as of the Closing
Date and executed by the Company, together with written authorization for Acquirer to deliver such notice form to the IRS on
behalf of the Company after the Closing, and (B) a FIRPTA Notification Letter,
in substantially the form attached hereto as Exhibit G-2, dated as of the
Closing Date and executed by the Company;

(xii)the Certificate of Merger, executed by the Company;

(xiii)the payoff letters described in Section 5.8(b);

(xiv)the Debt Settlement Agreements, if required pursuant to Section 5.9(c);
and

(xv)audited financial statements of the Company for the nine-month period
ended April 30, 2020 (including consolidated balance sheets, statements of
operations and comprehensive loss, consolidated statements of redeemable
convertible preferred stock and stockholders deficit, and consolidated
statements of cash flows, and the related notes to the consolidated financial
statements) (the "Audited Interim Financials").

Receipt by Acquirer of any of the agreements, instruments, certificates or
documents delivered pursuant to this Section 1.2(b) shall not be deemed to be
an agreement by Acquirer or Merger Sub that the information or statements
contained therein are true, correct or complete, and shall not diminish
Acquirer's or Merger Sub's remedies hereunder if any of the foregoing
agreements, instruments, certificates or documents are not true, correct or
complete.

1.3Effect on Capital Stock, Options, Warrants and RSUs

(a)Treatment of Company Capital Stock, Company Options, Company Warrants and
Company RSUs. Upon the terms and subject to the conditions set forth herein,
at the Effective Time, by virtue of the Merger and without any action on the
part of any party hereto, Company Stockholder, Company Optionholder, Company
Warrantholder, Company RSU Holder or any other Person:

(i)Company Capital Stock. Each share of Company Capital Stock held by a
Converting Holder immediately prior to the Effective Time (in each case, on an
as-converted to Company Common Stock basis and after giving effect to any
exercise of Company Options or Company Warrants and settlement of Company RSUs
prior to the Effective Time, including any such settlement pursuant to Section
1.3(a)(iv), but excluding any Dissenting Shares and shares that are owned by
the Company as treasury stock) shall be extinguished and cancelled and
converted automatically into, and represent only, the right to receive,
without interest and less any applicable and required Tax withholding, (A) an
amount in cash equal to the Closing Per Share Consideration and (B) the Future
Per Share Consideration, subject to the terms and conditions of Article VIII.

(ii)Company Options.

(A)Each Vested Company Option that is unexpired, unexercised and outstanding
immediately prior to the Effective Time (after giving effect to Section 1.6)
shall be terminated and cancelled at the Effective Time and shall not be
assumed by Acquirer. Upon cancellation thereof, each Vested Company Option
shall be converted into and represent the right to receive, without interest,
with respect to each share of Company Common Stock underlying such Vested
Company Option, (1) the Closing Per Option Consideration, and (2) the Future
Per Option Consideration, subject to the terms and conditions of Article VIII.
The amount of cash each Converting Holder holding Vested Company Options is entitled to receive
for such Vested Company Options shall be rounded down to the nearest cent and
will be reduced by any applicable payroll, income tax or other withholding
Taxes. Any Vested Company Option outstanding immediately prior to the
Effective Time that has a per share exercise price equal to or exceeding the
Per Share Consideration shall be cancelled and extinguished without any
conversion thereof or payment of any cash or other property or consideration
therefor. Notwithstanding anything contained herein to the contrary, no
portion of the Future Per Option Consideration with respect to a Vested
Company Option shall be payable after the fifth anniversary of the Closing
Date (unless otherwise permitted by Section 409A of the Code).

(B)Each Unvested Company Option held by a Continuing Employee that is
unexpired, unexercised and outstanding immediately prior to the Effective
Time, other than Performance Options, shall, on the terms and subject to the
conditions set forth in this Agreement, be converted into and become an option
with respect to Acquirer Common Stock, and Acquirer shall assume each such
Unvested Company Option, in accordance with the terms of the Company Equity
Plans and/or stock option agreement by which it is evidenced (including the
vesting schedule and any vesting acceleration for each such Unvested Company
Option, to the extent applicable), except that from and after the Effective
Time: (1) Acquirer and its compensation committee shall be substituted for the
Company and the Board, or such committee of the Board delegated authorization
for, administering such Company Equity Plans, (2) each Unvested Company Option
assumed by Acquirer pursuant to the terms herein shall not include an "early
exercise" provision, regardless of whether the original Unvested Company
Option included an "early exercise" provision, (3) each Unvested Company
Option assumed by Acquirer may be exercised solely for shares of Acquirer
Common Stock (or cash, if so provided under the terms of such Unvested Company
Option or required or necessary for compliance reasons under Applicable Law),
(4) the number of shares of Acquirer Common Stock subject to each Unvested
Company Option assumed by Acquirer shall be equal to the number of shares of
Company Common Stock subject to each such Unvested Company Option immediately
prior to the Effective Time multiplied by the Exchange Ratio, rounded down to
the nearest whole share and (5) the per share exercise price under each such
Unvested Company Option assumed by Acquirer shall be adjusted by dividing the
per share exercise price under each such Unvested Company Option by the
Exchange Ratio and rounding up to the nearest cent; provided that with respect
to any Unvested Company Option outstanding immediately prior to the Effective
Time that has a per share exercise price equal to or exceeding the Per Share
Consideration, such Unvested Company Option shall not be assumed by Acquirer
and shall automatically terminate as of the Effective Time. In addition, it is
intended that each such Unvested Company Option that is an "incentive stock
option" immediately prior to the Effective Time shall remain an incentive
stock option under Section 422 of the Code and along with each nonqualified
stock option shall be adjusted as required by Section 424 of the Code and
Section 409A of the Code and the Treasury Regulations thereunder, so as not to
constitute a modification, extension or renewal of the option, within the
meaning of Section 424(h) of the Code and the Treasury Regulations under
Section 409A of the Code, or otherwise result in adverse tax treatment or
penalties under Section 424 of the Code or Section 409A of the Code, and
clauses (4) and (5) of the first sentence of this Section 1.3(a)(ii)(B) shall
be modified to the extent necessary to ensure such compliance.

(C)Notwithstanding anything to the contrary herein, Acquirer will not assume
(1) Unvested Company Options held by Non-Continuing Employees or (2) Unvested
Company Options that are Performance Options. All such Unvested Company
Options that are unexpired, unexercised and outstanding immediately prior to
the Effective Time shall be cancelled and extinguished at the Effective Time without any present or future
right to receive any portion of the Total Consideration.

(iii)Company Warrants. Each Company Warrant that is unexpired, unexercised and
outstanding immediately prior to the Effective Time shall be terminated and
cancelled at the Effective Time and shall not be assumed by Acquirer. Upon
cancellation thereof, each Company Warrant shall be converted into and
represent the right to receive, without interest, with respect to each share
of Company Capital Stock underlying such Company Warrant, (A) an amount in
cash equal to the Closing Per Warrant Consideration, and (B) the Future Per
Warrant Consideration, subject to the terms and conditions of Article VIII.
The amount of cash each Converting Holder holding Company Warrants is entitled
to receive for such Company Warrants shall be rounded down to the nearest cent
and will be reduced by any applicable payroll, income tax or other withholding
Taxes. Any Company Warrants outstanding immediately prior to the Effective
Time that have an exercise price exceeding the Per Share Consideration shall
be cancelled and extinguished without any conversion thereof or payment of any
cash or other property or consideration therefor.

(iv)Company RSUs.

(A)Company RSUs other than Excess Promised Option RSUs. Each Company RSU
(excluding Excess Promised Option RSUs, which shall be treated as set forth
below) that is outstanding immediately prior to the Effective Time shall vest
immediately prior to the Effective Time in accordance with its terms and shall
be settled immediately upon such vesting. Each share of Company Common Stock
received in settlement of a Company RSU shall be treated as an outstanding
share of Company Common Stock as of immediately prior to the Effective Time
for purposes of this Agreement, including Section 1.3(a)(i). Any amounts due
in respect of such Company RSUs, including any applicable and required income
or employment Tax withholding, shall be automatically deducted without further
action of the Company RSU Holder from amounts otherwise payable to such
Company RSU Holder on the Closing Date. All such Company RSUs shall be taxed
in full at the time of such settlement.

(B)Excess Promised Option RSUs. Each Excess Promised Option RSU held by a
Continuing Employee that is outstanding immediately prior to the Effective
Time shall, on the terms and subject to the conditions set forth in this
Agreement, be converted into and become a restricted stock unit with respect
to Acquirer Common Stock, and Acquirer shall assume each such Excess Promised
Option RSU, in accordance with the terms of the Company's 2014 Equity
Incentive Plan and/or restricted stock unit agreement by which it is evidenced
(including the vesting schedule and any vesting acceleration for each such
Excess Promised Option RSU, to the extent applicable), except that from and
after the Effective Time: (i) Acquirer and its compensation committee shall be
substituted for the Company and the Board, or such committee of the Board
delegated authorization for, administering such Company Equity Plans, (ii)
each Excess Promised Option RSU assumed by Acquirer pursuant to the terms
herein may be settled solely in shares of Acquirer Common Stock, and (iii) the
number of shares of Acquirer Common Stock subject to each Excess Promised
Option RSU assumed by Acquirer shall be equal to the number of shares of
Company Common Stock subject to each such Excess Promised Option RSU
immediately prior to the Effective Time multiplied by the Exchange Ratio,
rounded down to the nearest whole share. Notwithstanding anything to the
contrary herein, Acquirer will not assume Excess Promised Option RSUs held by
Non-Continuing Employees. All such Excess Promised Option RSUs held by Non-
Continuing Employees, if any, that are outstanding immediately prior to the Effective Time shall be cancelled and extinguished at
the Effective Time without any present or future right to receive any portion
of the Total Consideration.

(b)Treatment of Retention RSUs. Upon the terms and subject to the conditions
set forth herein, at the Effective Time, by virtue of the Merger and without
any action on the part of any party hereto, Retention RSU Holder or any other
Person, each Retention RSU held by a Continuing Employee that is outstanding
immediately prior to the Effective Time shall, on the terms and subject to the
conditions set forth in this Agreement, be converted into and become a
restricted stock unit with respect to Acquirer Common Stock, and Acquirer
shall assume each such Retention RSU, in accordance with the terms of the
Company's 2014 Equity Incentive Plan and/or restricted stock unit agreement by
which it is evidenced (including the vesting schedule and any vesting
acceleration for each such Retention RSU, to the extent applicable), except
that from and after the Effective Time: (i) Acquirer and its compensation
committee shall be substituted for the Company and the Board, or such
committee of the Board delegated authorization for, administering such Company
Equity Plans, (ii) each Retention RSU assumed by Acquirer pursuant to the
terms herein may be settled solely in shares of Acquirer Common Stock, and
(iii) the number of shares of Acquirer Common Stock subject to each Retention
RSU assumed by Acquirer shall be equal to the number of shares of Company
Common Stock subject to each such Retention RSU immediately prior to the
Effective Time multiplied by the Exchange Ratio, rounded down to the nearest
whole share. Notwithstanding anything to the contrary herein, Acquirer will
not assume Retention RSUs held by Non-Continuing Employees. All such Retention
RSUs held by Non-Continuing Employees that are outstanding immediately prior
to the Effective Time shall be cancelled and extinguished at the Effective
Time without any present or future right to receive any consideration. For the
avoidance of doubt, the consideration payable in respect of the Retention RSUs
shall not be deemed a portion of the Total Consideration and shall have no
impact on the calculation of the Per Share Consideration, Per Option
Consideration or Per Warrant Consideration.

(c)Treatment of Company Capital Stock Owned by the Company. At the Effective
Time, all shares of Company Capital Stock that are owned by the Company as
treasury stock immediately prior to the Effective Time shall be cancelled and
extinguished without any conversion thereof or payment of any cash or other
property or consideration therefor and shall cease to exist.

(d)Treatment of Merger Sub Capital Stock. At the Effective Time, by virtue of
the Merger and without any action on the part of Acquirer, Merger Sub or any
other Person, each share of capital stock of Merger Sub that is issued and
outstanding immediately prior to the Effective Time shall be converted into
and become one share of common stock of the Surviving Corporation (and the
shares of the Surviving Corporation into which the shares of Merger Sub
capital stock are so converted shall be the only shares of the Surviving
Corporation's capital stock that are issued and outstanding immediately after
the Effective Time). From and after the Effective Time, each certificate
evidencing ownership of a number of shares of Merger Sub capital stock will
evidence ownership of such number of shares of common stock of the Surviving
Corporation.

(e)Adjustments. In the event of any stock split, reverse stock split, stock
dividend (including any dividend or distribution of securities convertible
into capital stock), reorganization, reclassification, combination,
recapitalization or other like change with respect to the Company Capital
Stock or Acquirer Common Stock occurring after the Agreement Date and prior to
the Effective Time, all references herein to specified numbers of shares of
any class or series affected thereby, and all calculations provided for that
are based upon numbers of shares of any class or series affected thereby,
shall be equitably adjusted to the extent necessary to provide the parties the
same economic effect as contemplated by this Agreement prior to such stock split, reverse stock split,
stock dividend, reorganization, reclassification, combination,
recapitalization or other like change.

(f)Appraisal Rights. Notwithstanding anything to the contrary contained
herein, any Dissenting Shares shall not be converted into the right to receive
the Closing Per Share Consideration and the Future Per Share Consideration but
shall instead be converted into the right to receive such consideration as may
be determined to be due with respect to any such Dissenting Shares pursuant to
the DGCL or the California Corporations Code, as applicable ("CCC"). Each
holder of Dissenting Shares who, pursuant to the DGCL or CCC, to the extent
applicable, becomes entitled to payment thereunder for such shares shall
receive payment therefor in accordance with the DGCL or CCC, to the extent
applicable (but only after the value therefor shall have been agreed upon or
finally determined pursuant to such provisions). If, after the Effective Time,
any Dissenting Shares shall lose their status as Dissenting Shares, then any
such shares shall immediately be deemed to have converted at the Effective
Time into the right to receive the Closing Per Share Consideration and the
Future Per Share Consideration as if such shares never had been Dissenting
Shares, and Acquirer shall cause the Paying Agent to deliver to the holder
thereof, subject to compliance with Section 1.4, the applicable portion of the
Closing Payment as if such shares never had been Dissenting Shares. The
Company or the Stockholders' Agent shall provide to Acquirer (i) prompt notice
of any demands for appraisal or purchase received by the Company or the
Stockholders' Agent, withdrawals of such demands and any other instruments
related to such demands served pursuant to the DGCL or CCC, to the extent
applicable, and received by the Company and (ii) the right to direct all
negotiations and proceedings with respect to such demands under the DGCL or
CCC, to the extent applicable. The Company (prior to the Effective Time) or
the Stockholders' Agent (after the Effective Time), as applicable, shall not,
except with the prior written consent of Acquirer (such consent not to be
unreasonably withheld, conditioned or delayed), or as otherwise required under
the DGCL or CCC, to the extent applicable, voluntarily make any payment or
offer to make any payment with respect to, or settle or offer to settle, any
claim or demand in respect of any Dissenting Shares. Subject to Section 8.2,
the payout of consideration under this Agreement to the Converting Holders
(other than in respect of Dissenting Shares, which shall be treated as
provided in this Section 1.3(f) and under the DGCL or CCC, to the extent
applicable) shall not be affected by the exercise or potential exercise of
appraisal rights or dissenters' rights under the DGCL or CCC, to the extent
applicable, by any other Company Stockholder.

(g)Rights Not Transferable. The rights of the Company Securityholders under
this Agreement as of immediately prior to the Effective Time are personal to
each such Company Securityholder and shall not be transferable for any reason,
other than by operation of law, will or the laws of descent and distribution
without action taken by or on behalf of such Company Securityholder. Any
attempted transfer of such right by any holder thereof (other than as
permitted by the immediately preceding sentence) shall be null and void.

(h)No Interest. Notwithstanding anything to the contrary contained herein,
except as provided in the Escrow Agreement with respect to the cash amounts in
the Escrow Fund, no interest shall accumulate on any cash payable in
connection with the consummation of the Merger or the other Transactions.

1.4Payment Procedures

(a)Closing Payment Fund. As soon as reasonably practicable (and in any event
within one (1) Business Day) after the Effective Time, Acquirer shall cause to
be deposited with Citibank, N.A. or other bank or trust company as Acquirer
and the Company may mutually agree (the "Paying Agent") in accordance with the
paying agent agreement between the Paying Agent and Acquirer, for the benefit of (i) the Company Stockholders, (ii) Company Optionholders holding
Vested Company Options and (iii) holders of outstanding Company Warrants, in
each case as of immediately prior to the Effective Time, cash in an amount
equal to (A) the Closing Payment minus (B) the aggregate Closing Per Option
Consideration payable to holders of Vested Company Options, who are subject to
income or employment Tax withholding by Acquirer or the Company (which will be
paid in accordance with Section 1.4(c)(i)) (the "Closing Payment Fund"). Any
earnings from investment of the Closing Payment Fund accruing pending
disbursement shall be the sole and exclusive property of Acquirer and no part
of such earnings shall accrue to the benefit of any Converting Holders.

(b)Surrender of Certificates.

(i)As soon as reasonably practicable (and in any event within two (2) Business
Days) after the Effective Time, to the extent not previously delivered,
Acquirer shall, or shall cause the Paying Agent to, mail or e-mail a letter of
transmittal in customary form together with instructions for use thereof in
the form attached hereto as Exhibit H (the "Letter of Transmittal") to every
holder of record of Company Capital Stock that was issued and outstanding
immediately prior to the Effective Time (to their addresses set forth opposite
such holder's name on the Spreadsheet). The Letter of Transmittal shall
specify that delivery of the certificates or instruments that immediately
prior to the Effective Time represented issued and outstanding Company Capital
Stock (the "Certificates"), if any, shall be effected, and risk of loss and
title to the Certificates shall pass, only upon receipt thereof by the Paying
Agent (or, in the case of any lost, stolen or destroyed Certificate,
compliance with Section 1.4(b)(iii)), together with a properly completed and
duly executed Letter of Transmittal, duly executed on behalf of each Person
effecting the surrender of such Certificates. Notwithstanding anything to the
contrary contained in this Agreement, any Company Stockholder holding shares
in book-entry form only, as set forth on the Spreadsheet (the "Book-Entry
Shares") shall not be required to deliver a Certificate to the Paying Agent to
receive his, her or its portion of the Closing Payment.

(ii)Upon delivery to the Paying Agent of a properly completed and duly
executed Letter of Transmittal and any other documentation required thereby
(including any required tax forms), together with, in the case of shares of
Company Capital Stock that are not Book-Entry Shares, a Certificate, (A) such
Certificate, if applicable, shall be cancelled and (B) as soon as reasonably
practicable after the date of such delivery, the holder of record of such
Certificate or Book-Entry Shares shall be entitled to receive from the Paying
Agent (by check or wire transfer of same-day funds) such holder's portion of
the Closing Payment (less any applicable Tax withholding).

(iii)If any Certificate shall have been lost, stolen or destroyed, upon the
making of an affidavit of that fact by a Converting Holder claiming such
document to be lost, stolen or destroyed and, if required by the Paying Agent,
the payment of any reasonable fees and the posting by such Converting Holder
of a bond in such reasonable amounts as the Paying Agent may require as
indemnity against any claim that may be made against it with respect to such
document, the Paying Agent will pay in exchange for such lost, stolen or
destroyed document such Converting Holder's portion of the Closing Payment.

(c)Surrender of Company Options.

(i)As soon as reasonably practicable after the Effective Time (and in any
event on or prior to the earlier of 30 days following the Closing and December
31st of the year of the Closing), the Surviving Corporation, at the direction
of Acquirer, shall cause the aggregate Closing Per Option Consideration in respect of Vested Company Options held by Company
Optionholders who are subject to income or employment Tax withholding by
Acquirer or the Company to be paid to such Company Optionholders through the
Surviving Corporation's payroll system and in accordance with standard payroll
practices (including withholding for applicable Taxes).

(ii)As soon as reasonably practicable (and in any event within two (2)
Business Days) after the Effective Time, to the extent not previously
delivered, Acquirer shall, or shall cause the Paying Agent to, mail or e-mail,
to each holder of Vested Company Options as of the Effective Time, who is not
subject to income or employment Tax withholding by Acquirer or the Company and
who is to receive his or her portion of the Closing Payment from the Paying
Agent, a Letter of Transmittal to the address set forth opposite such holder's
name on the Spreadsheet. As soon as reasonably practicable after the date of
delivery to the Paying Agent of a properly completed and duly executed Letter
of Transmittal and any other documentation required thereby (including any
required tax forms), the holder of record of such Vested Company Options shall
be entitled to receive from the Paying Agent (by check or wire transfer of
same-day funds) such holder's portion of the Closing Payment (less any
applicable Tax withholding).

(d)Surrender of Company Warrants. As soon as reasonably practicable after (and
in any event within two (2) Business Days) after the Effective Time, to the
extent not previously delivered, Acquirer shall, or shall cause the Paying
Agent to, to each holder of Company Warrants as of the Effective Time a Letter
of Transmittal to the address set forth opposite such holder's name on the
Spreadsheet. As soon as reasonably practicable after the date of delivery to
the Paying Agent of a properly completed and duly executed Letter of
Transmittal and any other documentation required thereby (including any
required tax forms), the holder of record of such Company Warrants shall be
entitled to receive from the Paying Agent (by check or wire transfer of same-
day funds) such holder's portion of the Closing Payment (less any applicable
Tax withholding).

(e)Escrow Amount. Acquirer shall deposit the Escrow Amount with the Escrow
Agent pursuant to Section 8.1. The Escrow Fund shall constitute partial
security for the benefit of Acquirer (on behalf of itself or any other
Indemnified Person) with respect to any indemnification obligations of the
Converting Holders under Article VIII, and shall be held and distributed in
accordance with Section 8.1. The adoption of this Agreement and the approval
of the Merger by the Company Stockholders shall constitute, among other
things, approval of the deposit of the Escrow Amount and the appointment of
the Stockholders' Agent. The Parties agree that, for Tax reporting purposes,
(1) the Acquirer shall be treated as the owner of the Escrow Fund, and all
interest and other income earned on the Escrow Fund shall be reported as
having been earned by Acquirer, whether or not such income was disbursed
during such calendar year until the distribution of the Escrow Amount (or
portions thereof) is determined, and (2) (a) the Escrow Amount (other than the
portion deposited with respect to holders of Vested Company Options) shall
qualify for installment sale reporting under Section 453 of the Code and (b)
the portion of the Escrow Amount deposited with respect to holders of Vested
Company Options shall not be compensation or wages, or subject to withholding
as such, unless and until such amount (or any part thereof) is paid to the
former holders of such Vested Company Options, and no party hereto shall take
any action or filing position inconsistent with such characterizations. At the
end of September 2020 and each calendar quarter thereafter, and immediately
before the final distribution of the Escrow Fund, the Escrow Agent shall
promptly transfer to Acquirer by wire transfer of immediately available funds
an amount equal to the product of 21% multiplied by the amount of accrued
interest or income earned on the Escrow Fund since the last payment date under
this Section 1.4(e). (f)Expense Fund. Notwithstanding anything to the contrary in the other
provisions of this Article I, Acquirer shall deposit (or cause to be
deposited) the amount of the Expense Fund with the Stockholders' Agent
pursuant to Section 8.7(d). The adoption of this Agreement and the approval of
the Merger by the Company Stockholders shall constitute, among other things,
approval of the deposit of the Expense Fund by the Converting Holders. The
parties agree that, for Tax reporting purposes, the Converting Holders shall
be treated as the owner of the Expense Fund and the Expense Fund shall not
earn any interest or other income.

(g)Transfers of Ownership. If any cash amount payable pursuant to Section
1.3(a) is to be paid to a Person other than the Person to which the
Certificate, Book-Entry Shares, Company Option or Company Warrant surrendered
in exchange therefor is registered, it shall be a condition of the payment
thereof that such Certificate, Book-Entry Shares, Company Option or Company
Warrant shall be properly endorsed and otherwise in proper form for transfer
and that the Person requesting such exchange shall have paid to Acquirer or
any agent designated by Acquirer any transfer or other Taxes required by
reason of the payment of cash in any name other than that of the registered
holder of such Certificate, Book-Entry Shares, Company Option or Company
Warrant, or established to the satisfaction of Acquirer or any agent
designated by Acquirer that such Tax has been paid or is not payable.

(h)Distribution of Future Payments. After the Closing, if and only if an
amount is released from the Escrow Fund or the Expense Fund pursuant to
Article VIII, in each case, to the Converting Holders, then Acquirer, the
Escrow Agent or the Stockholders' Agent, as applicable, shall deposit with the
Paying Agent such released amount in accordance with the paying agent
agreement, for payment through the Paying Agent for further distribution to
the Converting Holders (or, in the case of former Company Optionholders
holding Vested Company Options who are subject to income or employment Tax
withholding by Acquirer or the Surviving Corporation, through Acquirer's or
the Surviving Corporation's payroll system) in accordance with each Converting
Holder's Pro Rata Share. Any earnings from investment of such released amounts
accruing pending disbursement shall be the sole and exclusive property of
Acquirer and no part of such earnings shall accrue to the benefit of the
Converting Holders.

(i)Unclaimed Consideration. Each holder of a Certificate, Book-Entry Shares or
document or instrument representing a Company Option or Company Warrant who
has not theretofore complied with the exchange procedures set forth in and
contemplated by this Section 1.4 shall look only to Acquirer (subject to
abandoned property, escheat and similar Applicable Law) for such holder's
claim, only as a general unsecured creditor of Acquirer, to any portion of the
Total Consideration payable pursuant to Section 1.3(a) in respect of such
Certificate, Book-Entry Shares or document or instrument representing a
Company Option or Company Warrant. Notwithstanding anything to the contrary
contained herein, if any Certificate has not been surrendered or Letter of
Transmittal has not been delivered in accordance with the terms of this
Section 1.4 prior to the earlier of (1) the first anniversary of the Effective
Time and (2) such date on which the applicable portion of the Closing Payment
payable pursuant to Section 1.3(a) in respect of such Certificate, Book-Entry
Shares or document or instrument representing a Company Option or Company
Warrant would otherwise escheat to, or become the property of, any
Governmental Entity, any amounts payable in respect of such Certificate, Book-
Entry Shares or document or instrument representing a Company Option or
Company Warrant shall, to the extent permitted by Applicable Law, become the
property of Acquirer, free and clear of all claims or interests of any Person
previously entitled thereto. (j)No Liability. Notwithstanding anything to the contrary in this Section 1.4,
no party hereto shall be liable to any Person for any amount properly paid to
a public official pursuant to any applicable abandoned property, escheat or
similar Applicable Law.

1.5No Further Ownership Rights in the Company Capital Stock, Company Options,
Company Warrants, Company RSUs or Retention RSUs

(a)The Closing Per Share Consideration and the Future Per Share Consideration,
the Closing Per Option Consideration and the Future Per Option Consideration
and the Closing Per Warrant Consideration and the Future Per Warrant
Consideration, as the case may be, paid or payable following the surrender for
exchange of the Certificates, Book-Entry Shares, Vested Company Options,
Company RSUs (other than Excess Promised Option RSUs) and Company Warrants in
accordance with this Agreement shall be paid or payable in full satisfaction
of all rights pertaining to the shares of Company Capital Stock represented by
such Certificates or Book-Entry Shares or issuable pursuant to such Vested
Company Options, Company RSUs (other than Excess Promised Option RSUs) or
Company Warrants, as applicable, and there shall be no further registration of
transfers on the records of the Surviving Corporation of shares of Company
Capital Stock, Vested Company Options, Company RSUs (other than Excess
Promised Option RSUs) or Company Warrants that were issued and outstanding
immediately prior to the Effective Time. If, after the Effective Time, any
Certificate, Book-Entry Shares or document or instrument representing a Vested
Company Option, a Company RSU (other than Excess Promised Option RSUs) or a
Company Warrant is presented to the Surviving Corporation for any reason, such
Certificate, Book-Entry Shares, document or instrument (and the underlying
shares of Company Common Stock, Vested Company Options, Company RSUs (other
than Excess Promised Option RSUs) and Company Warrants) shall be cancelled and
exchanged as provided in this Article I.

(b)The conversion into stock options with respect to Acquirer Common Stock
pursuant to Section 1.3(a)(ii)(B) shall be in full satisfaction of all rights
pertaining to the shares of Company Capital Stock issuable pursuant to
Unvested Company Options, and the conversion into restricted stock units with
respect to Acquirer Common Stock pursuant to Sections 1.3(a)(iv)(B) and 1.3(b)
shall be in full satisfaction of all rights pertaining to the shares of
Company Capital Stock issuable pursuant to Retention RSUs and Excess Promised
Option RSUs, if any, respectively, and there shall be no further registration
of transfers on the records of the Surviving Corporation of any Unvested
Company Option, Excess Promised Option RSU or Retention RSU that was issued
and outstanding immediately prior to the Effective Time. If, after the
Effective Time, any document or instrument representing an Unvested Company
Option, Excess Promised Option RSU or Retention RSU is presented to the
Surviving Corporation for any reason, such document or instrument (and the
underlying Unvested Company Option, Excess Promised Option RSUs or Retention
RSUs) shall be cancelled and converted as provided in Section 1.3(b).

1.6Holdback Consideration. The Acquirer, the Company and the Holdback
Participant hereby agree to the terms set forth on Schedule 1.6.

1.7Tax Consequences. Neither Acquirer nor Merger Sub makes any representations
or warranties to the Company or to any Company Securityholder regarding the
Tax treatment of the Merger, or any of the Tax consequences to the Company or
any Company Securityholder of this Agreement, the Merger or the other
Transactions or the other agreements contemplated by this Agreement. The
Company acknowledges that the Company and the Company Securityholders are
relying solely on their own Tax advisors in connection with this Agreement,
the Merger and the other Transactions and the other agreements contemplated by
this Agreement. 1.8Certain Taxes. All transfer, documentary, sales, use, stamp, registration
and other Taxes and fees (including any penalties and interest) incurred in
connection with this Agreement shall be paid by the applicable Company
Securityholder when due, and such Company Securityholder shall, at its own
expense, file all necessary Tax Returns and other documentation with respect
to all such transfer, documentary, sales, use, stamp, registration and other
Taxes and fees.

1.9Withholding Rights. Each of Acquirer, the Surviving Corporation and the
Paying Agent shall be entitled to deduct and withhold from any payments of
cash pursuant to this Agreement to any Continuing Employee or any holder of
any shares of Company Capital Stock, Company Options or Company Warrants such
amounts in cash as Acquirer, the Surviving Corporation or the Paying Agent is
required to deduct and withhold with respect to any such payments under the
Code or any provision of state, local, provincial or foreign Tax law. To the
extent that amounts are so deducted or withheld, such deducted and withheld
amounts shall be (i) remitted promptly to the appropriate Tax Authority, and
(ii) treated for all purposes of this Agreement as having been paid to such
Persons in respect of which such deduction and withholding was made, and
Acquirer shall provide proof of such deducted and withheld amounts to such
Persons.

1.10Taking of Necessary Action; Further Action. If, at any time after the
Closing, any further action is necessary or desirable to carry out the
purposes of this Agreement and to vest the Surviving Corporation with full
right, title and interest in, to and under, and possession of, all assets,
property, rights, privileges, powers and franchises of the Company, the
officers and directors of the Surviving Corporation are fully authorized, in
the name and on behalf of the Company or otherwise, to take all lawful action
necessary or desirable to accomplish such purpose or acts, so long as such
action is not inconsistent with this Agreement.

ARTICLE II.

Representations and Warranties of the Company

Subject to the disclosures set forth in the disclosure letter of the Company
delivered to Acquirer concurrently with the execution of this Agreement (the
"Company Disclosure Letter") (each of which disclosures, in order to be
effective, shall clearly indicate the Section and, if applicable, the
Subsection of this Article II to which it relates (unless and only to the
extent the relevance to other representations and warranties is reasonably
apparent from the actual text of the disclosures without any reference to
extrinsic documentation or any independent knowledge on the part of the reader
regarding the matter disclosed), the Company represents and warrants to
Acquirer as follows:

2.1Organization, Standing, Power and Subsidiaries.

(a)The Company is a corporation duly organized, validly existing and in good
standing under the laws of the state of Delaware. Each Subsidiary is duly
organized, validly existing and, where applicable, in good standing under the
laws of its jurisdiction of organization. The Company and each Subsidiary has
the corporate or similar power to own, operate, use, distribute and lease its
properties and to conduct the Business. The Company and each Subsidiary is
duly licensed or qualified to do business and, to the extent applicable, is in
good standing in each jurisdiction where the character or location of its
assets or properties (whether owned, leased or licensed) or the nature of its
activities makes such qualification or licensing necessary to the Business of
the Company or its applicable Subsidiary, except where the failure to be so
qualified or licensed or in good standing, individually or in the aggregate
with any other such failures, would not reasonably be expected to result in a
Material Adverse Effect with respect to the Company. Schedule 2.1(a) of the Company Disclosure Letter sets
forth a true, correct and complete list of each Subsidiary. The Company is the
owner of all of the issued and outstanding shares of capital stock of each
Subsidiary, free and clear of all Encumbrances (other than restrictions
pursuant to applicable securities laws), and all such shares are duly
authorized, validly issued, fully paid and non-assessable and are not subject
to any preemptive right or right of first refusal created by statute, the
certificate of incorporation and bylaws or other equivalent organizational or
governing documents, as applicable, of such Subsidiary or any Contract to
which such Subsidiary is a party or by which it is bound. There are no
outstanding subscriptions, options, warrants, "put" or "call" rights,
exchangeable or convertible securities or other Contracts of any character
relating to the issued or unissued capital stock or other securities of any
Subsidiary, or otherwise obligating the Company or any Subsidiary to issue,
transfer, sell, purchase, redeem or otherwise acquire or sell any such
securities. The Company does not directly or indirectly own any equity or
similar interest in, or any interest convertible or exchangeable or
exercisable for, any equity or similar interest in, any Person, other than the
Subsidiaries listed in Schedule 2.1(a) of the Company Disclosure Letter.

(b)Schedule 2.1(b) of the Company Disclosure Letter sets forth, as of the
Agreement Date, a true, correct and complete list of: (i) the names of the
members of the Board (or similar body), (ii) the names of the members of each
committee of the Board (or similar body) and (iii) the names and titles of the
officers of the Company.

2.2Capital Structure.

(a)The authorized Company Capital Stock consists solely of (i) 127,763,000
shares of Company Common Stock and (ii) 65,734,205 shares of Company Preferred
Stock, (A) 17,304,000 of which are designated as Company Series A Stock, (B)
7,081,058 of which are designated as Company Series B Stock, (C) 9,274,536 of
which are designated as Company Series C Stock, (D) 5,588,313 of which are
designated as Company Series D Stock and (E) 26,486,298 of which are
designated as Company Series F Stock. A total of 19,494,388 shares of Company
Common Stock and 17,023,562 shares of Company Series A Stock, 6,749,074 shares
of Company Series B Stock, 7,986,317 shares of Company Series C Stock,
5,277,229 shares of Company Series D Stock and 25,989,431 shares of Company
Series F Stock are issued and outstanding as of the Agreement Date, and there
are no other issued and outstanding shares of Company Capital Stock and no
commitments or Contracts to issue any shares of Company Capital Stock other
than pursuant to the exercise of Company Options under the Company Equity
Plans that are outstanding as of the Agreement Date, the settlement of Company
RSUs under the Company Equity Plans that are outstanding as of the Agreement
Date, the exercise of Company Warrants that are outstanding as of the
Agreement Date or the settlement of Retention RSUs and Excess Promised Option
RSUs (if any), when issued, under the Company Equity Plans. The Company holds
no treasury shares. Schedule 2.2(a) of the Company Disclosure Letter sets
forth, as of the Agreement Date, (i) a true, correct and complete list of the
Company Stockholders and the number and type of such shares so owned by such
Company Stockholder and (ii) the number of shares of Company Common Stock that
would be owned by such Company Stockholder assuming conversion of all shares
of convertible Company Preferred Stock so owned by such Person after giving
effect to all anti-dilution and similar adjustments. All issued and
outstanding shares of Company Capital Stock are duly authorized, validly
issued, fully paid and non-assessable and are free of any outstanding
subscriptions, preemptive rights or "put" or "call" rights created by statute,
the Certificate of Incorporation, the Bylaws or any Contract to which the
Company is a party or by which the Company is bound. The Company has conducted
all repurchases (including by way of a tender offer) and redemptions of shares
of the Company Capital Stock in compliance with all Applicable Laws, including
applicable federal and state securities laws. None of the Company's issued and
outstanding shares of Company Capital Stock is subject to a vesting schedule
and/or repurchase rights. The Company has never declared or paid any dividends
on any shares of Company Capital Stock. There is no liability for dividends accrued and unpaid
by the Company. The Company is not under any obligation to register under the
Securities Act or any other Applicable Law any shares of Company Capital
Stock, any Equity Interests or any other securities of the Company, whether
currently outstanding or that may subsequently be issued. . Each share of
Company Preferred Stock is convertible into a share of Company Common Stock on
a one-for-one basis. All issued and outstanding shares of Company Capital
Stock, Company Options, Company RSUs and Company Warrants were issued in
compliance with Applicable Law and all requirements set forth in the
Certificate of Incorporation, the Bylaws and any applicable Contracts to which
the Company is a party or by which the Company or any of its assets is bound.

(b)As of the Agreement Date, the Company has reserved 57,627,105 shares of
Company Common Stock for issuance to employees, non-employee directors and
consultants pursuant to the Company Equity Plans, of which 35,196,774 shares
are subject to outstanding and unexercised Company Options, 314,000 are
subject to outstanding Company RSUs, and 3,187,576 shares remain available for
issuance thereunder. Schedule 2.2(b) of the Company Disclosure Letter sets
forth, as of the Agreement Date, a true, correct and complete list of (i) all
Company Optionholders, and each Company Option, whether or not granted under
the Company Equity Plans, including the number of shares of Company Capital
Stock subject to each Company Option, the number of such shares that are
vested or unvested, the "date of grant" of such Company Option (as defined
under Treasury Regulation 1.409A-1(b)(5)(vi)(B)), the vesting commencement
date, the vesting schedule (and the terms of any acceleration thereof), the
exercise price per share, the Tax status of such Company Option under Section
422 of the Code (or any applicable foreign Tax law providing favorable tax
treatment), the term of each Company Option, the Company Equity Plan from
which such Company Option was granted (if any) and the country and, if
applicable, state of residence of such Company Optionholder as and to the
extent reflected in the Company's books and records as of the Agreement Date,
and (ii) all Company RSU Holders, and each Company RSU, whether or not granted
under the Company Equity Plans, including the number of shares of Company
Capital Stock subject to each Company RSU, the number of such shares that are
vested or unvested, the date of grant of such Company RSU, the vesting
commencement date, the vesting schedule, including any performance conditions
(and the terms of any acceleration thereof), the Company Equity Plan from
which such Company RSU was granted (if any) and the country and state of
residence of such Company RSU Holder as and to the extent reflected in the
Company's books and records as of the Agreement Date. All Company Options
listed on Schedule 2.2(b) of the Company Disclosure Letter that are denoted as
incentive stock options under Section 422 of the Code so qualify. In addition,
Schedule 2.2(b) of the Company Disclosure Letter indicates, as of the
Agreement Date, which Company Optionholders and Company RSU Holders are
Persons that are not employees of the Company or any Subsidiary (including
non-employee directors, consultants, advisory board members, vendors, service
providers or other similar Persons), including a description of the
relationship between each such Person and the Company or applicable
Subsidiary. True, correct and complete copies of each Company Equity Plan, all
sub-plans relating to such Company Equity Plan, template forms and agreements
adopted under the Company Equity Plans, and executed copies of all Contracts
relating to any equity awards that (x) have not fully vested as of the
Agreement Date and provide for potential accelerated vesting in connection
with the Transactions, (y) were issued to Key Employees of the Company, or (z)
otherwise materially deviate from the terms of the template forms and
agreements adopted under the Company Equity Plans, in each case have been made
available to Acquirer, and such Company Equity Plans and Contracts have not
been amended, modified or supplemented since being made available to Acquirer
(other than and to the extent amended, modified or supplemented in accordance
with the terms of Section 4.2). The terms of the Company Equity Plans permit
the treatment of Company Options and Company RSUs as provided herein, without
notice to, or the consent or approval of, the Company Optionholders, the
Company RSU Holders, the Company Stockholders or otherwise and without any
acceleration of the exercise or settlement schedule or vesting provisions in effect for such
Company Options or Company RSUs. As of the Agreement Date there are no, and as
of immediately prior to the Closing there will be no, Company Options that
have an exercise price equal to or greater than the Per Share Consideration.

(c)Schedule 2.2(c) of the Company Disclosure Letter sets forth, as of the
Agreement Date, a true, correct and complete list of all Company
Warrantholders, including the number of shares and type of Company Capital
Stock subject to each Company Warrant, the date of grant, the exercise or
vesting schedule (and the terms of right to any acceleration thereof), the
exercise price per share and the term of each Company Warrant. True, correct
and complete copies of each Company Warrant have been made available to
Acquirer, and such Company Warrants have not been amended or supplemented
since being made available to Acquirer, and there are no Contracts providing
for the amendment or supplement of such Company Warrants. The terms of the
Company Warrants permit the treatment of Company Warrants as provided herein,
without notice to, or the consent or approval of, the Company Warrantholders,
the Company Stockholders or otherwise and without any acceleration of the
exercise schedule or vesting provisions in effect for such Company Warrants.

(d)As of the Agreement Date, there are no authorized, issued or outstanding
Equity Interests of the Company other than shares of Company Capital Stock,
Company Options, Company Warrants and Company RSUs. Other than as set forth on
Schedules 2.2(a), 2.2(b), 2.2(c) or 2.2(e) of the Company Disclosure Letter or
pursuant to Section 5.9(f), as of the Agreement Date, no Person has any Equity
Interests of the Company (including Company Options and Company RSUs), stock
appreciation rights, stock units, share schemes, calls or rights, or is party
to any Contract to which the Company is a party or by which it or its assets
is bound, (i) obligating the Company to issue, deliver, sell, repurchase or
redeem, or cause to be issued, delivered, sold, repurchased or redeemed, any
Equity Interests of the Company or other rights to purchase or otherwise
acquire any Equity Interests of the Company, whether vested or unvested, or
(ii) obligating the Company to grant, extend, accelerate the vesting or
repurchase rights of, change the price of, or otherwise amend or enter into
any such Company Option, Company Warrant, Company RSU, call, right or
Contract.

(e)No Company Debt (i) granting its holder the right to vote on any matters on
which any Company Securityholder may vote (or that is convertible into, or
exchangeable for, securities having such right) or (ii) the value of which is
in any way based upon or derived from capital or voting stock of the Company,
is issued or outstanding as of the Agreement Date (collectively, the "Company
Voting Debt").

(f)There are no Contracts relating to the voting, purchase, sale or transfer
of any Company Capital Stock (i) between the Company and any one or more
Company Securityholders, in each case that are currently in effect or provide
for any current or future obligations on the part of any party thereto, other
than written Contracts granting the Company the right to purchase unvested
shares upon termination of employment or service, and (ii) to the knowledge of
the Company, between or among any of the Company Securityholders. Other than
as set forth on Schedule 2.2(f) of the Company Disclosure Letter and the
Certificate of Incorporation, there are no Contracts between or among the
Company and any Company Securityholder providing any Company Securityholder
with any rights of first refusal, rights to any liquidation preference,
redemption rights, conversion rights or right of notice of any of the
Transactions. Neither the Company Equity Plans nor any Contract to which the
Company or any Subsidiary is a party to or by which the Company or any
Subsidiary or any of their respective assets is bound relating to any Company
Options, Company RSUs or Retention RSUs requires or otherwise provides for any
accelerated vesting of any Company Options, Company RSUs or Retention RSUs or
the acceleration of any other benefits thereunder, in each case in connection
with the Transactions or upon termination of employment or service with the Company or any Subsidiary, or
any other event, whether before, upon or following the Effective Time or
otherwise.

(g)As of the Closing, other than any Retention RSUs, (i) the number of shares
of Company Capital Stock set forth in the Spreadsheet as being owned by a
Person, or subject to Company Options, Company RSUs or Company Warrants owned
by such Person, will constitute the entire interest of such Person in the
issued and outstanding Company Capital Stock or any other Equity Interests of
the Company and (ii) no Person not disclosed in the Spreadsheet will have a
right to acquire from the Company any shares of Company Capital Stock, Company
Options, Company RSUs, Company Warrants or any other Equity Interests of the
Company.

(h)Schedule 2.2(h) of the Company Disclosure Letter identifies each employee
of the Company or any Subsidiary or other Person with an offer letter or other
Contract or Company Employee Plan that contemplates a grant of, or right to
purchase or receive: (i) options to purchase shares of Company Common Stock or
other equity awards with respect to Company Capital Stock or (ii) other
securities of the Company, that in each case, have not been issued or granted
as of the Agreement Date, together with the number of such options, other
equity awards or other securities and any promised terms thereof.

2.3Authority; Non-contravention.

(a)The Company has all requisite corporate power and authority to enter into
and deliver this Agreement and the other Company Transaction Documents and,
subject to obtaining the Company Stockholder Approval set forth in the Written
Consent, to consummate the Merger and the other Transactions. The execution,
delivery and performance of this Agreement and the other Company Transaction
Documents and the consummation of the Transactions have been duly authorized
by all necessary corporate action on the part of the Company (other than, in
the case of the consummation of the Merger, obtaining the Company Stockholder
Approval set forth in the Written Consent and the filing and recordation of
appropriate documents as required by the DGCL). This Agreement and each
Company Transaction Document has been, or if applicable, as of the Closing
will be, duly executed and delivered by the Company and, assuming the due
authorization, execution and delivery of such Transaction Document by the
other parties thereto, constitutes the valid and binding obligation of the
Company enforceable against the Company in accordance with its terms subject
only to the effect, if any, of (i) applicable bankruptcy and other similar
Applicable Law affecting the rights of creditors generally and (ii) rules of
law governing specific performance, injunctive relief and other equitable
remedies. The Board, by resolutions duly adopted (and not thereafter modified
or rescinded) by the unanimous vote of the Board, has (i) declared that this
Agreement and the Transactions, including the Merger, upon the terms and
subject to the conditions set forth herein, advisable, fair to and in the best
interests of the Company and the Company Stockholders, (ii) approved this
Agreement and the Transactions in accordance with Applicable Law and (iii)
directed that the adoption of this Agreement and approval of the Merger be
submitted to the Company Stockholders for consideration and recommended that
all of the Company Stockholders adopt this Agreement and approve the Merger.
The affirmative votes of (1) the holders of at least a majority of the
outstanding shares of Company Common Stock and Company Preferred Stock (voting
together as a single voting class on an as-converted to Company Common Stock
basis), (2) the holders of at least a majority of the outstanding shares of
the Company Preferred Stock (voting together as a single class and not as
separate series, on an as-converted to Company Common Stock basis) and (3) the
holders of at least a majority of the outstanding shares of the Company Common
Stock (voting together as a single class) are the only votes of the holders of
Company Capital Stock necessary to adopt this Agreement and approve the Merger
under Applicable Law, the Certificate of Incorporation and the Bylaws, each as in effect at the time of such adoption and approval
(collectively, the "Company Stockholder Approval"). The Written Consent, when
executed and delivered, will satisfy the Company Stockholder Approval. Prior
to their execution of the Written Consent, each signatory thereto shall have
received from the Company all information required by Applicable Law.

(b)The execution and delivery of this Agreement and the other Company
Transaction Documents by the Company does not, and the consummation of the
Transactions will not, (i) result in the creation of any Encumbrance on any of
the material assets of the Company or any Subsidiary or any of the shares of
Company Capital Stock or (ii) conflict with, or result in any violation of or
default under (with or without notice or lapse of time, or both), or give rise
to a right of termination, cancellation or acceleration of any obligation or
loss of any benefit under, or require any consent, approval or waiver from any
Person pursuant to, (A) any provision of the certificate of incorporation or
bylaws or other equivalent organizational or governing documents of the
Company or any Subsidiary, in each case as amended to date, (B) any Material
Contract or (C) assuming the making of all required registrations,
declarations, notices, or filings as described in Section 2.3(d) and the
receipt of all required consents, approvals, Orders, authorizations, or
waiting period expirations or terminations as described in Section 2.3(c), any
Applicable Law.

(c)No consent, approval, Order or authorization of, waiting period expiration
or termination, or registration, declaration or filing with, or notice to, any
Governmental Entity, employee representative body, including any works
council, union or employee delegate, or any other Person is required by or
with respect to the Company or any Subsidiary in connection with the execution
and delivery of this Agreement or any other Company Transaction Document or
the consummation of the Transactions, except for (i) the filing of the
Certificate of Merger, as provided in Section 1.1(d), (ii) such filings and
notifications as may be required to be made by the Company in connection with
the Merger and the other Transactions under the HSR Act and other applicable
Antitrust Laws and the authorizations, approvals, consents, or expiration or
early termination of the applicable waiting periods under the HSR Act and
other applicable Antitrust Laws and (iii) such other consents, approvals,
Orders, authorizations, registrations, declarations, filings and notices that,
if not obtained or made, would not materially and adversely affect, and would
not reasonably be expected to materially and adversely affect, the Company's
ability to perform or comply with the covenants, agreements or obligations of
the Company herein or in any other Company Transaction Document or to
consummate the Transactions in accordance with this Agreement or any other
Company Transaction Document, or Applicable Law.

(d)The Company, the Board and the Company Stockholders have taken all actions
such that the restrictive provisions of any "fair price," "moratorium,"
"control share acquisition," "business combination," "interested shareholder"
or other similar anti-takeover statute or regulation, and any anti-takeover
provision in the organizational or governing documents of the Company or the
Subsidiaries will not be applicable to any of Acquirer, the Company, the
Surviving Corporation or the Subsidiaries, or to the execution, delivery, or
performance of this Agreement, the Transaction Documents or any of the
Transactions.

2.4Financial Statements; No Undisclosed Liabilities.

(a)The Company has delivered to Acquirer its audited financial statements for
the fiscal years ending July 31, 2017, July 31, 2018 and July 31, 2019
(including, in each case, balance sheets, statements of operations and
statements of cash flows) and its unaudited financial statements for the
9-month period ended April 30, 2020 (including, in each case, balance sheets
and statements of operations) (collectively, the "Financial Statements"),
which are included as Schedule 2.4(a) of the Company Disclosure Letter. The Financial Statements and, as of the Closing,
the Audited Interim Financials: (i) are derived from and in accordance with
the books and records (including the general ledger) of the Company, (ii)
complied as to form with applicable accounting requirements with respect
thereto as of their respective dates, (iii) fairly and accurately present the
financial condition of the Company and the Subsidiaries at the dates therein
indicated and the consolidated results of operations and cash flows of the
Company for the periods therein specified (subject, in the case of unaudited
interim period financial statements, to normal recurring year-end audit
adjustments, none of which individually or in the aggregate are or will be
material in amount), (iv) are true, correct and complete in all material
respects and (v) were prepared in accordance with the Company Accounting
Principles, except for the absence of footnotes in the unaudited Financial
Statements, applied on a consistent basis throughout the periods involved.

(b)Neither the Company nor any Subsidiary has any Liabilities of any nature
other than (i) those set forth or adequately provided for in the balance sheet
included in the Financial Statements as of April 30, 2020 (such date, the
"Company Balance Sheet Date" and such balance sheet, the "Company Balance
Sheet"), (ii) those incurred in the conduct of the Company's business since
the Company Balance Sheet Date in the ordinary course consistent with past
practice that are of the type that ordinarily occur and do not result from any
breach of Contract, warranty, infringement, tort or violation of Applicable
Law, (iii) executory obligations under Contracts to which the Company is a
party and occurring in the ordinary course consistent with past practice that
are of the type that ordinarily occur and do not result from any breach of
Contract, warranty, infringement, tort or violation of Applicable Law, (iv)
Transaction Expenses or other Liabilities that are expressly contemplated by,
or incurred by the Company in connection with the execution and performance
of, this Agreement and the terms and conditions contained herein and (v)
Liabilities that do not exceed $3,500,000 in the aggregate. Except for
Liabilities reflected in the Financial Statements, the Company has no
Liability of any nature to, or any financial interest in, any third parties or
entities, the purpose or effect of which is to defer, postpone, reduce or
otherwise avoid or adjust the recording of expenses incurred by the Company.

(c)All reserves that are set forth in or reflected in the Company Balance
Sheet have been established in accordance with the Company Accounting
Principles and are adequate. At the Company Balance Sheet Date, there were no
material loss contingencies (as such term is used in the FASB Accounting
Standards Codification ("ASC") Topic 450) that are not adequately provided for
in the Company Balance Sheet as required by FASB ASC Topic 450. The Company's
revenue recognition methodologies reflected in the Financial Statements comply
with GAAP.

(d)Schedule 2.4(d) of the Company Disclosure Letter sets forth, as of the
Agreement Date, a true, correct and complete list of all Company Debt,
including, for each item of Company Debt, the agreement governing the Company
Debt and the interest rate, maturity date, any assets securing such Company
Debt and any prepayment or other penalties payable in connection with the
repayment of such Company Debt at the Closing. Without limiting the generality
of the foregoing, the Company has never guaranteed any debt or other
obligation of any other Person.

(e)Schedule 2.4(e) of the Company Disclosure Letter sets forth the names and
locations of all banks and other financial institutions at which the Company
and the Subsidiaries maintain accounts and the names of all Persons authorized
to make withdrawals therefrom.

(f)The accounts receivable of the Company (the "Accounts Receivable") as
reflected on the Company Balance Sheet arose in the ordinary course of
business consistent with past practice and represent bona fide claims against
debtors for sales and other charges. Allowances for doubtful accounts and warranty returns have been prepared in accordance with
the Company Accounting Principles. The Accounts Receivable arising after the
Company Balance Sheet Date and before the Closing Date (i) arose or shall
arise in the ordinary course of business consistent with past practice and
(ii) represented or shall represent bona fide claims against debtors for sales
and other charges. As of the Agreement Date, the Company has not received any
written notice from any debtor that such debtor does not intend to pay any
Accounts Receivable. As of the Agreement Date, none of the Accounts Receivable
is subject to any claim of offset, recoupment, set-off or counterclaim. No
material amount of Accounts Receivable is contingent upon the performance by
the Company of any obligation or Contract other than normal service, warranty
repair and replacement. No Person has any Encumbrance on any Accounts
Receivable, and no agreement for deduction or discount has been made with
respect to any such Accounts Receivable. Schedule 2.4(e) of the Company
Disclosure Letter sets forth, as of July 6, 2020, an aging of the Accounts
Receivable in the aggregate and by customer, and indicates the amounts of
allowances for doubtful accounts and warranty returns. Schedule 2.4(e) of the
Company Disclosure Letter sets forth, as of July 6, 2020, such amounts of
Accounts Receivable that are subject to asserted warranty claims by customers
and reasonably detailed information regarding asserted warranty claims made
within the 12 months preceding such date, including the type and amounts of
such claims.

(g)The Company has established and maintains a system of internal accounting
controls, comparable to similarly situated private companies, designed to
provide reasonable assurances (i) that transactions, receipts and expenditures
of the Company and the Subsidiaries are being executed and made only in
accordance with appropriate authorizations of management or the Board, as
applicable, (ii) that transactions are recorded as necessary (A) to permit
preparation of financial statements in conformity with the Company Accounting
Principles and (B) to maintain accountability for assets, (iii) regarding
prevention or timely detection of unauthorized acquisition, use or disposition
of the assets of Company and the Subsidiaries and (iv) that the amount
recorded for assets on the books and records of the Company is compared with
the existing assets at reasonable intervals and appropriate action is taken
with respect to any differences. None of the Company, the Subsidiaries, the
Board, the Company\'s independent auditors or any officer of the Company, and,
to the actual knowledge (without any duty of inquiry) of the Company, any
other Representative of the Company or any Subsidiary, has identified or been
made aware of any fraud, whether or not material, that involves the Company\'s
management or other current or former employees, consultants or directors of
the Company or any Subsidiary who have a role in the preparation of financial
statements or the internal accounting controls utilized by the Company or the
Subsidiaries, or any claim or allegation regarding any of the foregoing. None
of the Company, the Subsidiaries, the Board or any officer of the Company,
and, to the actual knowledge (without any duty of inquiry) of the Company, any
other Representative of the Company or any Subsidiary has received or
otherwise had or obtained knowledge of any material written or, to the
knowledge of the Company, oral complaint, allegation, assertion or claim, in
each case, regarding deficient accounting or auditing practices, procedure,
methodologies or methods of the Company or any Subsidiary or its internal
accounting controls or any material inaccuracy in the Company\'s financial
statements. To the knowledge of the Company, no attorney representing the
Company or any Subsidiary has reported in writing to the Board or any
committee thereof or to any director or officer of the Company evidence of a
material violation of securities laws, breach of fiduciary duty or similar
violation by the Company, the Subsidiaries or any of their respective
Representatives. To the knowledge of the Company, there are no significant
deficiencies or material weaknesses in the design or operation of the
Company\'s internal controls that would reasonably be expected to materially
and adversely affect the Company\'s ability to record, process, summarize and
report financial data. There has been no material change in the Company
accounting policies between January 1, 2017 and the Agreement Date, except as
described in the Financial Statements. 2.5Absence of Changes. Since the Company Balance Sheet Date, (a) through the
Agreement Date, the Company and each Subsidiary has conducted the Business in
the ordinary course of business consistent with past practice, except for
changes required by Applicable Law, (b) there has not occurred any Material
Adverse Effect and (c) through the Agreement Date, neither the Company nor any
Subsidiary has done, caused or permitted any action that would constitute a
breach of clauses (a)-(c), (f), (g), (j)-(z) or (aa) (to the extent applicable
to such foregoing clauses) of Section 4.2, other than, in the case of clauses
(f), (p) and (q), actions in the ordinary course of business consistent with
past practice, if such action were taken by the Company or any Subsidiary,
without the written consent of Acquirer, between the Agreement Date and the
earlier of the termination of this Agreement and the Effective Time.

2.6Litigation; DandO Indemnification Claims.

(a)There is no Legal Proceeding to which the Company is a party pending before
any Governmental Entity, or, to the knowledge of the Company, threatened in
writing against the Company or any Subsidiary of any of their respective
assets or any of their respective directors, officers or employees (in their
capacities as such or relating to their employment, services or relationship
with the Company or any Subsidiary), and, to the actual knowledge (without any
duty of inquiry) of the Company, there is not any reasonable basis for any
such Legal Proceeding. There is no Order against the Company or any
Subsidiary, any of their assets, or, to the knowledge of the Company, any of
their directors, officers or employees (in their capacities as such or
relating to their employment or termination of employment, services or
relationship with the Company or any Subsidiary). There is no claim against
the Company or any Subsidiary, or any of their respective officers or
directors (in their capacities as such) based upon: (i) the Company entering
into this Agreement, any Company Transaction Document or consummating any of
the Transactions, including a claim that such employee, director or officer
breached a fiduciary duty in connection therewith, or (ii) any claim that the
Company has agreed to sell or dispose of any of its material assets to any
party other than Acquirer, whether by way of merger, consolidation, sale of
assets or otherwise. As of the Agreement Date, neither the Company nor any
Subsidiary has any Legal Proceeding pending against any other Person.

(b)Current or former director or officer of the Company has asserted in
writing any claim for indemnification against the Company pursuant to his or
her indemnification agreement with the Company or pursuant to the Certificate
of Incorporation or Bylaws, nor, to the knowledge of the Company, has any such
claim been threatened in writing against the Company or any Subsidiary.

2.7Compliance with Laws; Governmental Permits.

(a)Since January 1, 2015, the Company and each of its Subsidiaries have
complied in all material respects with, is not in material violation of, and,
has not received any written notices of violation with respect to, Applicable
Law.

(b)The Company and each of its Subsidiaries has obtained each material
federal, state, county, local or foreign governmental consent, license,
permit, grant, product certifications, or other authorization of a
Governmental Entity that is required for the conduct of the Business or the
operation or holding of any interest in any of the Company's material assets
or properties (all of the foregoing consents, licenses, permits, grants and
other authorizations, collectively, the "Company Authorizations"), and all of
the Company Authorizations are in full force and effect. Neither the Company
nor any Subsidiary has received any written notice from any Governmental
Entity regarding (i) any actual or alleged violation of any Applicable Law or
Company Authorization or (ii) any actual or alleged revocation, withdrawal,
suspension, cancellation, termination or modification of any Company Authorization, and to the knowledge of the Company, no such notice is
forthcoming. The Company and each of the Subsidiaries has complied in all
material respects with all of the terms of the Company Authorizations and none
of the Company Authorizations that are material to the operation of the
Business will be terminated or materially impaired, or will become terminable,
in whole or in part, solely as a result of the consummation of the
Transactions.

(c)Each of the Company Products complies in all material respects with and has
since January 1, 2015, complied in all material respects with all Applicable
Laws in each of the jurisdictions in which such Company Product is or has been
sold directly or indirectly by or on behalf of the Company and its
Subsidiaries.

2.8Title to, Condition and Sufficiency of Assets; Real Property.

(a)The Company and each Subsidiary has good and marketable title to, or valid
leasehold interest in all of their respective properties, and interests in
properties and tangible assets, real and personal, reflected on the Company
Balance Sheet or acquired after the Company Balance Sheet Date (except
properties and tangible assets, or interests in properties and tangible
assets, sold or otherwise disposed of since the Company Balance Sheet Date in
the ordinary course of business consistent with past practice), or, with
respect to leased properties and tangible assets, valid leasehold interests in
such properties and tangible assets that afford the Company valid leasehold
possession of the properties and tangible assets that are the subject of such
leases, in each case, free and clear of all Encumbrances, except Permitted
Encumbrances. "Properties", "licenses", and "assets" as used in this Section
2.8 shall not include the Company Intellectual Property.

(b)The tangible assets and properties owned by the Company and the
Subsidiaries (i) constitute all of the tangible assets and properties that are
necessary for the Company and the Subsidiaries to conduct, operate and
continue after Closing the conduct of the Business and to sell and otherwise
enjoy full rights to exploitation of its tangible assets, properties and all
products and services that are provided in connection with its tangible assets
and properties and (ii) constitute all of the tangible assets and properties
that are used in the conduct of the Business, without (A) the need for
Acquirer to acquire or license any other tangible asset or property or (B) the
breach or violation of any Contract.

(c)Schedule 2.8(c) of the Company Disclosure Letter identifies each parcel of
real property leased or subleased by the Company or any Subsidiary. The
Company has made available to Acquirer true, correct and complete copies of
all leases, subleases and other agreements under which the Company uses or
occupies or has the right to use or occupy any real property or facility,
including all material modifications, amendments and supplements thereto. The
Company does not currently own any real property.

2.9Intellectual Property.

(a)Status. The Company and the Subsidiaries have full title and ownership of,
or are duly licensed under or otherwise authorized to use all Intellectual
Property necessary to enable them to carry on the Business, free and clear of
any Encumbrances, other than Permitted Encumbrances. The Company Intellectual
Property collectively constitutes all of the Intellectual Property used or
held for use by the Company and its Subsidiaries in connection with the
operation of the Business without the need for Acquirer or the Company to
acquire or license any other Intellectual Property. Neither the Company nor
any Subsidiary has transferred ownership of, or granted any exclusive rights
in, any Intellectual Property developed or created by the Company or any of
its Subsidiaries to any Person. (b)Company Registered Intellectual Property and Additional Scheduled
Intellectual Property. Schedule 2.9(b)(i) of the Company Disclosure Letter
lists all Company Registered Intellectual Property, the title of such Company
Registered Intellectual Property, the jurisdictions in which it has been
issued or registered or in which any application for such issuance or
registration has been filed or the jurisdictions in which any other filing or
recordation has been made and all actions that are required to be taken by the
Company or any Subsidiary within 120 days following the Agreement Date in
order to avoid prejudice to, impairment or abandonment of Intellectual
Property Rights in such Company Registered Intellectual Property (including
all office actions, provisional conversions, annuity or maintenance fees or
re-issuances). Each item of Company Registered Intellectual Property is
subsisting, and to the knowledge of the Company, valid and enforceable (or in
the case of applications, subsisting and applied for) and all registration,
maintenance and renewal fees currently due in connection with any Company
Registered Intellectual Property have been paid and all documents,
recordations and certificates in connection with such Company Registered
Intellectual Property currently required to be filed have been filed with the
relevant patent, copyright, trademark or other authorities in the United
States or foreign jurisdictions, as the case may be, for the purposes of
prosecuting, maintaining and perfecting such Company Registered Intellectual
Property and recording the Company's and the Subsidiaries' ownership interests
therein. Except as set forth on Schedule 2.9(b)(iii), none of the Company and
the Subsidiaries are now or have ever been a member or promoter of any patent
pool, industry standards body, standards setting organization or similar
organization, and none of the Company and the Subsidiaries are now or have
ever been a contributor to, or made any commitments to or agreements with any
patent pool, industry standards body, standards setting organization or
similar organization.

(c)Company Products. Schedule 2.9(c) of the Company Disclosure Letter lists
all Company Products that are currently available for use or purchase by the
Company or any Subsidiary, including any product or service currently under
development and scheduled for commercial release within 90 days following the
Agreement Date, for each such Company Product (and each version thereof)
identifying the date when it was first made generally commercially available.
Other than Open Source Materials set forth on Schedule 2.9(m)-1 in accordance
with Section 2.9(m), no Third-Party Intellectual Property is used or
integrated in any Company Products.

(d)No Assistance. In connection with the creation, development, conception of
or reduction to practice of any of the material Company-Owned Intellectual
Property, at no time was the Company or any Subsidiary, or any developer,
inventor or other contributor to such Company-Owned Intellectual Property (i)
operating in cooperation with any Governmental Entities, universities or
research centers, (ii) operating under any grants from any Governmental Entity
or agency or private source, (iii) performing research sponsored by any
Governmental Entity or agency or private source, (iv) to the knowledge of the
Company, operating outside of the United States, or (v) subject to any
employment agreement or invention assignment or nondisclosure agreement or
other agreement or obligation with any Person, in the case of each of clauses
(i) through (v), in a manner that would reasonably be expected to adversely
affect the Company's or any Subsidiary's rights in such Company-Owned
Intellectual Property.

(e)Invention Assignment and Confidentiality Agreement.

(i)The Company and each Subsidiary has secured from (A) all current and prior
consultants, advisors, employees, founders, independent contractors and other
Persons who independently or jointly contributed to or participated in the
conception, reduction to practice, creation or development of any Intellectual
Property for the Company or any Subsidiary, and (B) all named inventors of
patents and patent applications owned or purported to be owned by the Company
or any Subsidiary (any Person described in clause (A) or (B), an "Author"),
unencumbered and unrestricted exclusive ownership of, all of the Authors' right, title and interest in and to such
Intellectual Property, and the Company and each Subsidiary has obtained the
irrevocable and perpetual waiver of all non-assignable rights. To the
knowledge of the Company, no Author has ever retained any rights, licenses,
claims or interest whatsoever with respect to any Intellectual Property
created, developed, conceived or reduced to practice by the Author for or
purportedly assigned to the Company or any Subsidiary.

(ii)Without limiting the foregoing, the Company and each Subsidiary has
obtained written and enforceable proprietary information and invention
disclosure and Intellectual Property assignment agreements from all current
and former Authors, and all forms of such agreements currently in use have
been made available to Acquirer. The Company has recorded all applicable
assignments of its patents and patent applications with the relevant
authorities in the applicable jurisdiction or jurisdictions. Neither the
Company nor any Subsidiary has created any Intellectual Property under any
"work for hire" or similar terms, or otherwise under an obligation to assign
title or ownership to such created Intellectual Property to any Person.

(f)No Violation. To the knowledge of the Company, no current or former
employee, consultant or contractor of the Company or any Subsidiary: (i) is
bound by any Contract with any prior employer or other third party that
assigns, agrees to assign or purports to assign to such prior employer or
third party any Intellectual Property such Person developed within the scope
of their employment with the Company or any Subsidiary, or in connection with
performing services for, the Company or any Subsidiary; (ii) is in violation
of any term or covenant of any Contract relating to employment, invention
disclosure, invention assignment, non-disclosure or non-competition or any
other Contract with any other party by virtue of such employee's consultant's
or contractor's being employed or engaged by the Company or any Subsidiary or
using trade secrets or proprietary information of others without permission or
(iii) has created, developed, conceived or reduced to practice any technology,
software or other Intellectual Property in the scope of their employment or in
connection with performing services for the Company or any Subsidiary that is
subject to any agreement under which such employee, consultant or contractor
has assigned or otherwise granted (or agreed to or purported to assign or
otherwise grant) to any third party any rights (including Intellectual
Property Rights) in or to such technology, software or other Intellectual
Property. To the knowledge of the Company, neither the execution nor delivery
of this Agreement will conflict with or result in a breach of the terms,
conditions or provisions of, or constitute any default under, any Contract of
the type described in clauses (i) or (ii).

(g)Confidential Information. The Company and the Subsidiaries have taken
commercially reasonable steps to protect and preserve the confidentiality of
all confidential or non-public information (including trade secrets and other
confidential Company-Owned Intellectual Property) of the Company and the
Subsidiaries or provided by any Person to the Company or any Subsidiary under
binding obligations of confidentiality ("Confidential Information"), including
by requiring any Person having access (or who had access) to Confidential
Information to execute and deliver to the Company or a Subsidiary a written
and enforceable agreement regarding the protection of such Confidential
Information. The Company and the Subsidiaries have implemented and maintained
(and presently implement and maintain) security, disaster recovery and
business continuity plans and controls consistent with industry practices of
companies offering similar services, and acts in compliance in all material
respects therewith and has tested such plans on a periodic basis, and such
plans have proven effective upon testing. There has been no Company,
Subsidiary or, to the knowledge of the Company, third-party breach of
confidentiality. (h)Non-Infringement. To the knowledge of the Company, there is no unauthorized
use, unauthorized disclosure, infringement, dilution, tarnishment, violation
or misappropriation (collectively, "Infringement" and cognate terms have
cognate meanings) of any Company-Owned Intellectual Property by any Person.
Since January 1, 2015, neither the Company nor any Subsidiary has brought any
Legal Proceeding for Infringement of any Company-Owned Intellectual Property.
The operation of the Business, including (i) the design, development,
manufacturing, reproduction, marketing, licensing, sale, offer for sale,
importation, distribution, and provision, and other exploitation of any
Company Product or Company-Owned Intellectual Property (individually or in
combination) or use of any Company Product or Company-Owned Intellectual
Property (individually or in combination) and (ii) the Company's and the
Subsidiaries' use of any product, device, process or service used in the
Business, in each case (i) and (ii) as conducted since January 1, 2015 by the
Company or any Subsidiary, has not and does not (A) Infringe (directly or
indirectly, including via contribution or inducement) any Third-Party
Intellectual Property, (B) breach any terms of service, click-through
agreement or any other agreement or rules, policies or guidelines applicable
to use of such Third-Party Intellectual Property by the Company, or (C)
constitute unfair competition or unfair trade practices under the Applicable
Law of any jurisdiction in which the Company or any Subsidiary conducts its
business or in which Company Products are manufactured, marketed, distributed,
licensed or sold. Since January 1, 2015, neither the Company nor any
Subsidiary has been sued in any Legal Proceeding or received any written
communications (including any third-party reports by users) alleging that the
Company or any Subsidiary has Infringed, is Infringing or, by conducting the
Business, would Infringe any Intellectual Property of any other Person. No
Company-Owned Intellectual Property or Company Product is subject to any Legal
Proceeding, Order, settlement agreement or right that restricts in any manner
the use, transfer or licensing thereof by the Company, or that may affect the
ownership, validity, use or enforceability of any Company-Owned Intellectual
Property.

(i)Licenses; Agreements.

(i)Neither the Company nor any Subsidiary has granted or entered into any
options, licenses or agreements of any kind relating to any Company-Owned
Intellectual Property with any Governmental Entity.

(ii)Neither the Company nor any Subsidiary is obligated to pay any royalties
to any Person with respect to the use, sale, offering for sale, making, or
having made, or importing any Company Products under a license to a third
party's Intellectual Property

(j)Other Intellectual Property Agreements. With respect to the Company
Intellectual Property Agreements:

i.each such agreement is valid, enforceable and subsisting;

ii.neither the Company nor any Subsidiary is (and will not be as a result of
the execution and delivery or effectiveness of this Agreement or the
performance of the Company's obligations under this Agreement), in breach of
any material Company Intellectual Property Agreement and the consummation of
the Transactions will not result in the modification, cancellation,
termination, suspension of, or acceleration of any payments, rights,
obligations or remedies with respect to (or increase in royalties or other
amounts payable under) any material Company Intellectual Property Agreements,
or give any non-Company or non-Subsidiary party to any material Company
Intellectual Property Agreement the right to do any of the foregoing; iii.to the knowledge of the Company, no counterparty to any Company
Intellectual Property Agreement is in breach thereof;

iv.at and after the Closing, the Surviving Corporation (as a wholly owned
subsidiary of Acquirer) and each Subsidiary will be permitted to exercise all
of the Company's or Subsidiary's rights under the Company Intellectual
Property Agreements to the same extent the Company or such Subsidiary would
have been able to had the Transactions not occurred and without the payment of
any additional amounts or consideration other than ongoing fees, royalties or
payments that the Company or such Subsidiary would otherwise be required to
pay;

v.there are no disputes or Legal Proceedings (pending or, to the knowledge of
the Company, threatened) regarding the scope of any Company Intellectual
Property Agreements, or performance under any Company Intellectual Property
Agreements including with respect to any payments to be made or received by
the Company or any Subsidiary thereunder;

vi.no Company Intellectual Property Agreement requires the Company or any
Subsidiary to include any Third-Party Intellectual Property in or with any
Company Product or obtain any Person's approval of any Company Product at any
stage of development, licensing, distribution or sale of that Company Product;

vii.none of the Company Intellectual Property Agreements grants any Person
exclusive rights to or under any Company-Owned Intellectual Property;

viii.none of the Company Intellectual Property Agreements grants any Person
the right to sublicense any Company-Owned Intellectual Property;

ix.none of the Company Intellectual Property Agreements assign title or
ownership of any Company-Owned Intellectual Property from the Company or any
Subsidiary to any Person;

x.none of the Company Intellectual Property Agreements restricts the Company
or any Subsidiary from enforcing any Company-Owned Intellectual Property
(other than non-exclusive licenses);

xi.the Company and each Subsidiary has obtained valid, written licenses to all
Third-Party Intellectual Property that is incorporated into, integrated or
bundled by the Company or any Subsidiary with any of the Company Products; and

xii.no Person that has licensed Third-Party Intellectual Property to the
Company or any Subsidiary has ownership or exclusive license rights to
improvements or derivative works made by the Company or any Subsidiary in such
Third-Party Intellectual Property that has been licensed to the Company or any
Subsidiary.

(k)Non-Contravention. Neither the execution and performance of this Agreement,
nor the consummation of the Transactions will result in, pursuant to any
Contracts that Company or any Subsidiary is a party: (i) Acquirer or any of
its Affiliates granting to any Person any right to or with respect to any
Intellectual Property Rights owned by, or licensed to, Acquirer or any of its
Affiliates, or (ii) Acquirer or the Surviving Corporation being obligated to
pay any royalties or other material amounts to any third party in excess of
those payable by any of them with respect to use of any Intellectual Property
Rights, respectively, in the absence of this Agreement or the Transactions. (l)Company Source Code. Neither the Company nor any Subsidiary has disclosed,
delivered or licensed to any Person or agreed or obligated itself to disclose,
deliver or license to any Person, or permitted the disclosure or delivery to
any escrow agent or other Person of, any Company Source Code, other than
disclosures to employees, consultants, and contractors (i) involved in the
development of Company Products and (ii) subject to a written confidentiality
agreement with confidentiality obligations. No event has occurred, and no
circumstance or condition exists, that (with or without notice or lapse of
time, or both) will, or would reasonably be expected to, result in the
disclosure, delivery or license by the Company or any Subsidiary of any
Company Source Code, other than disclosures to employees, contractors and
consultants involved in the development of Company Products who have entered
into a written confidentiality agreement with the Company with confidentiality
obligations. Without limiting the foregoing, neither the execution nor
performance of this Agreement nor the consummation of any of the Transactions
will result in a release from escrow or other delivery to a third party of any
Company Source Code.

(m)Open Source Software. Schedule 2.9(m)-1 of the Company Disclosure Letter
identifies all Open Source Materials used or integrated in any Company
Products, identifies the Company Product(s) in which such Open Source
Materials were used, describes whether the Open Source Materials were modified
and/or distributed by the Company or any Subsidiary and identifies the
licenses under which such Open Source Materials were used. The Company and
each Subsidiary is in compliance with the terms and conditions of all licenses
for the Open Source Materials. Except as set forth on Schedule 2.9(m)-2 of the
Company Disclosure Letter, neither the Company nor any Subsidiary has (i)
incorporated Open Source Materials into, or combined Open Source Materials
with, the Company Products, or (ii) distributed Open Source Materials in
conjunction with any Company Products. Neither the Company nor any Subsidiary
has used or distributed Open Source Materials, in such a way that creates, or
purports to create, obligations for the Company or any Subsidiary with respect
to any Company-Owned Intellectual Property to grant, or purport to grant, to
any Person any rights or immunities under any Company-Owned Intellectual
Property (including using any Open Source Materials that require, as a
condition of use, modification and/or distribution of such Open Source
Materials that other software incorporated into, derived from or distributed
with such Open Source Materials be (A) disclosed or distributed in source code
form, (B) be licensed for the purpose of making derivative works, or (C) be
redistributable at no charge). Neither the Company or any Subsidiary nor any
of their employees, have contributed any material Company Owned Intellectual
Property to Open Source Materials.

2.10Information Technology.

(a)Status. Schedule 2.10(a)(i) of the Company Disclosure Letter sets forth
material details of the information and communications technology
infrastructure and systems (including software, hardware, firmware, networks
and the Company Websites) that is used in the Business as currently conducted
(collectively, the "ICT Infrastructure") and any security and disaster
recovery arrangements relating thereto. The arrangements relating to the ICT
Infrastructure (including its operation and maintenance and any amendments or
modifications thereto) will not be adversely affected by the Transactions, and
the ICT Infrastructure will continue to be available for use by the Company
and the Subsidiaries immediately following the consummation of the
Transactions and thereafter on substantially the same terms and conditions as
prevailed immediately before the Closing, without further action or payment by
Acquirer or the Company. The Company and the Subsidiaries are the sole legal
and beneficial owner of the ICT Infrastructure or have valid and subsisting
rights to use the ICT Infrastructure. The ICT Infrastructure that is currently
used in the Business constitutes all the information and communications
technology and other systems infrastructure reasonably necessary to carry on
the Business as currently conducted, including having sufficient capacity and
maintenance and support requirements to satisfy the requirements of the Business as currently
conducted. The ICT Infrastructure is in good working order and functions in
all material respects in accordance with all applicable documentation and
specifications. Since January 1, 2015, except as set forth on Schedule
2.10(a)(i) of the Company Disclosure Letter, there have been (I) no material
failures or other materially substandard performance of any ICT Infrastructure
(or outsourced IT assets used in the Business) which have caused any material
disruption to the Business, (II) no material unauthorized intrusions or
breaches of the security of the ICT Infrastructure which have caused any
material disruption to the Business, (III) to the knowledge of the Company, no
other breach of security or unauthorized access by any Person to the
Confidential Information, including Personal Data in the Company's possession,
custody or control, and (IV) no other material failures with respect to any of
the computer systems, including software, used by the Company in the conduct
of the Business.

(b)No Faults. Neither the Company nor any Subsidiary has experienced, and, to
the knowledge of the Company, no circumstances exist that are likely or
expected to give rise to, any material disruption in or to the operation of
the Business as a result of: (A) any material substandard performance or
defect in any part of the ICT Infrastructure whether caused by any viruses,
bugs, worms, software bombs or otherwise, lack of capacity or otherwise or (B)
a breach of security in relation to any part of the ICT Infrastructure. To the
knowledge of the Company, none of the Company Products: (I) contains any bug,
defect or error that may materially affect Acquirer's ability to sell or use,
or the functionality or performance of the Company Products, other than those
discovered and corrected in the normal course of the Company's maintenance
procedures, or (II) has failed or currently fails to operate or comply, in any
material respect, with any applicable warranty, specifications or contractual
commitment relating to the use, functionality or performance of the Company
Products. None of the Company Products contain any computer virus,
unauthorized disabling or erasing mechanism, worm, unauthorized software lock,
drop dead device, Trojan horse, back door, trap door, time bomb (each, a
"Contaminant"), or any undocumented hidden command, undocumented hidden code,
undocumented instructions key or any other code or instruction that may be
used to access, modify, delete, damage or disable any of the Company Products
without the authorization of the end user (each, a "Disabling Code"). The
Company and its Subsidiaries have taken commercially reasonable steps designed
to prevent the introduction of Contaminants and Disabling Code into the
Company Products. Schedule 2.10(b) lists all material warranty and
indemnification claims asserted in writing against the Company or any of its
Subsidiaries, customers, resellers, partners or distributors related to the
Company Products and which remain unresolved as of the Agreement Date.

(c)Company Websites. To the knowledge of the Company, no domain names have
been registered by any Person that are the same as or similar to any
trademarks, service marks, domain names or business or trading names used,
created or owned by the Company or any Subsidiary. The contents of any Company
Website and all transactions conducted over the Internet materially comply
with Applicable Law in any applicable jurisdiction.

2.11Privacy and Personal Data.

(a)The Company's and each Subsidiary's privacy and security practices and
Processing of Personal Data conform to and comply with, and since January 1,
2015 have conformed to and complied with, all of the Company Privacy
Commitments, Privacy Laws and Company Data Agreements. The Company and each
Subsidiary has: (i) provided notice and obtained any necessary consents from
individuals as required by applicable Privacy Laws for the Processing of
Personal Data as conducted by or for the Company or any Subsidiary and (ii)
abided by any privacy choices (including opt-out preferences) of individuals
relating to Personal Data (such obligations along with those contained in Company Privacy Policies, collectively, "Company Privacy Commitments"). Except
as disclosed on Schedule 2.11, the execution, delivery and performance of this
Agreement will not cause, constitute, or result in a breach or violation of
any Privacy Laws, Company Privacy Commitments, any Company Data Agreements, or
standard terms of service entered into by end users of the Company Products
relating to the Processing of Personal Data. All Company Websites contain
privacy notices or policies, as applicable. To the knowledge of the Company,
the Company does not store or maintain sensitive Personal Data except in a
manner consistent with Company Privacy Policies and in a manner that provides
commercially-reasonable secure storage and protection of such information.
Copies of all current and prior Company Privacy Policies have been made
available to Acquirer and such copies are true, correct and complete.

(b)The Company and each Subsidiary has established and maintains commercially
reasonable technical, physical and organizational measures and security
systems and technologies designed for compliance with applicable data security
requirements under Privacy Laws, Company Privacy Commitments, and
cybersecurity laws, and designed to protect Personal Data against accidental
or unlawful Processing in a manner appropriate to the risks represented by the
Processing of such data by the Company and its data processors.

(c)No breach, security incident or material violation of any data security
policy in relation to Personal Data has occurred or to the knowledge of the
Company has been threatened, and to the knowledge of the Company there has
been no unauthorized or illegal Processing of any Personal Data. No
circumstance has arisen in which applicable Privacy Laws or cybersecurity laws
would require the Company or any Subsidiary to notify a Governmental Entity
and/or individuals of a data security breach or security incident.

(d)Neither the Company nor any Subsidiary has received written notice of any
Legal Proceeding, Order, notice, communication, warrant, regulatory opinion,
audit result or allegation from a Governmental Entity or any other Person
(including an end user): (A) alleging or confirming non-compliance with a
relevant requirement of Privacy Laws or Company Privacy Commitments, (B)
requiring or requesting the Company or any Subsidiary to amend, rectify, cease
Processing of Personal Data, de-combine, permanently anonymize, block or
delete any Personal Data, (C) permitting or mandating relevant Governmental
Entities to investigate, requisition information from, or enter the premises
of, the Company or any Subsidiary or (D) claiming compensation from the
Company or any Subsidiary. There is no circumstance (including any
circumstance arising as a result of an audit or inspection carried out by any
Governmental Entity) that would reasonably be expected to give rise to any
such Legal Proceeding, Order, notice, communication, warrant, regulatory
opinion, audit result or allegation from a Governmental Entity or any other
Person. Neither the Company nor any Subsidiary has been involved in any Legal
Proceedings involving a breach or alleged breach of Privacy Laws or Company
Privacy Commitments.

(e)Schedule 2.11(e) of the Company Disclosure Letter contains the complete
list of notifications and registrations made by the Company under Privacy Laws
with relevant Governmental Entities (including pursuant to the Company's
compliance with GDPR and the Company's certification under the EU-U.S. Privacy
Shield or Swiss-U.S. Privacy Shield) in connection with the Company's
Processing of Personal Data. All such notifications and registrations are
valid, accurate, complete and fully paid up and, to the knowledge of the
Company, the consummation of the Transactions will not invalidate such
notification or registration. Other than the notifications and registrations
set forth on Schedule 2.11(e) of the Company Disclosure Letter, to the
knowledge of the Company, no other registrations or notifications are required in connection with the Processing
of Personal Data by Company.

(f)Where the Company or any Subsidiary uses a data processor to Process
Personal Data (including Company-Licensed Data), the processor has provided
guarantees, warranties or covenants in relation to Processing of Personal Data
(including Company-Licensed Data), confidentiality, security measures and
compliance with those obligations that are sufficient for the Company's
compliance with Privacy Laws and Company Privacy Commitments, and there is in
existence a written Contract between the Company or such Subsidiary and each
such data processor that complies with the requirements of all Privacy Laws
and Company Privacy Commitments. To the knowledge of the Company, such data
processors have not breached any such Contracts pertaining to Personal Data
Processed by such Persons on behalf of Company or any Subsidiary.

(g)Neither the Company nor any Subsidiary has transferred or permitted the
transfer of Personal Data originating in the EEA outside the EEA, except where
such transfers have complied with the requirements of Privacy Laws and Company
Privacy Commitments, including the Company's certification under the U.S.-EU
Privacy Shield or Swiss-U.S. Privacy Shield.

(h)Neither the Company nor any Subsidiary has processed any Personal Data in a
manner that would constitute a "sale" under the California Consumer Protection
Act, Cal. Civ. Code.  1798.100 et seq.

(i)Schedule 2.11(i) of the Company Disclosure Letter identifies and describes
each distinct electronic or other repository or database containing (in whole
or in part) Personal Data maintained by or for the Company or any Subsidiary
at any time (the "Company Databases"), the types of Personal Data in each such
database, the means by which the Personal Data was collected or received and
the security policies that have been adopted and maintained with respect to
each such Company Database.

(j)The Company and each Subsidiary has valid and subsisting contractual rights
to Process or to have Processed all third-party-owned data, (including
Personal Data), howsoever obtained or collected by or for the Company, in the
manner that it is Processed by or for the Company or any Subsidiary, including
in relation to delivery of the Company Products (all such data, "Company-
Licensed Data"). The Company and each Subsidiary has all rights, and all
permissions or authorizations required under Privacy Laws and relevant
Contracts (including Company Data Agreements), to Process, retain, produce
copies, prepare derivative works, disclose, combine with other data, and grant
any Person rights, as the case may be, to each of the Company-Licensed Data as
necessary for the operation of the Business, including the delivery of the
Company Products. The Company and each Subsidiary has been and is in
compliance with all Contracts pursuant to which the Company Processes or has
Processed Company-Licensed Data, including in relation to international
transfers of Company-Licensed Data, and the consummation of the Transactions
will not conflict with, or result in any violation or breach of, or default
under, any such Contract.

(k)The Company and the Subsidiaries are the owners of all right, title and
interest in and to each element of Company Data that (i) is used or held for
use in the Business that is not Company-Licensed Data or (ii) the Company or
the Subsidiaries purport to own (collectively, "Company-Owned Data"). The
Company and the Subsidiaries have the right to Process all Company-Owned Data
without obtaining any permission or authorization of any Person. (l)To the knowledge of the Company, other than the Personal Data of the
dependents of Employees which is processed for the purpose of providing
employee benefits, neither the Company nor any Subsidiary Processes the
Personal Data of any natural Person under the age of 16.

(m)Neither the Company nor any Subsidiary has directly stated or implied that
Company Products enhance the security of Personal Data accessed, provided or
sent by end users.

2.12Taxes.

(a)The Company and each Subsidiary has timely filed when due all income and
other material Tax Returns required to be filed by it prior to the Closing
Date (after giving effect to any valid extensions of time in which to make
such filings) and has timely paid in full all Taxes required to be paid by it
(whether or not shown on any Tax Return). All such Tax Returns were true,
correct, complete and accurate and have been prepared in compliance with
Applicable Law. To the knowledge of the Company, there is no claim for income
and other material Taxes that has resulted in an Encumbrance against any of
the assets of the Company or any Subsidiary.

(b)The Company has delivered to Acquirer true, correct and complete copies of
all income and other material Tax Returns for the three years prior to the
Agreement Date, examination reports and statements of deficiencies,
adjustments and proposed deficiencies and adjustments in respect of the
Company and each Subsidiary.

(c)The Company Balance Sheet reflects (i) all material Liabilities for accrued
but unpaid Taxes of the Company and/or any Subsidiary for periods (or portions
of periods) through the Company Balance Sheet Date, and (ii) reserves for
uncertain tax positions required by GAAP. Neither the Company nor any
Subsidiary has any Liability for accrued but unpaid Taxes accruing after the
Company Balance Sheet Date except for Taxes arising in the ordinary course of
business consistent with past practice following the Company Balance Sheet
Date.

(d)There is (i) no past or, to the knowledge of the Company, pending audit of,
or Tax controversy associated with, any Tax Return of the Company or any
Subsidiary that has been or is being conducted by a Tax Authority, (ii) to the
knowledge of the Company, no other procedure, proceeding or contest of any
refund or deficiency in respect of Taxes pending or on appeal with any
Governmental Entity, (iii) no extension of any statute of limitations on the
assessment of any Taxes granted by the Company currently in effect and (iv) no
agreement to any extension of time (other than routine extensions available by
statute) for filing any Tax Return that has not been filed. No power of
attorney with respect to any Tax matter is currently in force. No written
claim has ever been made by any Governmental Entity in a jurisdiction where
the Company or any Subsidiary does not file Tax Returns that the Company or
any Subsidiary is or may be subject to taxation by that jurisdiction.

(e)Neither the Company nor any Subsidiary has been or will be required to
include any adjustment in Taxable income for any Tax period (or portion
thereof) pursuant to Section 481 or 263A of the Code or any comparable
provision of state, local or foreign Applicable Law as a result of
transactions, events or accounting methods employed prior to the Merger.

(f)Neither the Company nor any Subsidiary is a party to or bound by any Tax
sharing, Tax indemnity, or Tax allocation agreement (other than customary
commercial agreements entered into in the ordinary course of business not
primarily related to Taxes), and the Company does not have any Liability or
potential Liability to another party under any such agreement. (g)The Company and each Subsidiary has disclosed on its Tax Returns any Tax
reporting position taken in any Tax Return that could result in the imposition
of penalties under Section 6662 of the Code or any comparable provision of
state, local or foreign Applicable Law.

(h)Neither the Company nor any Subsidiary has participated in, and is not
currently participating in, any (i) "reportable transaction" within the
meaning of Section 6707A(c) of the Code or any transaction requiring
disclosure under any corresponding or similar provision of state, local, or
foreign Applicable Law or (ii) any cross-border arrangement that is a
reportable cross-border arrangement within the meaning of European Council
Directive 2018/822 (the "DAC 6 Directive") or any Applicable Law implementing
the DAC 6 Directive.

(i)Neither the Company nor any Subsidiary, nor any predecessor of the Company
or any Subsidiary is or has ever been a member of a consolidated, combined,
unitary or aggregate group of which the Company or any predecessor of the
Company was not the ultimate parent corporation.

(j)Neither the Company nor any Subsidiary has any Liability for the Taxes of
any Person under Section 1.1502-6 of the Treasury Regulations (or any
corresponding or similar provision of state, local or foreign Applicable Law),
as a transferee or successor, by operation of Applicable Law, by Contract or
otherwise.

(k)Neither the Company nor any Subsidiary will be required to include any
material item of income in, or exclude any material item of deduction from,
Taxable income for any Taxable period (or portion thereof) ending after the
Closing Date as a result of any (i) change in method of accounting that is
made on or prior to the Closing Date, (ii) "closing agreement" described in
Section 7121 of the Code (or any corresponding or similar provision of state,
local, or foreign Applicable Law) executed on or prior to the Closing Date,
(iii) intercompany transactions (including any intercompany transaction
subject to section 367 or 482 of the Code) or any excess loss account
described in Treasury Regulations under Section 1502 of the Code (or any
corresponding or similar provision of state, local, or foreign Applicable Law)
with respect to a transaction occurring on or prior to the Closing Date, (iv)
installment sale or open transaction disposition made on or prior to the
Closing Date or (v) election under Section 108(i) of the Code made on or prior
to the Closing Date. All amounts received by the Company or any Subsidiary
prior to the Closing Date and accounted for as advance payments for Tax
purposes by deferred recognition in income qualify as advance payments within
the meaning of Section 451(c)(4) of the Code and Revenue Procedure 2004-34 and
have been or will be included in income no later than the taxable year in
which such advance payments are required to be included in income under
Section 451(c) of the Code and Revenue Procedure 2004-34.

(l)Neither the Company nor any Subsidiary has incurred a dual consolidated
loss within the meaning of Section 1503 of the Code (or any corresponding or
similar provision of state, local or foreign Applicable Law).

(m)Neither the Company nor any Subsidiary has received any private letter
ruling from the IRS (or any comparable Tax ruling from any other Governmental
Entity).

(n)Neither the Company nor any Subsidiary is a party to any joint venture,
partnership or other Contract or arrangement that could be treated as a
partnership for U.S. federal income Tax purposes.

(o)To the knowledge of the Company, neither the Company nor any Subsidiary is
subject to Tax in any jurisdiction other than its country of incorporation,
organization or formation by virtue of having employees (including any employee of a Professional Employer
Organization that provides services to the Company or any Subsidiary), a
permanent establishment or any other place of business in, or connections to,
such jurisdiction.

(p)The Company and each Subsidiary has in its possession official foreign
government receipts for any Taxes paid by it to any foreign Tax Authorities
for which receipts have been provided or are customarily provided.

(q)The Company for itself and for each Subsidiary has made available to
Acquirer all documentation relating to any applicable Tax holidays or
incentives. The Company and the Subsidiaries are in material compliance with
all requirements for any applicable Tax holidays or incentives. Each
applicable Tax holiday or incentive, whether presently in effect or previously
applicable, made available to any of the Company or any Subsidiary does not
and did not at the time provided constitute state aid under principles of
European Union law including article 107(1) of the Treaty of the Functioning
of the European Union.

(r)Neither the Company nor any Subsidiary is, or has ever been, a "United
States real property holding corporation" within the meaning of Section 897 of
the Code.

(s)Neither the Company nor any Subsidiary has constituted either a
"distributing corporation" or a "controlled corporation" in a distribution of
stock intended to qualify for Tax-free treatment under Section 355 of the Code
(i) in the two years prior to the Agreement Date or (ii) in a distribution
that could otherwise constitute part of a "plan" or "series of related
transactions" (within the meaning of Section 355(e) of the Code) in
conjunction with the Merger.

(t)The Company and each Subsidiary (i) complied with all Applicable Law
relating to the payment, reporting and withholding of Taxes (including
withholding of Taxes pursuant to Sections 1441, 1442, 1445, 1446, 1471, 1472,
3402 and 3406 of the Code or similar provisions under any foreign Applicable
Law), (ii) withheld (within the time and in the manner prescribed by
Applicable Law) from employee wages or consulting compensation and paid over
to the proper Governmental Entities (or is properly holding for such timely
payment) all amounts required to be so withheld and paid over under all
Applicable Law, including federal and state income Taxes, Federal Insurance
Contribution Act, Medicare, Federal Unemployment Tax Act, relevant state
income and employment Tax withholding laws, and (iii) timely filed all
withholding Tax Returns, for all periods through and including the Closing
Date.

(u)Neither the Company nor any Subsidiary has at any time owned any interest
in any controlled foreign corporation (as defined in Section 957 of the Code)
(other than the Subsidiaries), passive foreign investment company (as defined
in Section 1297 of the Code), or other entity the income of which is required
to be included in whole or in part in the income of the Company or any
Subsidiary.

(v)The Company has delivered to Acquirer true, correct and complete copies of
all election statements under Section 83(b) of the Code, together with
evidence of timely filing of such election statements with the appropriate IRS
Center with respect to any Company Common Stock that was initially subject to
a vesting arrangement or to other unvested property issued by the Company or
any Subsidiary to any of their respective current or former employees, non-
employee directors, consultants or other service providers. No payment to any
Company Securityholder of any amount payable pursuant to Section 1.3(a)(i) or
Section 1.3(a)(iii) will result in compensation or other income to any Company
Securityholder with respect to which Acquirer or the Company would be required
to deduct or withhold any Taxes. (w)Schedule 2.12(w) of the Company Disclosure Letter lists all "nonqualified
deferred compensation plans" (within the meaning of Section 409A of the Code)
to which the Company or any Subsidiary is a party. Each such nonqualified
deferred compensation plan to which the Company or any Subsidiary is a party
complies with the requirements of paragraphs (2), (3) and (4) of Section
409A(a) of the Code by its terms and has been operated in accordance with such
requirements. No event has occurred that would be treated by Section 409A(b)
of the Code as a transfer of property for purposes of Section 83 of the Code.
Neither the Company nor any Subsidiary is under any obligation to pay, or pay
a gross-up bonus for, any Taxes under Section 409A of the Code.

(x)The Company has made available to Acquirer copies of all valuation reports
prepared for the Company by an independent valuation firm to determine the
fair market value of the stock of the Company for purposes of setting the
exercise price of stock options granted by the Company for purposes of
Sections 409A and 422 of the Code. The exercise price of all Company Options
is at least equal to the fair market value of the Company Common Stock on the
date such Company Options were granted, and none of the Company, any
Subsidiary or Acquirer has incurred or will incur any Liability or obligation
to withhold Taxes under Section 409A of the Code upon the vesting of any
Company Options. All Company Options constitute "service recipient stock" (as
defined under Treasury Regulation 1.409A-1(b)(5)(iii)) with respect to the
grantor thereof.

(y)The Company and each Subsidiary is in material compliance with Applicable
transfer pricing Laws and regulations, including the maintenance of
documentation sufficient to satisfy the requirements of Section
6662(e)(3)(B)(i)(II) of the Code (or any corresponding or similar provision of
state, local or foreign Applicable Law). The Company and its Subsidiaries are
in material compliance with all applicable country-by-country reporting
requirements under Section 1.6038-4 of the Treasury Regulations and any
similar provision of non-U.S. law.

(z)No independent contractor was or will be considered as an employee of the
Company or any Subsidiary by an applicable Tax Authority and/or Company
Employee Plan.

(aa)Except as set forth on Schedule 2.12(aa) of the Company Disclosure Letter,
there is no agreement, plan, arrangement or other Contract covering any
current or former employee, non-employee director, consultant or other service
provider of the Company, any Subsidiary or any ERISA Affiliate to which the
Company and/or any Subsidiary is a party or by which the Company and/or any
Subsidiary or their respective assets is bound that, considered individually
or considered collectively with any other such agreements, plans, arrangements
or other Contracts, will, or would reasonably be expected to, as a result of
the Transactions (whether alone or upon the occurrence of any additional or
subsequent events), give rise directly or indirectly to the payment of any
amount that would reasonably be expected to be non-deductible under Section
162 of the Code (or any corresponding or similar provision of state, local or
foreign Tax law) or be characterized as a "parachute payment" within the
meaning of Section 280G of the Code (or any corresponding or similar provision
of state, local or foreign Tax law). Schedule 2.12(aa) of the Company
Disclosure Letter lists each Person (whether United States or foreign) who as
of the Closing will be, with respect to the Company, a "disqualified
individual" (within the meaning of Section 280G of the Code and the
regulations promulgated thereunder), as determined as of the Agreement Date.
No security of the Company or any Company Securityholder is readily tradable
on an established securities market or otherwise (within the meaning of
Section 280G of the Code and the regulations promulgated thereunder) such that
the Company is ineligible to seek shareholder approval in a manner that
complies with Section 280G(b)(5) of the Code. Neither the Company nor any
Subsidiary has ever had any obligation to report, to withhold or to pay (or
pay a gross-up bonus for) any excise Taxes under Section 4999 of the Code. (ab)Neither the Company nor any Subsidiary has at any time been subject to (i)
a digital tax or other similar Tax in France, the United Kingdom or any other
jurisdiction which has enacted comparable legislation or (ii) the UK diverted
profits tax other similar Tax in any other jurisdiction which has enacted
comparable legislation, and no amounts received by the Company or any of its
Subsidiaries in respect of the enjoyment or exercise of rights in respect of
intangible property is subject to Tax in the United Kingdom under the UK rules
on offshore payments in respect of intangible property or in any other
jurisdiction which has enacted comparable legislation.

Notwithstanding anything to the contrary in this Section 2.12, neither the
Company nor any Subsidiary makes any representation or warranty as to the
amount, condition or availability for use in any Post-Closing Tax Period, of
any net operating loss, tax credit carryforward or similar Tax attribute of
the Company or any Subsidiary.

2.13Employee Benefit Plans.

(a)Schedule 2.13(a) of the Company Disclosure Letter lists, with respect to
the Company, any Subsidiary and any trade or business (whether or not
incorporated) that is treated as a single employer with the Company (an "ERISA
Affiliate") within the meaning of Section 414(b), (c), (m) or (o) of the Code,
(i) all "employee benefit plans" within the meaning of Section 3(3) of the
Employee Retirement Income Security Act of 1974, as amended ("ERISA"), (ii)
each loan to an employee, (iii) all stock option, stock purchase, phantom
stock, stock appreciation right, restricted stock unit, supplemental
retirement, severance, sabbatical, medical, dental, vision care, disability,
employee relocation, cafeteria plan benefit (Section 125 of the Code),
dependent care (Section 129 of the Code), life insurance or accident insurance
plans, programs or arrangements, (iv) all bonus, pension, profit sharing,
savings, severance, retirement, deferred compensation or incentive plans
(including cash incentive plans), programs or arrangements, (v) all other
material fringe or employee benefit plans, programs or arrangements and (vi)
all employment, individual consulting, retention, change of control or
employee or executive compensation or severance agreements, written or
otherwise, as to which any unsatisfied obligations of the Company or any
Subsidiary remain for the benefit of, or relating to, any current or former
employee, non-employee director, consultant or other service provider of the
Company or any Subsidiary, provided that for purposes of this clause (vi), the
Company shall not be required to separately list each of its and each
Subsidiary's individual standard offer letters that are currently in effect
that is on an employment agreement form already provided to Acquirer and set
forth on Schedule 2.13(a) of the Company Disclosure Letter (all of the
foregoing described in clauses (i) through (vi), collectively, including any
Foreign Plans, the "Company Employee Plans").

(b)The Company has made available to Acquirer a true, correct and complete
copy of all material Company Employee Plans and related plan documents
(including trust documents, insurance policies or Contracts, employee
booklets, summary plan descriptions, summary of material modifications and
other authorizing documents, and any material employee communications relating
thereto) and has, with respect to each Company Employee Plan that is subject
to ERISA reporting requirements, made available to Acquirer true, correct and
complete copies of the Form 5500 reports filed for the last three plan years.
Any Company Employee Plan intended to be qualified under Section 401(a) of the
Code has either obtained from the IRS a favorable determination letter as to
its qualified status under the Code, including all amendments to the Code
effected by the Tax Reform Act of 1986 and subsequent legislation, or has been
established under a standardized prototype plan for which an IRS opinion
letter has been obtained by the plan sponsor and is valid as to the adopting
employer. The Company has made available to Acquirer a true, correct and
complete copy of the most recent (as of the Agreement Date) IRS determination
or opinion letter issued with respect to each such Company Employee Plan, and nothing has occurred since the issuance of each such letter
that would reasonably be expected to cause the loss of the Tax-qualified
status of any Company Employee Plan subject to Section 401(a) of the Code. All
individuals who, pursuant to the terms of any Company Employee Plan, are
entitled to participate in any Company Employee Plan, are currently
participating in such Company Employee Plan or have been offered an
opportunity to do so and have declined in writing. All assets of any Company
Employee Plan that is a retirement plan consist solely of cash and actively
traded securities.

(c)Neither the Company nor any Subsidiary sponsors or maintains any self-
funded employee benefit plan, including any plan to which a stop-loss policy
applies. None of the Company Employee Plans promises or provides post-
termination medical or other post-termination welfare benefits to any person,
and the Company has no obligation and has made no promise to provide such
benefits, other than as required under the Consolidated Omnibus Budget
Reconciliation Act of 1985, as amended ("COBRA") or similar Applicable Law and
the Company and, to the extent applicable, each Subsidiary has, since January
1, 2015, complied in all material respects with the requirements of COBRA and
any applicable local country equivalent. Neither the Company nor any
Subsidiary has any obligations to provide subsidized coverage under COBRA or
similar Applicable Law equivalent with respect to any former employees or
qualifying beneficiaries thereunder. Since January 1, 2015, there has been no
"prohibited transaction" (within the meaning of Section 406 of ERISA and
Section 4975 of the Code and not exempt under Section 408 of ERISA and
regulatory guidance thereunder) with respect to any Company Employee Plan.
Since January 1, 2015, (i) each Company Employee Plan has been administered in
all material respects in accordance with its terms and in compliance with the
requirements prescribed by any and all statutes, rules and regulations
(including ERISA and the Code), and (ii) the Company, each Subsidiary and each
ERISA Affiliate has performed in all material respects all obligations
required to be performed by it under, is not in default under or in violation
of, and has no knowledge of any default or violation by any other party to,
any of the Company Employee Plans. None of the Company, any Subsidiary or any
ERISA Affiliate is subject to any Liability or penalty under Sections 4976
through 4980 of the Code, Section 4980B through 4980H of the Code or Title I
of ERISA with respect to any Company Employee Plans. All contributions
required to be made by the Company, any Subsidiary or any ERISA Affiliate to
any Company Employee Plan have been made on or before their due dates and a
reasonable amount has been accrued for contributions to each Company Employee
Plan for the current plan years (and no further contributions will be due or
will have accrued thereunder as of the Closing Date, other than contributions
accrued in the ordinary course of business consistent with past practice after
the Company Balance Sheet Date as a result of the operations of the Company or
any Subsidiary after the Company Balance Sheet Date). In addition, with
respect to each Company Employee Plan intended to include a Code Section
401(k) arrangement, the Company, each Subsidiary and each of the ERISA
Affiliates have at all times made timely deposits of employee salary reduction
contributions and participant loan repayments, as determined pursuant to
regulations issued by the United States Department of Labor. No Company
Employee Plan is covered by, and none of the Company, any Subsidiary or ERISA
Affiliate has incurred or expects to incur any Liability under Title IV or
Section 302 of ERISA or Section 412 of the Code. Each Company Employee Plan
can be amended, terminated or otherwise discontinued after the Effective Time
in accordance with its terms, without liability to Acquirer (other than
ordinary and reasonable administrative expenses typically incurred in a
termination event). With respect to each Company Employee Plan, since January
1, 2015, the Company, each applicable Subsidiary and any applicable ERISA
Affiliate have prepared in good faith and timely filed all requisite
governmental reports (which were true, correct and complete as of the date
filed), including any required audit reports, and have properly and timely
filed and distributed or posted all notices and reports to employees required
to be filed, distributed or posted with respect to each such Company Employee
Plan. No suit, administrative proceeding, action, litigation or claim has been
brought, or to the knowledge of the Company, is threatened in writing, against or with respect to any such Company
Employee Plan, including any audit or inquiry by the IRS or United States
Department of Labor.

(d)There has been no amendment to, written interpretation or announcement
(whether or not written) by the Company, any Subsidiary or other ERISA
Affiliate relating to, or change in participation or coverage under, any
Company Employee Plan that would materially increase the expense of
maintaining such Company Employee Plan above the level of expense incurred
with respect to such Company Employee Plan for the most recent full fiscal
year included in the Financial Statements.

(e)None of the Company, any Subsidiary or any current or former ERISA
Affiliate currently maintains, sponsors, participates in or contributes to, or
has ever maintained, established, sponsored, participated in, or contributed
to, or has incurred or expects to incur any Liability with respect to any
pension plan (within the meaning of Section 3(2) of ERISA) that is subject to
Part 3 of Subtitle B of Title I of ERISA, Title IV of ERISA or Section 412 of
the Code.

(f)None of the Company, any Subsidiary or any ERISA Affiliate is a party to,
or has made any contribution to, or has been required to make any contribution
to or otherwise incurred any obligation or Liability under, any "multiemployer
plan" as such term is defined in Section 3(37) of ERISA, any "multiple
employer plan" as such term is defined in Section 413(c) of the Code or local
country equivalent or any "multiple employer welfare plan" as such term is
defined in Section 3(40) of ERISA or similar Applicable Law.

(g)None of the execution, delivery and performance of this Agreement, the
consummation of the Transactions, any termination of employment or service and
any other event in connection therewith or subsequent thereto will,
individually or together or with the occurrence of some other event (whether
contingent or otherwise), (i) result in any material payment or benefit
(including severance, unemployment compensation, golden parachute, bonus or
otherwise) becoming due or payable, or required to be provided, to any current
or former employee, non-employee director, consultant or other service
provider of the Company or any Subsidiary, (ii) materially increase the amount
or value of any benefit or compensation otherwise payable or required to be
provided to any current or former employee, non-employee director, consultant
or other service provider of the Company or any Subsidiary, (iii) result in
the acceleration of the time of payment, vesting or funding of any such
benefit or compensation, (iv) increase the amount of compensation due to any
current or former employee, non-employee director, consultant or other service
provider of the Company or any Subsidiary, or (v) result in the forgiveness in
whole or in part of any outstanding loans made by the Company or any
Subsidiary to any current or former employee, non-employee director,
consultant or other service provider of the Company or any Subsidiary. No
amount paid or payable or benefit provided or to be provided by the Company or
any Subsidiary in connection with the Transactions, whether alone or in
combination with another event, will be an "excess parachute payment" within
the meaning of Section 280G of the Code or Section 4999 of the Code or will
not be deductible by the Company by reason of Section 280G of the Code.

(h)To the extent permitted to be disclosed pursuant to Applicable Law, each
Company Employee Plan maintained or contributed to by the Company or any
Subsidiary under the Applicable Law of a relevant jurisdiction outside of the
United States or covering employees of the Company working outside of the
United States (each such plan, a "Foreign Plan") is listed in Schedule 2.13(h)
of the Company Disclosure Letter. With respect to each Foreign Plan, (i) the
Company, each Subsidiary and each ERISA Affiliate has materially complied with
all applicable reporting and notice requirements, and such Foreign Plan has
obtained from the Governmental Entity having jurisdiction with respect to such Foreign Plan any required determinations
that such Foreign Plan is in compliance in all material respects with
Applicable Law, if such determinations are required in order to give effect to
such Foreign Plan, (ii) the consummation of the Transactions will not by
itself create or otherwise result in any liability with respect to such
Foreign Plan, (iii) except as required by Applicable Law, no condition exists
that would prevent the Company or any Subsidiary from terminating or amending
any Foreign Plan at any time for any reason in accordance with the terms of
each such Foreign Plan without the payment of any fees, costs or expenses
(other than the payment of benefits accrued on the Company Balance Sheet and
any normal and reasonable expenses typically incurred in a termination event).
No Foreign Plan has unfunded Liabilities that will not be offset by insurance
or that are not fully accrued on the financial statements of the Company. No
employee of the Company or any Subsidiary who is domiciled or, to the
knowledge of the Company, would properly be categorized as domiciled outside
of the United States (or any of their dependents) is entitled to any pension,
superannuation, retirement (including on early retirement) or death benefits
(including in the form of a lump sum) that become payable before their normal
retirement age as stated in their contract of employment or an applicable
Foreign Plan.

2.14Employment Matters.

(a)The Company is in compliance in all material respects with all Applicable
Laws, applicable recognition or collective bargaining agreements and other
agreements with any works councils, labor unions, employee representatives or
other labor organizations or group of employees, extension orders and binding
customs, including their own policies, practices, handbooks, work rules and
internal regulations, respecting labor and employment, discrimination,
harassment and retaliation in employment, terms and conditions of employment,
employee benefits, worker classification (including the proper classification
of workers as independent contractors and consultants), wages (including
proper classification of employees for purposes of overtime payments under
Applicable Law), disability, paid sick leave, background checks, drug testing,
salary history, inquiries, workers' compensation, immigration, meal and rest
breaks, hours and occupational safety and health and employment practices,
including the Immigration Reform and Control Act and, with respect to each
Company Employee Plan, (i) the applicable health care continuation and notice
provisions of COBRA and the regulations (including proposed regulations)
thereunder, (ii) the applicable requirements of the Family Medical and Leave
Act of 1993 and the regulations (including proposed regulations) thereunder,
(iii) the applicable requirements of the federal Affordable Care Act and the
Health Insurance Portability and Accountability Act of 1996 and the
regulations (including proposed regulations) thereunder, (iv) the applicable
requirements of the Americans with Disabilities Act of 1990, as amended and
the regulations (including proposed regulations) thereunder, (v) the Age
Discrimination in Employment Act of 1967, as amended, and (vi) the applicable
requirements of the Women's Health and Cancer Rights Act of 1998 and the
regulations (including proposed regulations) thereunder. Neither the Company
nor any Subsidiary has or is engaged in any unfair labor practice. Neither the
Company nor any Subsidiary is liable for any arrears of wages, accrued but
untaken vacation or holiday pay, compensation, Taxes, penalties or other sums
for failure to comply with any of the foregoing. The Company and each
Subsidiary has paid in full to all current or former employees, non-employee
directors, consultants and other service providers all wages, salaries,
commissions, bonuses, benefits and other compensation due to or on behalf of
such employees, non-employee directors, consultants and other service
provider. Neither the Company nor any Subsidiary is liable for any payment to
any trust or other fund or to any Governmental Entity, with respect to
unemployment compensation benefits, social security or other benefits or
obligations for employees (other than routine payments to be made in the
normal course of business and consistently with past practice). As of the
Agreement Date, there are no pending claims against the Company or any
Subsidiary under any workers compensation plan or policy or for long term
disability. As of the Agreement Date, there are no controversies pending or, to the knowledge of the Company,
threatened in writing, between the Company or any of the Subsidiaries and any
of their current or former job applicants, employees, paid or unpaid interns,
non-employee directors, consultants or other service providers, which
controversies have resulted or would reasonably be expected to result in a
Legal Proceeding before any Governmental Entity. Each nonqualified deferred
compensation plan established by the Company or any Subsidiary or ERISA
Affiliate has been operated and maintained in operational and documentary
compliance with Sections 409A and 457A of the Code and applicable guidance
thereunder.

(b)The Company has required that all current and former employees working in
the United States complete a Form I-9 in connection with the commencement of
their employment and has made available to Acquirer all Forms I-9 with respect
to all of its current and former employees for whom such a form is required by
Applicable Law. To the knowledge of the Company, every employee of the Company
or any Subsidiary who requires a visa, employment pass or other required
permit to work in the country in which he or she is employed has produced a
current employment pass or such other required permit to the Company.

(c)There are no works councils, unions, labor organizations, employee
delegates or other employee representative bodies at the Company. Neither the
Company nor any Subsidiary is a party to or bound by any collective bargaining
agreement, recognition agreement, works council arrangement or other labor
union Contract, no collective bargaining agreement or recognition agreement is
being negotiated by the Company or any Subsidiary and neither the Company nor
any Subsidiary has any duty to bargain with any labor organization. There is
no pending demand for recognition or any other request or demand from a labor
organization for representative status with respect to any Person employed by
the Company or any Subsidiary. To the knowledge of the Company, there are no
activities or proceedings of any labor union, works council, employee
representative body or other labor organization or group of employees to
organize the employees of the Company. There is no labor dispute, strike or
work stoppage against the Company or any Subsidiary pending or, to the
knowledge of the Company, threatened in writing that would reasonably be
expected to materially interfere with the conduct of the Business, nor have
there been any such labor disputes, strikes or work stoppages in the past
three years. Neither the Company nor any Subsidiary, to the knowledge of the
Company, any of their respective Representatives has committed any unfair
labor practice in connection with the conduct of the Business, and there is no
charge or complaint against the Company or any Subsidiary by the National
Labor Relations Board or any comparable Governmental Entity pending or, to the
knowledge of the Company, threatened in writing.

(d)To the knowledge of the Company, no employee of the Company or any
Subsidiary is in violation in any material respect of any term of any
employment agreement, non-competition agreement or any restrictive covenant to
a former employer relating to the right of any such employee to be employed by
the Company or any Subsidiary because of the nature of the Business or to the
use of trade secrets or proprietary information of others. To the knowledge of
the Company, no contractor of the Company or any Subsidiary is in violation in
any material respect of any term of any non-competition agreement or any
restrictive covenant to a former employer relating to the right of any such
contractor to be providing services to the Company or any Subsidiary because
of the nature of the Business or to the use of trade secrets or proprietary
information of others. Except as set forth on Schedule 2.14(d) of the Company
Disclosure Letter, as of the Agreement Date, no employee of the Company or any
Subsidiary has given written notice to the Company that he or she intends to
terminate his or her employment with the Company or any Subsidiary and, to the
knowledge of the Company, no Key Employee has a present intent to terminate
his or her employment with the Company or any Subsidiary. Except as set forth
on Schedule 2.14(d) of the Company Disclosure Letter, the employment of each
of the employees of the Company and the Subsidiaries is "at will" and neither
the Company nor any Subsidiary has any obligation to provide any particular form or period of
notice, severance or termination payments prior to terminating the employment
of any of their respective employees. Neither the Company nor any Subsidiary
has, and to the knowledge of Company, any other Person (other than, for the
avoidance of doubt, Acquirer or any of its subsidiaries) has, (i) entered into
any Contract that obligates or purports to obligate Acquirer to make an offer
of employment to any present or former employee, non-employee director,
consultant or other service provider of the Company or any Subsidiary or (ii)
promised or otherwise provided any assurances (contingent or otherwise) to any
present or former employee, non-employee director, consultant or other service
provider of the Company or any Subsidiary of any terms or conditions of
employment with Acquirer following the Effective Time.

(e)Schedule 2.14(e)(i) of the Company Disclosure Letter sets forth, as of the
Agreement Date and to the extent permitted to be disclosed pursuant to
Applicable Law, a true, correct and complete list of all officers, directors
and other employees of the Company and the Subsidiaries, showing each such
individual's name, position, location (including city, state and country),
date of hire, annual remuneration (including allowances, bonuses and
commissions, as applicable), full-time or part-time status, health and
retirement benefits participation, current employment status (active or on
leave but without disclosing private information), name of legal employer,
status as exempt/non-exempt, and bonuses for the current fiscal year and the
most recently completed fiscal year. Schedule 2.14(e)(ii) of the Company
Disclosure Letter sets forth, as of the Agreement Date and to the extent
permitted to be disclosed pursuant to Applicable Law, the additional following
information for each of the Company's and the Subsidiaries' international
employees: city/country of employment, citizenship, manager's name, and date
of birth. For purposes of the lists on Schedules 2.14(e)(i) and 2.14(e)(ii) of
the Company Disclosure Letter, employees who are engaged through a
professional employer organization are included in "employees of the Company",
and such list indicates which employees are so engaged and the applicable
professional employer organization. Except as set forth on Schedule
2.14(e)(ii), no employee of the Company resides or primarily performs work for
or on behalf of the Company of any Subsidiary outside of the United States.
Schedule 2.14(e)(iii) of the Company Disclosure Letter sets forth, as of the
Agreement Date and to the extent permitted to be disclosed pursuant to
Applicable Law, a true, correct and complete list of all of the Company's and
the Subsidiaries' consultants, advisory board members and independent
contractors and, for each, (i) such individual's compensation, (ii) such
individual's initial date of engagement, (iii) whether such engagement has
been terminated by notice provided or other action or omission on or before
the Agreement Date by either party thereto and (iv) the notice or termination
provisions applicable to the services provided by such individual. The Company
shall update Schedules 2.14(e)(i), 2.14(e)(ii) and 2.14(e)(iii) from time to
time and as of the Closing Date.

(f)As of the Agreement Date, there are no material performance improvements or
disciplinary actions pending against any of the Company's or any Subsidiary's
employees. To the Company's knowledge, since January 1, 2015, (i) no
allegations of sexual harassment or discrimination have been made against any
current or former officer, Key Employee or employee at a level of Senior Vice
President or above of the Company or any of its Subsidiaries and (ii) neither
the Company nor any of the Subsidiaries have entered into any settlement
agreements related to allegations of sexual harassment or discrimination or
misconduct by any current or former officer, Key Employee or employee at a
level of Senior Vice President or above of the Company or any of its
Subsidiaries.

(g)The Company and each Subsidiary is in compliance in all material respects
with the Worker Adjustment Retraining Notification Act of 1988, as amended
(the "WARN Act"), or any similar Applicable Law. In the past two years, (i)
neither the Company nor any Subsidiary has effectuated a "plant closing" (as
defined in the WARN Act) affecting any site of employment or one or more
facilities or operating units within any site of employment or facility of its
business, (ii) there has not occurred a "mass layoff" (as defined in the WARN Act) affecting any site of employment or
facility of the Company or any Subsidiary and (iii) neither the Company nor
any Subsidiary has been affected by any transaction or engaged in layoffs or
employment terminations sufficient in number to trigger application of any
similar Applicable Law. Neither the Company nor any Subsidiary has caused any
of its employees to suffer an "employment loss" (as defined in the WARN Act)
during the 90-day period immediately preceding the Agreement Date.

2.15Interested-Party Transactions. None of the officers and directors of the
Company or any Subsidiary or any Company Stockholder holding 5% or more of any
class of Company Capital Stock, and, to the actual knowledge (without any duty
of inquiry) of the Company, none of the other employees, consultants and
contractors of the Company or any Subsidiary, none of the other Company
Stockholders of any class of Company Capital Stock, and none of the immediate
family members of any of the foregoing, (i) has any direct or indirect
ownership, participation, royalty or other interest in, or is an officer,
director, employee of or consultant or contractor for any firm, partnership,
entity or corporation that competes with, or does business with, or has any
contractual arrangement with, the Company or any Subsidiary (except with
respect to any interest in less than 5% of the stock of any corporation whose
stock is publicly traded, or in the case of institutional and venture capital
investors, with respect to interests in portfolio companies in arm's length
transactions occurring in the ordinary course of business), (ii) is a party
to, or to the knowledge of the Company, otherwise directly or indirectly
interested in, any Contract to which the Company or any Subsidiary is a party
or by which the Company or Subsidiary or any of their respective assets is
bound, except for (A) normal compensation for services as an officer, director
or employee thereof or (B) any Contract with the Company pursuant to which
such person became such an officer, director, owner of Company Capital Stock,
employee, consultant or contractor (including any standard offer letter and/or
proprietary information and invention assignment agreements executed in favor
of the Company at the time of the hiring of such employee, any standard
consulting agreement executed at the time of the engagement of such consultant
or contractor, or any stock option agreement issued to such employee,
consultant or contractor), as the case may be (collectively, after taking into
consideration such exceptions, the "Related Party Contracts"), (iii) to the
knowledge of the Company, has any interest in any property, real or personal,
tangible or intangible (including any Intellectual Property) that is used in,
or that relates to, the Business, except for the rights of Company
Stockholders under Applicable Law or (iv) owes any money to, or is owed any
money by, the Company.

2.16Insurance. As of the Agreement Date, the Company and the Subsidiaries
maintain the policies of insurance and bonds set forth in Schedule 2.16 of the
Company Disclosure Letter, including all legally required workers'
compensation insurance and errors and omissions, casualty, fire and general
liability insurance. Schedule 2.16 of the Company Disclosure Letter sets
forth, as of the Agreement Date, the name of the insurer under each such
policy and bond, the type of policy or bond, the coverage amount (including
the coverage amounts for claims related to customer indemnification,
liabilities to customers indemnification, liabilities to customers for data
loss and any breaches of customer Contracts), any applicable deductible and
all material claims made under such policies and bonds since January 1, 2017.
The Company has made available to Acquirer true, correct and complete copies
of all such policies of insurance and bonds issued at the request or for the
benefit of the Company or any Subsidiary. There is no claim pending under any
of such policies or bonds as to which coverage has been denied or disputed by
the underwriters of such policies or bonds. All premiums due and payable under
all such policies and bonds have been timely paid and the Company and each
Subsidiary is otherwise in compliance in all material respects with the terms
of such policies and bonds. All such policies and bonds remain in full force
and effect, and the Company has no knowledge of any threatened in writing
termination of, or, as of the Agreement Date, material premium increase with
respect to, any of such policies. 2.17Books and Records. The Company has made available to Acquirer true,
correct and complete copies of (i) all documents identified on the Company
Disclosure Letter, (ii) the certificate of incorporation and bylaws or
equivalent organizational or governing documents of the Company and each
Subsidiary, each as currently in effect, (iii) the minute books containing
records of all consents, actions and meetings of the Board, committees of
Board and the stockholders of the Company and each Subsidiary, since February
10, 2015 (but excluding those records of the Board and committees of the Board
since January 1, 2019 concerning the Company's sale process and negotiation of
and entry into this Agreement and the other Transaction Documents) and (iv)
the stock ledger reflecting all stock issuances and transfers and all stock
option and warrant grants and agreements of the Company or any Subsidiary. The
minute books of the Company and each Subsidiary contain a summary that is
true, correct and complete in all material respects of all meetings of
directors and of the stockholders or actions by written consent since the time
of incorporation of the Company and the respective Subsidiaries. The books,
records and accounts of the Company and the Subsidiaries (A) have been
maintained in accordance with reasonable business practices on a basis
consistent with prior years, (B) are stated in reasonable detail and
accurately and fairly reflect all of the material transactions and
dispositions of the assets and properties of the Company and such Subsidiaries
and (C) to the extent applicable, accurately and fairly reflect the basis for
the Financial Statements.

2.18Material Contracts.

(a)Schedules 2.18 (a)(i) through (xxv) of the Company Disclosure Letter set
forth a list of each of the following Contracts to which the Company or any
Subsidiary is a party, or to which the Company or any Subsidiary or any of
their respective assets or properties are bound that are in effect on the
Agreement Date (the "Material Contracts"):

i.any Contract with a Significant Customer or Significant Supplier;

ii.any Contract providing for payments to the Company or any Subsidiary (or
under which the Company or any Subsidiary has made payments) since August 1,
2017 in an annual amount of $1,000,000 or more;

iii.any dealer, distributor, referral or similar agreement, or any Contract
providing for the grant of rights to reproduce, license, market, refer or sell
its products or services to any other Person;

iv.(A) any partnership, joint venture or joint marketing Contract, (B) any
Contract that involves a sharing of revenues, profits, cash flows, expenses or
losses with other Persons and (C) any Contract that involves the payment of
royalties to any other Person;

v.any separation agreement, severance agreement or release with any current or
former employees under which the Company or any Subsidiary has or would
reasonably be expected to have any actual or potential liability and was
entered into since January 1, 2017;

vi.any Contract (A) that limits or restricts or purports to limit or restrict
the freedom of the Company, any Affiliate of the Company (including, from and
after the Closing, the Acquirer and its Subsidiaries) or any of their
respective successors or assigns to own or make use of assets, property or
rights, engage or participate, or compete with any other Person, in any line
of business, market or geographic area, including any grants by the Company or
any Subsidiary of exclusive rights or licenses or limits on the right to sell, distribute or manufacture any
products or services or to purchase or otherwise obtain any software,
components, parts or services, (B) that contains any most favored nation
pricing, "take or pay," minimum commitments or similar provisions that limit
the freedom of the Company or any of its Affiliates (including, from and after
the Closing, the Acquirer and its Subsidiaries) to freely set prices for its
products, services or technologies or (C) that, for Contracts entered into
since January 1, 2017, contains any non-solicitation covenants or other
similar restrictions against the Company or any of its Affiliates (including,
from and after the Closing, the Acquirer and its Subsidiaries) soliciting or
hiring potential employees, consultants, contractors or other suppliers or
customers, including any Contracts set forth on Schedule 2.14(d) of the
Company Disclosure Letter that fall into this category;

vii.other than Standard Inbound Licenses, all licenses, sublicenses and other
Contracts to which the Company or any Subsidiary is a party and pursuant to
which the Company or any Subsidiary acquired or is authorized to use any
Intellectual Property Rights contained in Third-Party Intellectual Property
used in the development, marketing, offering, provision, distribution, sale or
licensing of the Company Products;

viii.other than Standard Outbound Licenses, any license, sublicense or other
Contract to which the Company or any Subsidiary is a party and pursuant to
which any Person is authorized to use any Intellectual Property Rights
contained in Company-Owned Intellectual Property;

ix.any license, sublicense or other Contract pursuant to which the Company or
any Subsidiary has agreed to any restriction on the right of the Company or
any Subsidiary to use, assert or enforce any Intellectual Property Rights
contained in Company-Owned Intellectual Property (other than non-exclusive
licenses granted in the ordinary course of business consistent with past
practice), or pursuant to which the Company agrees to encumber (other than
grants of non-exclusive licenses in the ordinary course of business consistent
with past practice), transfer or sell rights in or with respect to any
Intellectual Property Rights contained in Company-Owned Intellectual Property;

x.any Contracts relating to the membership of, or participation by, the
Company or any Subsidiary in, or the affiliation of the Company or any
Subsidiary with, any patent pool, industry standards group or association or
similar organization;

xi.any Contract providing for the development of any software or other
Intellectual Property, independently or jointly, either by or for the Company
or any Subsidiary (other than employee invention assignment agreements and
consulting agreements with Authors substantially on the Company's standard
form of agreement, copies of which have been made available to Acquirer);

xii.any Contract to license or authorize any third party to manufacture or
distribute any of the Company Products or Company-Owned Intellectual Property;

xiii.any terms of service entered into by end users of the Company Products
since June 1, 2018 containing any indemnification, limitation on liability,
warranty, support, maintenance or service obligation or cost on the part of
the Company or any Subsidiary that deviates in any material respect from the
Company's standard forms;

xiv.any settlement agreement with respect to any Legal Proceeding; xv.any Contract or plan (including any stock option, merger or stock bonus
plan) relating to the sale, issuance, grant, exercise, award, purchase,
repurchase or redemption of any shares of Company Capital Stock or any other
securities of the Company or any options, warrants, convertible notes or other
rights to purchase or otherwise acquire any such shares of stock, other
securities or options, warrants or other rights therefor, except for the
repurchase rights disclosed on Schedule 2.2(a) or Schedule 2.2(b) of the
Company Disclosure Letter;

xvi.any Contract with any labor union, works council or similar labor
organization, or any collective bargaining agreement or similar Contract with
any of their respective employees;

xvii.any Related Party Contract;

xviii.any trust indenture, mortgage, promissory note, loan agreement or other
Contract for the borrowing of money, any currency exchange, commodities or
other hedging arrangement or any leasing transaction of the type required to
be capitalized in accordance with GAAP or evidencing an Encumbrance;

xix.any Contract of guarantee, surety, support, indemnification (other than
Company Intellectual Property Agreements, Standard Inbound Licenses and
Standard Outbound Licenses), assumption or endorsement of, or any similar
commitment with respect to, the Liabilities or indebtedness of any other
Person;

xx. any Contract pursuant to which the Company or any Subsidiary is a lessor,
sublessor, lessee or sublessee of any real property or any machinery,
equipment, motor vehicles, office furniture, fixtures or other personal
property;

xxi.any power of attorney other than routine powers of attorney relating to
representation before Governmental Entities or relating to recordation of
assignments of Intellectual Property;

xxii.any Contract pursuant to which the Company has acquired a business or
entity, or assets of a business or entity, whether by way of merger,
consolidation, purchase of stock, purchase of assets, license or otherwise, or
any Contract pursuant to which it has any ownership interest in any other
Person;

xxiii.any Direct Government Contract;

xxiv.any Company Government Subcontract; and

xxv.any Contract for the disposition of any material assets or properties.

(b)All Material Contracts are in written form. The Company and each Subsidiary
has performed all of the material obligations required to be performed by it
in accordance with the terms of the respective Material Contract and is
entitled to all benefits under, and is not alleged to be in material default
in respect of, any Material Contract. Each of the Material Contracts is in
full force and effect, subject only to (x) the effect, if any, of applicable
bankruptcy and other similar Applicable Law affecting the rights of creditors generally and rules of law governing specific
performance, injunctive relief and other equitable remedies and (y)
terminations following the Agreement Date in accordance with Section 4.2.
There exists no default or event of default with respect to the Company or any
Subsidiary or, to the knowledge of the Company, with respect to any other
contracting party, that, with the giving of notice, the lapse of time or the
happening of any other event or condition, would reasonably be expected to (i)
become a default or event of default under any Material Contract or (ii) give
any third party (A) the right to declare a default under any Material
Contract, (B) the right to a rebate, chargeback, refund, credit, penalty or
change in delivery schedule under any Material Contract, (C) the right to
accelerate the maturity or performance of any obligation of the Company or any
Subsidiary under any Material Contract, or (D) the right to cancel, terminate
or materially modify any Material Contract. Neither the Company nor any
Subsidiary has received any written notice regarding any actual or alleged
material violation or material breach of any Material Contract or default
under any Material Contract, in each case by the Company or its applicable
Subsidiary. As of the Agreement Date, neither the Company nor any Subsidiary
has received any written notice from a counterparty to a Material Contract
expressing its intention to cancel or materially modify any Material Contract.
Neither the Company nor any Subsidiary has any Liability for renegotiation of
Government Contracts. True, correct and complete copies of all Material
Contracts have been made available to Acquirer.

2.19Transaction Fees. No broker, finder, financial advisor, investment banker
or similar Person is entitled to any brokerage, finder's or other fee or
commission in connection with the origin, negotiation or execution of this
Agreement or in connection with the Transactions. Set forth in Schedule 2.19
of the Company Disclosure Letter is the Company's good faith estimate of all
Transaction Expenses (including Transaction Expenses reasonably anticipated to
be incurred in the future).

2.20Antitrust Laws. Neither the Company, nor any Subsidiary has taken, or
failed to take any action, either directly or indirectly, that constituted a
violation of any Antitrust Laws.

2.21Anti-Corruption Law.

(a)Neither the Company, its Subsidiaries, nor any of their respective
directors, officers, or employees, or, to the knowledge of the Company, their
respective distributors, resellers, agents, sales intermediaries, or
Representatives (in each case, acting in their capacities as such) has, since
the inception of the Company, directly or indirectly through its
representatives or any Person authorized to act on its behalf, (i) violated
any Anti-Corruption Law or (ii) offered, given, promised to give or authorized
the giving of money or anything of value, to any Government Official or to any
other Person: (A) for the purpose of (I) corruptly or improperly influencing
any act or decision of any Government Official in their official capacity,
(II) inducing any Government Official to do or omit to do any act in violation
of their lawful duties, (III) securing any improper advantage or (IV) inducing
any Person to use his or her respective influence with a Governmental Entity
to affect any act or decision of such Governmental Entity in order to, in each
case of clauses (I) through (IV), assist the Company in obtaining or retaining
business for or with, or directing business to, any Person or (B) in a manner
that would constitute or have the purpose or effect of public or commercial
bribery, acceptance of, or acquiescence in, extortion, kickbacks or other
unlawful or improper means of obtaining business or any improper advantage.

(b)The Company and its Subsidiaries have maintained complete and accurate
books and records reflecting payments to any agents, consultants,
representatives, third parties and Government Officials, in accordance with
the Company Accounting Principles. The Company and each Subsidiary have in
place controls and systems designed to ensure compliance with the Anti-
Corruption Laws, and there have been no false or fictitious entries made in the books and records
of the Company or its Subsidiaries relating to any unlawful offer, payment,
promise to pay or authorization of the payment of any money, or unlawful
offer, gift, promise to give, or authorization of the giving of anything of
value, including any bribe, kickback or other illegal or improper payment.

(c)Neither the Company, its Subsidiaries, nor any of their respective
directors, officers or employees, or, to the knowledge of the Company, their
respective distributors, resellers, agents, sales intermediaries, or
Representatives or other persons acting on behalf of any of the Company or any
of its Subsidiaries (in each case, acting in their capacities as such) (i) has
used or is using any corporate funds for any illegal contributions, gifts,
entertainment or other unlawful expenditures, (ii) has used or is using any
corporate funds for any direct or indirect unlawful payments to any official,
employee or representative of a Governmental Entity, any political party or
official thereof, any candidate for political office, or any other person,
(iii) has violated or is violating any provision of Anti-Corruption Laws, (iv)
has established or maintained, or is maintaining, any secret, illegal or
unrecorded fund of corporate monies or other properties or (v) has engaged or
is engaged in any activity that would constitute any bribe, unlawful rebate,
payoff, influence payment, kickback or other unlawful payment of any nature.

(d)Neither the Company, its Subsidiaries, nor any of their respective
directors, officers, or employees, or, to the knowledge of the Company, their
respective distributors, resellers, agents, sales intermediaries, or
Representatives or other person acting on behalf of any of the Company or any
of its Subsidiaries (in each case, acting in their capacities as such), is, or
has been, (i) under administrative, civil, or criminal investigation,
indictment, suspension, debarment, or audit (other than a routine contract
audit) by any party, (ii) under internal investigation by any party, (iii) the
subject of any inquiry or written allegations of any kind, in connection with
alleged or possible violations of any Anti-Corruption Laws or (iv) has
received a whistleblower report of alleged or possible violations of any Anti-
Corruption Laws. Neither the Company, its Subsidiaries, nor any of their
respective directors, officers, or employees, or, to the knowledge of the
Company, their respective distributors, resellers, agents, sales
intermediaries, or Representatives or other persons acting on behalf of any of
the Company or any of its Subsidiaries (in each case, acting in their
capacities as such), has received notice, inquiry, or other communication
from, or made a voluntary disclosure to, the U.S. Department of Justice or
other criminal, civil or administrative enforcement agency of any domestic or
non-U.S. jurisdiction in connection with alleged or possible violations of any
Anti-Corruption Law.

2.22Environmental, Health and Safety Matters.

(a)The Company and each Subsidiary is in compliance in all material respects
with all Environmental, Health and Safety Requirements in connection with the
ownership, use, maintenance or operation of its business or assets or
properties and the production, distribution and sale of its Products. The
Company and each Subsidiary possess all material consents, licenses, permits
or other authorizations of Governmental Entities required under applicable
Environmental, Health and Safety Requirements for the conduct of the Business,
and are, and have been since January 1, 2015, in compliance in all material
respects with the terms and conditions thereof. There are no pending, or to
the knowledge of the Company, any threatened in writing allegations by any
Person that (i) the properties or assets of the Company or any Subsidiary are
not, or that the Business has not been conducted, in compliance with all
Environmental, Health and Safety Requirements or (ii) the Company or any
Subsidiary has not obtained any consent, license, permit or other
authorization of a Governmental Entity required under applicable
Environmental, Health and Safety Requirements. Neither the Company nor any
Subsidiary has knowledge of any actual or threatened (in writing) revocation,
withdrawal, suspension, cancellation, termination, or modification of any
consent, license, permit or other authorization of any Governmental Entity
required under applicable Environmental, Health and Safety Requirements. Neither the
Company nor any Subsidiary has retained or assumed any Liability of any other
Person under any Environmental, Health and Safety Requirements. To the
knowledge of the Company, there are no past or present facts, circumstances or
conditions that would reasonably be expected to give rise to any material
Liability of the Company or any Subsidiary with respect to Environmental,
Health and Safety Requirements.

(b)To the Company's knowledge, none of the property currently or formerly
owned by or leased by or occupied by any of the Company or any of the
Subsidiaries contains (i) any underground storage tank, asbestos, equipment
using PCBs or underground injection well or (ii) any septic system (including
any septic tank or septic leach or drain field) in which process wastewater or
any Materials of Environmental Concern have been disposed. Neither the Company
nor any Subsidiary has received written notice from any Governmental Entity of
liability or potential liability arising out of the generation, handling or
transportation of any Materials of Environmental Concern to a site that: (A)
been placed on the "National Priorities List" of hazardous waste sites or any
similar state list, (B) is otherwise designated or identified as a potential
site for remediation, cleanup, closure or other environmental response
activity or (C) is subject to an Environmental, Health and Safety Requirement
to take "response," "removal" or "remedial" action or to make payment for the
cost of cleaning up any site.

(c)Since January 1, 2015, neither the Company nor any Subsidiary has received
any written notice or other written communication, from a Governmental Entity,
citizens group or other Person that alleges that any Company Product is not in
compliance with any Environmental, Health and Safety Requirements in any
jurisdiction in which the Company Products are manufactured, assembled,
distributed, transported or sold.

(d)The Company has made available to Acquirer a copy of all studies, audits,
assessments or investigations containing material information concerning
compliance with, or Liability or obligations under, Environmental, Health and
Safety Requirements affecting the Company and/or the Subsidiaries that are in
the possession or control of the Company, each of which, if any, is identified
in Schedule 2.22(d) of the Company Disclosure Letter. The Company Products are
and have been in material compliance with Environmental, Health and Safety
Requirements, including any associated marking and labeling requirements.

2.23Import, Export Control and Sanctions Laws. Except as disclosed on Schedule
2.23 of the Company Disclosure Letter, the Company and each of its
Subsidiaries have conducted their import and export transactions in accordance
in all material respects with applicable provisions of (i) United States
export control and sanctions laws (including the International Traffic in Arms
Regulations, the Export Administration Regulations, the regulations
administered by the Department of Treasury, Office of Foreign Assets Control
("OFAC"), and any applicable anti-boycott compliance regulations), (ii) the
import laws and regulations administered by the Bureau of Customs and Border
Protection in the United States Department of Homeland Security, and (iii)
export, sanctions, and import laws of the other countries where they conducted
and currently conduct business (collectively, "Import and Export Laws"), and
neither the Company nor any of its Subsidiaries has received any written
notice of noncompliance, complaints, or warnings with respect to its
compliance with the Import and Export Laws. Without limiting the foregoing:

(a)the Company and each of its Subsidiaries have obtained all export and
import licenses, license exceptions and other consents, notices, waivers,
approvals, orders, authorizations, registrations, declarations and filings
with any Governmental Entity required for (i) the export, import and re-export of products, services, software and technologies and (ii) releases
of technologies and software to foreign nationals located in the United States
and abroad (collectively, "Import and Export Approvals");

(b)the Company and each of its Subsidiaries (i) are in compliance in all
material respects with the terms of all applicable Import and Export Approvals
and (ii) have in place adequate controls and systems to ensure compliance with
applicable Import and Export Laws in each of the jurisdictions in which the
Company and its Subsidiaries currently do business, either directly or
indirectly;

(c)there are no pending or, to the knowledge of the Company, threatened in
writing claims against the Company or any of its Subsidiaries with respect to
alleged noncompliance with such Import and Export Approvals or Import and
Export Laws;

(d)no government approvals for the transfer of Import and Export Approvals to
Acquirer or the Surviving Corporation are required, except for such Approvals
that can be obtained expeditiously and without material cost;

(e) (i) the Company and each Subsidiary (to the extent applicable) has
prepared and timely filed with the Bureau of Industry and Security of the
United States Department of Commerce ("BIS") all required semi-annual reports
of exports of the Company's products made under authority of license exception
ENC, as required by section 740.17(e) of the U.S. Export Administration
Regulations ("EAR"), 15 C.F.R. sec. 740.17(e), and all of the information
contained in each of those semi-annual reports is correct and complete in all
material respects and (ii) the Company's and each Subsidiary's records of all
exports of the Company's and the respective Subsidiaries' products under
authority of license exception ENC are up-to-date, correct, complete and
sufficient to allow Acquirer to prepare and file a correct and complete semi-
annual report of those Company and Subsidiary export transactions with the
Bureau of Industry and Security and the ENC Encryption Request Coordinator
when due following the Closing Date;

(f)neither the Company, nor any of the Subsidiaries, nor any directors,
administrators, officers, directors or, to the knowledge of the Company,
employees of the Company or its Subsidiaries is, or has been within the past
five years, identified on (A) OFAC's List of Specially Designated Nationals
and Blocked Persons; (B) the BIS "Denied Persons List," "Entity List" or
"Unverified List"; or (C) the Office of Defense Trade Controls of the United
States Department of State "List of Debarred Parties";

(g)(i) all transactions engaged in by or on behalf of the Company, directly or
indirectly, involving the sale, licensing, supply, export, re-export, transfer
or furnishing of any of the Company Products, or any software code, other
Intellectual Property or services pertaining to those products, have been
screened against (A) the list of countries that are subject to United States
Government export embargoes and (B) the lists set forth in subsection (g)
above and the lists of parties prohibited or restricted from participating in
any transaction involving commodities, software, other Intellectual Property
or services exported, or to be exported, from the United States (subsections
(A) and (B) collectively "Prohibited and Restricted Parties"), (ii) neither
the Company nor any Subsidiary has sold, licensed, supplied, exported, re-
exported, transferred or furnished any of the Company Products, or any
software code, other Intellectual Property or services, directly or indirectly
to (A) any Person located in, or any national or resident of, any country that
is subject to a United States government export embargo or (B) any Prohibited
and Restricted Party and (iii) none of the Company Products, or any software
code, other Intellectual Property or services pertaining to those products,
have been sold, licensed, supplied, exported, re-exported, transferred or furnished to any
Person for use in any activities directly or indirectly related to the design,
development, production, stockpiling, testing or use of any nuclear, chemical
or biological weapons or missiles;

(h)neither the Company nor or any of its Subsidiaries has made any alteration
of any hardware, software, or any other modification to any of its generally
available commercial off-the-shelf items, software, or services that would
classify any such item, software, or service as a "defense article" or
"defense service," as those terms are defined in the International Traffic in
Arms Regulations, nor does the Company or any of its Subsidiaries have any
knowledge that any other Person made such alteration;

(i)other than as specifically set forth in Schedule 2.23(i) of the Company
Disclosure Letter, none of the Company's nor any Subsidiary's computer program
code (whether in source, executable or other form) has been distributed
outside of the Company and its Subsidiaries, to any publisher or other
customer, partner or other Person, either within the United States or outside
the United States, in violation of applicable Import and Export Laws.

2.24Government Contracts.

(a)With respect to each Government Contract for which performance is ongoing
as of the Agreement Date or which has not been formally closed out as of the
Agreement Date:

i.to the knowledge of the Company, each Government Contract was legally
awarded, is binding on the parties thereto, and is in full force and effect in
accordance with their terms; provided, that for purposes of this clause (i),
the term "Government Contract" shall not include any Bids;

ii.no Governmental Entity, Contractor or other Person or entity has notified
the Company or any of Subsidiary in writing or, to the knowledge of the
Company, orally, that the Company or any Subsidiary has, or may have, breached
or violated any Applicable Law, certification, representation, clause,
provision or requirement pertaining to any Government Contract, including
mischarging, overcharging, defective pricing, fraud, bid rigging, or price
fixing (as such concepts are defined under the state or federal laws of the
United States) in connection with any Government Contract;

iii.all facts set forth in or acknowledged by any representations, claims or
certifications submitted by or on behalf of the Company or any Subsidiary in
connection with any Government Contract were current, accurate and complete as
of their effective dates;

iv.neither the Company nor any Subsidiary has received any written notice of
termination, "show cause" or cure notice pertaining to any Government
Contract;

v.no cost incurred by the Company or any Subsidiary pertaining to a Government
Contract (A) has been questioned in writing provided to the Company or any
Subsidiary by any Governmental Entity, (B) to the knowledge of the Company, is
the subject of any audit (other than routine audits and similar inquiries) or
(C) is under investigation or has been disallowed by any Governmental Entity;
provided that for purposes of this clause (vii) the term "Government Contract"
shall not include any Bids; vi.each of the Company and the Subsidiaries has complied with (A) all
requirements relating to the safeguarding of, and access to, classified
information under each Government Contract and (B) any Applicable Law relating
to the safeguarding of, and access to, classified information (or, in the case
of Contracts governed by Applicable Laws other than the state or federal laws
of the United States, the functional equivalent thereof, if any), and each of
cases of (A) and (B), all violations thereof have been reported to the
appropriate Governmental Entity and contracting parties as required by the
applicable Government Contract or any Applicable Law relating to the
safeguarding of, and access to, classified information;

vii.with respect to each Government Contract, (A) neither the Company nor any
Subsidiary has credible evidence that a Principal, Employee, Agent, or
Subcontractor (as such terms are defined by Federal Acquisition Regulation
("FAR") 52.203-13(a)) of the Company or any Subsidiary has committed a
violation of federal criminal law involving fraud, conflict of interest,
bribery, or gratuity violations found in Title 18 of the United States Code or
a violation of The False Claims Act, 31 U.S.C.  3729 (the "False Claims
Act") and (B) neither the Company nor any Subsidiary has conducted or is
conducting an investigation to determine whether credible evidence exists that
a Principal, Employee, Agent, or Subcontractor (as such terms are defined by
FAR 52.203-13(a)) of the Company or any Subsidiary has committed a violation
of federal criminal law involving a violation of federal criminal law
involving fraud, conflict of interest, bribery, or gratuity violations found
in Title 18 of the United States Code or a violation of the civil False Claims
Act; and

viii.with respect to each Government Contract, (A) neither the Company nor any
Subsidiary has credible evidence of any significant overpayment(s) in
connection with such Government Contract, other than overpayments resulting
from contract financing payments (as defined in FAR 32.001) and (B) neither
the Company nor any Subsidiary has conducted or is conducting an investigation
to determine whether credible evidence exists of any significant
overpayment(s) on such Government Contract, other than overpayments resulting
from contract financing payment (as defined in FAR 32.001); provided that for
purposes of this clause (x) the term Government Contract shall not include any
Bids.

(a)Neither the Company nor any Subsidiary is, nor has any of them ever been,
suspended or debarred from doing business with a Governmental Entity or, to
the knowledge of the Company, proposed for suspension or debarment by a
Governmental Entity, and, to the knowledge of the Company, has not been the
subject of a finding of non-responsibility or ineligibility for contracting
with a Governmental Entity.

(b) (i) Neither the Company, the Subsidiaries, nor any of their respective
directors or officers or Principals (as such term is defined by FAR
52.209-5(a)(2)) is or has been under indictment with respect to any alleged
irregularity, misstatement or omission arising under or relating to any
Government Contract and (ii) neither the Company nor any Subsidiary has
entered into any consent order or administrative agreement relating directly
or indirectly to any such Government Contract.

(c)To the knowledge of the Company, no employee of the Company or any
Subsidiary as of the Agreement Date who was formerly employed by a
Governmental Entity in the ten years immediately preceding the Agreement Date
("Former Government Employee") participated on behalf of the Company
personally and substantially in any procurement decisions by such Governmental
Entity and, to the actual knowledge (without any duty of inquiry) of the
Company, all Former Government Employees are in compliance with all Applicable Laws regarding
post-employment conflict of interest restrictions applicable to such Former
Government Employees.

2.25Customers and Suppliers.

(a)Neither the Company nor any Subsidiary has any outstanding material
disputes concerning any Company Products with any of the top ten (10) largest
managed service provider customers or top ten (10) largest distributors of the
Company and the Subsidiaries, in each case, measured by aggregate contract
value for the two year period ending on April 30, 2020 (each, a "Significant
Customer"), and, as of the Agreement Date, to the knowledge of the Company,
there is no material dissatisfaction on the part of any Significant Customer
with respect to any Company Products. Each Significant Customer is listed on
Schedule 2.25(a) of the Company Disclosure Letter. As of the Agreement Date,
neither the Company nor any Subsidiary has received any written notice from
any Significant Customer that such Significant Customer shall not continue as
a customer of the Company or any Subsidiary (or the Surviving Corporation or
Acquirer) after the Closing or that such Significant Customer intends to
terminate or materially modify existing Contracts with the Company or any
Subsidiary (or the Surviving Corporation or Acquirer). Since January 1, 2015,
neither the Company nor any Subsidiary has had any Company Products returned
by a purchaser thereof except for normal returns (including with respect to
frequency and magnitude) occurring in the ordinary course of business. No
customer, value added reseller or distributor has asserted or threatened in
writing to assert any material claim against the Company of any of its
Subsidiaries alleging injury form the use, ownership or operation of any
Company Products.

(b)(i) Neither the Company nor any Subsidiary has any outstanding material
disputes concerning products and/or services provided by any supplier,
licensor or other third-party vendor who, for the 9-month starting on August
1, 2019 and ending on April 30, 2020, was one of the top ten (10) suppliers of
products and/or services to the Company and the Subsidiaries, based on amounts
paid or payable with respect to such periods or sub-period (as applicable)
(each, a "Significant Supplier"), (ii) as of the Agreement Date, there is no
material dissatisfaction on the part of the Company or any Subsidiary with
respect to any Significant Supplier and (iii) as of the Agreement Date, to the
knowledge of the Company, there is no material dissatisfaction on the part of
any Significant Supplier with respect to the Company or any Subsidiary. Each
Significant Supplier is listed on Schedule 2.25(b) of the Company Disclosure
Letter. As of the Agreement Date, neither the Company nor any Subsidiary has
received written notice from any Significant Supplier that such supplier shall
not continue as a supplier to the Company or any Subsidiary (or the Surviving
Corporation or Acquirer) after the Closing or that such Significant Supplier
intends to terminate or materially modify existing Contracts with the Company
or any Subsidiary (or the Surviving Corporation or Acquirer).

(c)The Company and the Subsidiaries have access, on commercially reasonable
terms, to all products and services (including those provided by its payment
partners) reasonably necessary to carry on the Business.

2.26Stockholder Notice. Neither the Stockholder Notice nor any amendment or
supplement thereto (other than any of the information supplied or to be
supplied by Acquirer in writing specifically for inclusion therein) will
contain, as of the date of the mailing of such document, any untrue statement
of a material fact, or will omit to state any material fact necessary in order
to make the statements therein, in light of the circumstances under which they
are made, not misleading. ARTICLE III.

Representations and Warranties of Acquirer and Merger Sub

Acquirer and Merger Sub represent and warrant to the Company as follows:

3.1Organization and Standing. Each of Acquirer and Merger Sub is a corporation
duly organized, validly existing and in good standing under the laws of its
jurisdiction of organization. Neither Acquirer nor Merger Sub is in violation
of any of the provisions of its articles or certificate of incorporation, as
applicable, or bylaws or equivalent organizational or governing documents.

3.2Authority; Non-contravention.

(a)Each of Acquirer and Merger Sub has all requisite corporate power and
authority to enter into this Agreement and to consummate the Transactions. The
execution and delivery of this Agreement and the consummation of the
Transactions have been duly authorized by all necessary corporate action on
the part of Acquirer and Merger Sub. This Agreement has been duly executed and
delivered by each of Acquirer and Merger Sub and, assuming the due execution
and delivery of this Agreement by the other parties hereto, constitutes the
valid and binding obligation of Acquirer and Merger Sub enforceable against
Acquirer and Merger Sub, respectively, in accordance with its terms, subject
only to the effect, if any, of (i) applicable bankruptcy and other similar
Applicable Law affecting the rights of creditors generally and (ii) rules of
law governing specific performance, injunctive relief and other equitable
remedies.

(b)The execution and delivery of this Agreement by Acquirer and Merger Sub do
not, and the consummation of the Transactions will not, conflict with, or
result in any violation of, or default under (with or without notice or lapse
of time, or both), or give rise to a right of termination, cancellation or
acceleration of any obligation or loss of a benefit under, or require any
consent, approval or waiver from any Person pursuant to, (i) any provision of
the articles or certificate of incorporation, as applicable, or bylaws or
other equivalent organizational or governing documents of Acquirer and Merger
Sub, in each case as amended to date or (ii) Applicable Law, except where such
conflict, violation, default, termination, cancellation or acceleration,
individually or in the aggregate, would not materially impair Acquirer's or
Merger Sub's ability to consummate the Merger or to perform their respective
obligations under this Agreement, and subject in all cases to the making or
receipt of any required consent, approval, order or authorization of, or
registration, declaration or filing with, any banking or other regulatory
authority with jurisdiction over Acquirer or any of its Affiliates.

(c)Except for (i) such filings and notifications as have been made or as may
be required to be made by Acquirer in connection with the Merger and the other
Transactions under the HSR Act or other applicable Antitrust Laws and the
authorizations, approvals, consents, or expiration or early termination of the
applicable waiting periods under the HSR Act or other applicable Antitrust
Laws and (ii) the filing of a registration statement on Form S-8 with the U.S.
Securities and Exchange Commission after the Closing Date covering the shares
of Acquirer Common Stock issuable pursuant to certain Unvested Company
Options, the Excess Promised Option RSUs (if any) and the Retention RSUs
assumed hereunder, no consent, approval, order or authorization of, or
registration, declaration or filing with, any Governmental Entity or any other
Person is required by or with respect to Acquirer or Merger Sub in connection
with the execution and delivery of this Agreement or the consummation of the
Transactions that, if not obtained or made, would reasonably be expected to
adversely affect the ability of Acquirer or Merger Sub to consummate the
Merger or any of the other Transactions. 3.3No Prior Merger Sub Operations. Merger Sub was formed solely for the
purpose of effecting the Merger and has not engaged in any business activities
or conducted any operations other than in connection with the Transactions.

3.4Sufficiency of Funds. Acquirer has, or has available to it, sufficient
funds to consummate the Transactions and satisfy its obligation hereunder.

ARTICLE IV.

Conduct Prior to the Effective Time

4.1.Conduct of the Business; Notices. During the period from the Agreement
Date and continuing until the earlier of the termination of this Agreement and
the Effective Time (the "Pre-Closing Period"), the Company shall, and shall
cause each Subsidiary to (except to the extent expressly provided otherwise
herein, and subject in all cases to (x) changes in Applicable Law occurring
after the Agreement Date, or (y) the prior written consent of Acquirer (it
being hereby agreed by Acquirer that (1) following an e-mail request for
consent by the Company, consent via e-mail from any Acquirer Authorized
Representative shall be deemed written consent for purposes of this Section
4.1 and (2) in the event Acquirer receives a request in a manner specified in
clause (1) above regarding actions to be taken (or omitted to be taken) by the
Company or any of its Subsidiaries in response to COVID-19 that are reasonably
designed to protect the health or welfare of employees or other relevant
individuals (as expressly noted in such request by the Company) and failure to
respond by Acquirer on a timely manner would reasonably be expected to
jeopardize the health or welfare of employees or other relevant individuals,
Acquirer shall be deemed to have consented to such action or omission if it
fails to respond within 24 hours following the receipt of such request)):

(a)use its commercially reasonable efforts to conduct the Business in the
ordinary course consistent with past practice;

(b)(i) pay and perform all of its undisputed debts for borrowed money when due
and other obligations (including Taxes) in the ordinary course of business
consistent with past practice, (ii) use commercially reasonable efforts
consistent with past practice to collect accounts receivable when due and not
extend credit outside of the ordinary course of business consistent with past
practice, (iii) sell the Company's products and services consistent with past
practice as to discounting, license, service and maintenance terms, incentive
programs and revenue recognition and other terms and (iv) use its commercially
reasonable efforts consistent with past practice and policies to preserve
intact its present business organizations, keep available the services of its
present officers and key employees and preserve its relationships with
customers, suppliers, distributors, licensors, licensees, and others having
business dealings with it, including Significant Customers and Significant
Suppliers;

(c)use commercially reasonable efforts to ensure that each of its Contracts
(other than with Acquirer) entered into after the Agreement Date will not
require the procurement of any consent, waiver or novation or provide for any
material change in the obligations of any party thereto in connection with, or
terminate as a result of the consummation of, the Transactions;

(d)maintain each of its leased premises in accordance with the terms of the
applicable lease; and

(e)promptly notify Acquirer upon the Company obtaining actual knowledge
(without any duty of inquiry) of: (i) the Company's receipt of any written
notice from any Person alleging that the consent of such Person is or may be required in connection with the
Transactions; (ii) the Company's receipt of any notice or other communication
(oral or written) from any Governmental Entity (A) relating to the
Transactions, (B) indicating that a Company Authorization has been or is about
to be revoked or (C) indicating that a Company Authorization is required in
any jurisdiction in which such Company Authorization has not been obtained,
which revocation or failure to obtain has had or would reasonably be expected
to be material to the Company; (iii) material inaccuracy in any representation
or warranty or breach of any covenant of the Company herein; and (iv) to the
extent not otherwise required by this Section 4.1, any change, occurrence or
event that, individually or in the aggregate with any other changes,
occurrences and events, would reasonably be expected to cause any of the
conditions to the Closing set forth in Article VI not to be satisfied;
provided that, notwithstanding anything to the contrary in this Section
4.1(e), the failure to provide notice of an inaccuracy in a representation or
warranty (including in relation to any notices regarding Company
Authorizations) shall not be deemed to be a breach of covenant under this
Section 4.1(e), but shall instead only constitute a breach of the underlying
representation or warranty.

4.2.Restrictions on Conduct of the Business. Without limiting the generality
or effect of this Section 4.1, except as expressly set forth on Schedule 4.2
of the Company Disclosure Letter, during the Pre-Closing Period, the Company
shall not, and shall cause each Subsidiary not to do, cause or permit any of
the following (except to the extent expressly provided otherwise herein and
subject in all cases to (x) changes in Applicable Law occurring after the
Agreement Date or (y) the prior written consent of Acquirer (it being hereby
agreed by Acquirer that (1) following an e-mail request for consent by the
Company, consent via e-mail from any Acquirer Authorized Representative shall
be deemed written consent for purposes of this Section 4.2 and (2) in the
event Acquirer receives a request in a manner specified in clause (1) above
regarding actions to be taken (or omitted to be taken) by the Company or any
of its Subsidiaries in response to COVID-19 that are reasonably designed to
protect the health or welfare of employees or other relevant individuals (as
expressly noted in such request by the Company) and failure to respond by
Acquirer on a timely manner would reasonably be expected to jeopardize the
health or welfare of employees or other relevant individuals, Acquirer shall
be deemed to have consented to such action or omission if it fails to respond
within 24 hours following the receipt of such request)):

(a)Charter Documents. Cause, propose or permit any amendments to its
certificate of incorporation or bylaws or equivalent organizational or
governing documents;

(b)Merger, Reorganization. Merge or consolidate itself with any other Person
or adopt a plan of complete or partial liquidation, dissolution,
consolidation, restructuring, recapitalization or other reorganization;

(c)Dividends; Changes in Capital Stock. Declare or pay any dividends on or
make any other distributions (whether in cash, stock or other property) in
respect of any of its Equity Interests, or split, combine or reclassify any of
its Equity Interests or issue or authorize the issuance of any Equity
Interests or other securities in respect of, in lieu of or in substitution for
its Equity Interests, or repurchase or otherwise acquire, directly or
indirectly, any of its Equity Interests, in each case except for Permitted
Issuances;

(d)Material Contracts. Except in the ordinary course of business, consistent
with past practice: (i) enter into, amend or modify any (A) Contract that
would (if entered into, amended or modified prior to the Agreement Date)
constitute a Material Contract or (B) Contract requiring a novation or consent
in connection with the Merger or the other Transactions, (ii) violate,
terminate, amend or modify (including by entering into a new Contract with
such party or otherwise) or waive any of the terms of any of its Material Contracts or of the Written Consent or (iii) enter
into, amend, modify or terminate any Contract or waive, release or assign any
rights or claims thereunder, which if so entered into, modified, amended,
terminated, waived, released or assigned would be likely or reasonably
expected to (A) adversely affect the Company or any Subsidiary (or, following
consummation of the Merger, Acquirer or any of its Affiliates) in any material
respect, (B) impair the ability of the Company or the Stockholders' Agent to
perform their respective obligations under this Agreement or the Written
Consent or (C) prevent or materially delay or impair the consummation of the
Merger and the other Transactions; provided that this Section 4.2(d) shall not
require the Company to seek or obtain Acquirer's consent in order to set or
change the prices at which the Company or any of its Subsidiaries sells
products or provides services to current end users in the ordinary course of
business consistent with past practice;

(e)Issuance of Equity Interests. Issue, deliver, grant or sell or authorize or
propose the issuance, delivery, grant or sale of, or purchase or propose the
purchase of, any Company Voting Debt or any Equity Interests, or enter into or
authorize or propose to enter into any Contracts of any character obligating
it to issue any Equity Interests, other than: (i) the issuance of shares of
Company Common Stock pursuant to the exercise of Company Options or Company
Warrants that are outstanding as of the Agreement Date in accordance with
their current terms and are vested at the time of exercise, (ii) the grant of
the Promised Option RSUs in accordance with Section 5.9(f) and the grant of
the Retention RSUs in accordance with Section 5.9(g), (iii) the issuance of
Company Common Stock upon conversion of Company Preferred Stock outstanding on
the Agreement Date and (iv) the repurchase of any shares of Company Capital
Stock from former employees, non-employee directors and consultants in
accordance with Contracts providing for the repurchase of shares in connection
with any termination of service (clauses (i)-(iv), "Permitted Issuances");

(f)Employees; Consultants; Independent Contractors. (i) Hire, or offer to
hire, any additional officers or other employees, or any consultants or other
service providers, other than (A) employees below the director level in
engineering, product management or sales hired in the ordinary course of
business consistent with past practice, (B) any employees hired to fill
positions in engineering, product management or sales open as of the Agreement
Date and set forth on Schedule 4.2(f) of the Company Disclosure Letter or (C)
engineering, product management or sales positions below the director level
that become open subsequent to the Agreement Date as a result of a current
employee's departure, in each case who receive compensation and benefits
substantially comparable to that which the Company or the applicable
Subsidiary has historically provided to employees in similar positions, (ii)
terminate (other than for "cause" or as a result of termination by the
employee) the employment or change the title, office or position of any
employee with a title of director or higher, (iii) enter into, amend or extend
the term of any employment or consulting agreement with, or Company Option or
Company RSU held by, any current or former employee, non-employee director,
consultant or other service provider, other than the amendment of any Company
Option held by a then-active employee or member of the Board that may expire
prior to the Closing Date in order to facilitate the exercise of such Company
Option by means of a promissory note from the Company to pay the exercise
price and any taxes associated with such exercise (each, an "Option Exercise
Note"), (iv) enter into any Contract with a labor union or collective
bargaining agreement (unless required by Applicable Law) or (v) add any new
members to its board of directors;

(g)Loans and Investments. Make any loans or advances (other than (i) routine
expense advances to employees of the Company or any Subsidiary consistent with
past practice and (ii) the Option Exercise Notes) to, or any investments in or
capital contributions to, any Person, or forgive or discharge in whole or in
part any outstanding loans or advances, or prepay any indebtedness for
borrowed money; (h)Intellectual Property. (i) Except in the ordinary course of business
consistent with past practice, license from any Person any rights to any
Intellectual Property, (ii) transfer or license to any Person any rights to
any Company-Owned Intellectual Property (except with respect to non-exclusive
customer end user licenses or non exclusive licenses granted to channel
partners and non-exclusive licenses granted to manufacturing, technology
alliance partners, or marketing partners, in each case entered into in the
ordinary course of business consistent with past practice), (iii) transfer or
provide a copy of any Company Source Code or any other trade secrets or
confidential information included in the Company-Owned Intellectual Property
to any Person (including any current or former employee or consultant of the
Company or any Subsidiary or any contractor or commercial partner of the
Company or any Subsidiary) (other than providing access to Company Source Code
or any trade secrets or confidential information included in the Company-Owned
Intellectual Property to current employees and consultants of the Company or
any Subsidiary involved in the development of the Company Products on a need
to know basis in the ordinary course of business consistent with past
practice), or (iv) distribute, convey or otherwise make available any Company
Source Code in a manner that would require the disclosure or licensing of any
Company Source Code;

(i)Patents. Other than in the ordinary course of business, take any action
regarding a patent, patent application or other Intellectual Property right,
other than filing continuations for existing patent applications or completing
or renewing registrations of existing patents, domain names, trademarks or
service marks, responding to office actions, and otherwise filing
applications, papers, paying fees, requesting extensions and taking necessary
actions for the prosecution of patents and trademarks in the ordinary course;

(j)Dispositions. Sell, lease, license or otherwise dispose or permit to lapse
of any of its tangible assets, other than sales and nonexclusive licenses of
Company Products in the ordinary course of business consistent with past
practice, or enter into any Contract with respect to the foregoing;

(k)Indebtedness. Incur any indebtedness for borrowed money in excess of
$20,000,000 in the aggregate;

(l)Payment of Obligations. Pay, discharge or satisfy (i) any Liability to any
Person who is an officer, director or stockholder of the Company (other than
compensation due for services as an officer or director) or (ii) any claim or
Liability arising other than in the ordinary course of business consistent
with past practice, other than the payment, discharge or satisfaction of
Liabilities reflected or reserved against in the Financial Statements and
Transaction Expenses, or defer payment of any accounts payable other than in
the ordinary course of business consistent with past practice, or give any
discount, accommodation or other concession other than in the ordinary course
of business consistent with past practice, in order to accelerate or induce
the collection of any receivable;

(m)Capital Expenditures. Make any capital expenditures, capital additions or
capital improvements that are in excess of $300,000 in the aggregate or
outside the ordinary course of business;

(n)Insurance. Materially change the amount of, or terminate, any insurance
coverage, other than the purchase of any directors' and officers' tail
insurance policy;

(o)Termination or Waiver. Cancel, release or waive any material claims or
material rights held by the Company;

(p)Employee Benefit Plans; Pay Increases. (i) Adopt or amend any Company
Employee Plan (other than the adoption of the 2014 Plan Amendment in
accordance with Section 5.9(f)) or other employee or compensation benefit plan, including any stock issuance
or stock option plan, or amend any compensation, benefit, entitlement, grant
or award provided or made under any such plan, except in each case as required
under ERISA, Applicable Law or as necessary to maintain the qualified status
of such plan under the Code, (ii) grant or pay any special bonus or special
remuneration or any other bonus to any employee or non employee director or
consultant, other than in accordance with the terms of a Company Employee Plan
in effect as of the Agreement Date and set forth in the Company Disclosure
Letter, or (iii) increase or offer to increase the salaries, wage rates or
fees of its employees, directors or consultants or other service providers;

(q)Severance Arrangements. Grant or pay, or enter into any Contract providing
for the granting of any severance, retention or termination pay, or the
acceleration of vesting or other benefits, to any Person, other than in
accordance with the terms of a Company Employee Plan in effect as of the
Agreement Date and set forth in the Company Disclosure Letter;

(r)Lawsuits; Settlements. (i) Commence a lawsuit other than (A) for the
routine collection of bills, (B) in such cases where the Company in good faith
determines that failure to commence suit would result in the material
impairment of a valuable aspect of its business (provided that the Company
consults with Acquirer prior to the filing of such a suit) or (C) for a breach
of this Agreement or (ii) settle or agree to settle any pending or threatened
lawsuit or other dispute;

(s)Acquisitions. Acquire or agree to acquire by merging or consolidating with,
or by purchasing a substantial portion of the assets of, or by any other
manner, any business or any corporation, partnership, association or other
business organization or division thereof, or otherwise acquire or agree to
acquire any assets that are material, individually or in the aggregate, to the
Company, any Subsidiary or the Business, or enter into any Contract with
respect to a joint venture, strategic alliance or partnership;

(t)Taxes. Make or change any election in respect of Taxes, adopt or change any
accounting method in respect of Taxes, file any federal, state, or foreign
income Tax Return or any other material Tax Return without the consent of
Acquirer prior to filing, file any amendment to a federal, state, or foreign
income Tax Return or any other material Tax Return, enter into any Tax sharing
or similar agreement or closing agreement, assume any Liability for the Taxes
of any other Person (whether by Contract or otherwise), settle any claim or
assessment in respect of Taxes, consent to any extension or waiver of the
limitation period applicable to any claim or assessment in respect of Taxes,
enter into intercompany transactions giving rise to deferred gain or loss of
any kind or take any other similar action relating to the filing of any Tax
Return or the payment of any Tax if such similar action would have the effect
of increasing the Tax liability of Acquirer or its Affiliates for any period
ending after the Closing Date or decreasing any Tax attribute of the Company
or any of its Subsidiaries existing on the Closing Date;

(u)Accounting. Change accounting methods or practices (including any change in
depreciation or amortization policies) or revalue any of its assets (including
writing down the value of inventory or writing off notes or accounts
receivable otherwise than in the ordinary course of business), except in each
case as required by changes in GAAP as concurred with its independent
accountants and after notice to Acquirer;

(v)Real Property. Enter into any agreement for the purchase, sale or lease of
any real property; (w)Encumbrances. Place or allow the creation of any Encumbrance (other than a
Permitted Encumbrance) on any of its properties;

(x)Sales and Promotional Activities. Engage in (i) any promotional sales or
discount activity with any customers or distributors in which the total amount
of discount offered on the Company's software product would reasonably be
expected to have a value that is equal to or exceeds the amount specified in
Schedule 4.2(x) of the Company Disclosure Letter, (ii) any practice that is
designed to accelerate to pre-Closing periods collections of receivables that
would otherwise be expected (based on past practice) to be made in post-
Closing periods, or (iii) any practice that is designed to postpone to post-
Closing periods payments by the Company that would otherwise be expected
(based on past practice) to be made in pre-Closing periods;

(y)Interested Party Transactions. Enter into any Contract that, if entered
prior to the Agreement Date, would be required to be listed on Schedule 2.15
of the Company Disclosure Letter, other than any Option Exercise Notes;

(z)Subsidiaries. Take any action that would result in the Company having one
or more Subsidiaries; and

(aa)Other. Take or agree in writing or otherwise to take, any of the actions
described in clauses (a) through (z) in this Section 4.2.

4.3.Certain Limitations. Notwithstanding anything to the contrary in this
Article IV, Acquirer and the Company acknowledge and agree that (a) nothing in
this Agreement shall give Acquirer, directly or indirectly, the right to
control or direct the Company's operations for purposes of the HSR Act prior
to the expiration or termination of any applicable waiting period pursuant to
the HSR Act and (b) no consent of Acquirer shall be required with respect to
any matter set forth in this Agreement to the extent the requirement of such
consent would violate any Antitrust Law.

ARTICLE V.

Additional Agreements

5.1.Board Recommendation, Stockholder Approval and Stockholder Notice.

(a)The Board has unanimously recommended that the Company Stockholders vote or
deliver consents in favor of the adoption of this Agreement and the approval
of the Merger, and for the duration of the Pre-Closing Period, neither the
Board nor any committee thereof shall withhold, withdraw, amend or modify, or
propose or resolve to withhold, withdraw, amend or modify in a manner adverse
to Acquirer, the unanimous recommendation of the Board that the Company
Stockholders vote or deliver consents in favor of the adoption of this
Agreement and the approval of the Merger.

(b)The Company shall use its reasonable best efforts to secure, immediately
after the execution and delivery of this Agreement (but no later than three
(3) hours thereafter), the delivery of the Written Consent, which shall
constitute the Company Stockholder Approval.

(c)Promptly (and in any case within ten (10) days) after the Company obtains
the Company Stockholder Approval through the Written Consent, the Company
shall prepare, with the cooperation of Acquirer, and mail to each Company
Stockholder other than the Consenting Stockholders, a notice (as it may be
amended or supplemented from time to time, the "Stockholder Notice")
comprising (i) the notice contemplated by Section 228(e) of the DGCL or Chapter 13 of the
CCC, to the extent applicable, of the taking of a corporate action without a
meeting by less than a unanimous written consent, (ii) the notice contemplated
by Section 262(d)(2) of the DGCL or Chapter 13 of the CCC, to the extent
applicable, together with copies of Section 262 of the DGCL or Chapter 13 of
the CCC, respectively, and (iii) an information statement to the Company
Stockholders in connection with the solicitation of their signatures to the
Joinder Agreement. The Stockholder Notice shall include (x) a statement to the
effect that the Board had unanimously recommended that the Company
Stockholders vote or deliver consents in favor of the adoption of this
Agreement and the approval of the Merger and (y) such other information as
Acquirer and the Company may agree is required or advisable under Applicable
Law to be included therein. Prior to its mailing, the Stockholder Notice shall
have been approved by Acquirer (such approval not to be unreasonably withheld,
condition or delayed), and, following its mailing, no amendment or supplement
to the Stockholder Notice shall be made by the Company without the approval of
Acquirer (such approval not to be unreasonably withheld, condition or
delayed). Each of Acquirer and the Company agrees to provide promptly to the
other such information concerning its business, financial statements and
affairs as, in the reasonable judgment of Acquirer or of the Company or their
respective counsel, may be required or advisable to be included under
Applicable Law in the Stockholder Notice or in any amendment or supplement
thereto, and Acquirer and the Company agree to cause their respective
Representatives to cooperate in the preparation of the Stockholder Notice and
any amendment or supplement thereto.

5.2.No Solicitation.

(a)During the Pre-Closing Period, neither the Company nor any Subsidiary will,
nor will any of them authorize or permit any of their respective
Representatives to, directly or indirectly, (i) solicit, initiate, seek,
knowingly encourage, facilitate, support or induce the making, submission or
announcement of any inquiry, expression of interest, proposal or offer that
constitutes, or would reasonably be expected to lead to, an Acquisition
Proposal, (ii) enter into, participate in, maintain or continue any
communications (except solely to provide written notice as to the existence of
these provisions) or negotiations regarding, or deliver or make available to
any Person any non-public information with respect to, or take any other
action regarding, any inquiry, expression of interest, proposal or offer that
constitutes, or would reasonably be expected to lead to, an Acquisition
Proposal, (iii) agree to, accept, approve, endorse or recommend (or publicly
propose or announce any intention or desire to agree to, accept, approve,
endorse or recommend) any Acquisition Proposal, (iv) enter into any letter of
intent or any other Contract contemplating or otherwise relating to, or that
would reasonably be expected to lead to, any Acquisition Proposal, (v) submit
any Acquisition Proposal to the vote of any Company Securityholders or
stockholders of any Subsidiary or (vi) enter into any other transaction or
series of transactions not in the ordinary course of business consistent with
past practice, the consummation of which would impede, prevent or materially
delay, or would reasonably be expected to impede, prevent or materially delay,
the consummation of the Merger or the other Transactions. The Company will,
and will cause the Subsidiaries and their respective Representatives to, (A)
immediately cease and cause to be terminated any and all existing activities,
discussions or negotiations with any Persons conducted prior to or on the
Agreement Date with respect to any Acquisition Proposal and (B) immediately
revoke or withdraw access of any Person (other than Acquirer and its
Representatives) to any data room (virtual or actual) containing any non-
public information with respect to the Company or any Subsidiary in connection
with an Acquisition Proposal and request from each Person (other than Acquirer
and its Representatives) the prompt return or destruction of all non-public
information with respect to the Company or any Subsidiary previously provided
to such Person in connection with an Acquisition Proposal. If any of the
Subsidiaries or any of the Company's or Subsidiary's Representatives, whether
in his, her or its capacity as such or in any other capacity, takes any action
that the Company is obligated pursuant to this Section 5.2 not to authorize or permit such
Representative to take, then the Company shall be deemed for all purposes of
this Agreement to have breached this Section 5.2.

(b)The Company shall immediately (but in any event, within 24 hours) notify
Acquirer orally and in writing after receipt by the Company and/or any
Subsidiary (or, to the knowledge of the Company, by any of the Company's or
Subsidiary's Representatives), of (i) any Acquisition Proposal, (ii) any
inquiry, expression of interest, proposal or offer that constitutes, or would
reasonably be expected to lead to, an Acquisition Proposal, (iii) any other
written notice that any Person is considering making an Acquisition Proposal
or (iv) any request for non-public information relating to the Company any
Subsidiary. Such notice shall describe (A) the material terms and conditions
of such Acquisition Proposal, inquiry, expression of interest, proposal,
offer, notice or request and (B) the identity of the Person or Group making
any such Acquisition Proposal, inquiry, expression of interest, proposal,
offer, notice or request. The Company shall keep Acquirer reasonably informed
of the status and details of, and any material modification to, any such
inquiry, expression of interest, proposal or offer and any correspondence or
communications related thereto and shall provide to Acquirer a true, correct
and complete copy of such inquiry, expression of interest, proposal or offer
and any amendments, correspondence and communications related thereto, if it
is in writing, or a reasonable written summary thereof, if it is not in
writing. The Company shall provide Acquirer with 48 hours prior notice (or
such lesser prior notice as is provided to the members of the Board) of any
meeting of the Board at which the Board is reasonably expected to discuss any
Acquisition Proposal.

5.3.Confidentiality; Public Disclosure.

(a)The parties hereto acknowledge that Acquirer and the Company have
previously executed a mutual non-disclosure agreement, dated as of February
11, 2020 (the "Confidentiality Agreement"), which shall continue in full force
and effect in accordance with its terms. Each party hereto agrees that it and
its Representatives shall hold the terms of this Agreement, and the fact of
this Agreement's existence, in strict confidence. Except to the extent
necessary for purposes of the Stockholder Notice or as otherwise permitted
under this Section 5.3, at no time shall any party hereto disclose any of the
terms of this Agreement (including the economic terms) or any non-public
information about a party hereto to any other Person without the prior written
consent of the party hereto to which such non-public information relates.
Notwithstanding anything to the contrary in the foregoing, a party hereto
shall be permitted to disclose any and all terms to its financial, tax and
legal advisors (each of whom is subject to a similar obligation of
confidentiality), and to any Governmental Entity or administrative agency to
the extent necessary or advisable to comply with Applicable Law and the rules
of NYSE. The Stockholders' Agent hereby agrees to be bound by the terms and
conditions of the Confidentiality Agreement to the same extent as though the
Stockholders' Agent were a party thereto; provided that the Stockholders'
Agent shall be permitted to disclose Confidential Information to the Advisory
Group in its capacity as such to the extent necessary or incidental to its
services and responsibilities under Section 8.7 of this Agreement. With
respect to the Stockholders' Agent, as used in the Confidentiality Agreement,
the term "Confidential Information" shall also include information relating to
the Merger or this Agreement received by the Stockholders' Agent after the
Closing or relating to the period after the Closing.

(b)The Company shall not, and shall cause each Subsidiary and their respective
Representatives not to, issue any press release or other public communications
(except to the extent consistent with, and containing only information already
included in, any press release or other public communications previously
issued or made in accordance with this Agreement) relating to the terms of
this Agreement or the Transactions or use Acquirer's name or refer to Acquirer
directly or indirectly in connection with Acquirer's relationship with the Company in any media
interview, advertisement, news release, press release or professional or trade
publication, or in any print media, whether or not in response to an inquiry,
without the prior written approval of Acquirer, except to the extent (i)
required by Applicable Law (in which case such party shall promptly notify
Acquirer of this and cooperate with Acquirer to the extent practicable so as
to seek to limit the information disclosed to the information it is advised by
counsel is required by such Applicable Law to be disclosed), (ii) as
reasonably necessary for the Company to obtain the Written Consent and the
other consents and approvals of the Company Stockholders and other third
parties contemplated by this Agreement, (iii) necessary to enforce such
party's rights under this Agreement or any other Transaction Document, (iv)
such information is or becomes generally known to the public without violation
of this Agreement or the Confidentiality Agreement or any other agreement or
obligations restricting the disclosure of such information by such party or
(v) made by a Company Stockholder permitted by, and in accordance with, the
confidentiality terms set forth in the Joinder Agreement. Notwithstanding
anything to the contrary contained herein or in the Confidentiality Agreement,
Acquirer may make such public communications regarding this Agreement or the
Transactions as Acquirer may determine is reasonably appropriate.

5.4.Reasonable Best Efforts; Regulatory Approvals.

(a)Subject to other provisions in this Section 5.4, each of the parties hereto
agrees to use its reasonable best efforts, and to cooperate with each other
party hereto, to take, or cause to be taken, all actions, and to do, or cause
to be done, all things necessary, appropriate or desirable to consummate and
make effective the Merger and the other Transactions, including the
satisfaction of the respective conditions set forth in Article VI, and
including to execute and deliver such other instruments and do and perform
such other acts and things as may be necessary or reasonably desirable for
effecting completely the consummation of the Merger and the other
Transactions.

(b)Acquirer and the Company each shall (or each shall cause its ultimate
parent entities as that term is defined in the HSR Act) to file a notification
under the HSR Act and under the Austrian Cartel Act in connection with the
Merger within 10 Business Days after the Agreement Date. Acquirer and the
Company shall promptly execute and file, or join in the execution and filing
of, any additional application, notification (including the provision of any
required information in connection therewith) or other document that may be
required in order to obtain the authorization, approval or consent of any
Governmental Entity, or expiration or termination of the applicable waiting
periods under such Antitrust Laws, that may be reasonably required, or that
Acquirer may reasonably request to be made, in connection with the
consummation of the Merger and the other Transactions. Acquirer and the
Company shall each use their respective commercially reasonable efforts to
obtain, and to cooperate with each other to obtain promptly, all such
authorizations, approvals, consents, expirations and terminations, and
Acquirer shall pay any filing fees associated therewith.

(c)Notwithstanding anything to the contrary contained herein, it is expressly
understood and agreed that Acquirer shall be under no obligation to (and,
without the prior written consent of Acquirer, the Company shall not) proffer,
make proposals, negotiate, execute, carry out or submit to agreements or
Orders providing for (i) the sale, transfer, license, divestiture, encumbrance
or other disposition or holding separate (through the establishment of a trust
or otherwise) of any assets, categories of assets, operations or categories of
operations of Acquirer or any of its Affiliates or of the Company or any of
its Affiliates, (ii) the discontinuation of any product or service of Acquirer
or any of its Affiliates or of the Company or any of its Affiliates, (iii) the
licensing or provision of any technology, software or other Intellectual
Property of Acquirer or any of its Affiliates or of the Company or any of its
Affiliates to any Person, (iv) the imposition of any limitation or regulation
on the ability of Acquirer or any of its Affiliates or the Company or any of its Affiliates to freely
conduct their business or own their respective assets, (v) the holding
separate of the shares of Company Capital Stock or any of the assets,
properties or rights of the Acquirer, the Company or any of their respective
Affiliates or any limitation or regulation on the ability of Acquirer or any
of its Affiliates to exercise full rights of ownership of the shares of
Company Capital Stock or of the Acquirer, the Company or any of their
respective Affiliates to exercise full rights of ownership of the assets,
properties and rights of the Acquirer, the Company or any of their respective
Affiliates or (vi) any actions that are not conditioned on the consummation of
the Merger, if taking any such action described in (i) through (vi) above
would be reasonably expected to have, either individually or in the aggregate,
a material and adverse impact on Acquirer, the Company or any of their
respective Subsidiaries (it being understood and agreed that, for purposes of
this Section 5.4(c), a material and adverse impact shall be measured relative
to the size of the Company and its Subsidiaries, taken as a whole, regardless
of whether such actions are imposed on, or affect Acquirer, the Company, or
any of their respective Subsidiaries (any one or more of the foregoing, an
"Antitrust Restraint").

(d)Each of Acquirer and the Company shall promptly inform the other of any
material communication between such party and any Governmental Entity
regarding any of the Transactions. Subject to Applicable Law relating to the
exchange of information, Acquirer shall have the right (i) to direct overall
strategy with respect to any Governmental Entity relating to the Transactions
and (ii) to have its outside legal counsel review in advance any filing,
application, notification or other material document to be submitted by the
Company to any Governmental Entity under any Antitrust Law. To the extent
practicable, each Party shall consult with the other Party and consider in
good faith the views of such other Party with respect to the information
related to such other Party that appears in any such filing, application,
notification or other document. If Acquirer or any Affiliate of Acquirer
receives any formal or informal request for supplemental information or
documentary material from any Governmental Entity with respect to any of the
Transactions, then Acquirer shall make or cause to be made, as soon as
reasonably practicable, a response in compliance with such request. If the
Company or any Affiliate of the Company receives any formal or informal
request for supplemental information or documentary material from any
Governmental Entity with respect to any of the Transactions, then the Company
shall make or cause to be made, a response in compliance with such request.
The Company shall not, without the prior written consent of Acquirer, (A)
participate or permit any of the Company's Representatives to participate in
any material meeting with any Governmental Entity relating to the Transactions
unless the Company consults with Acquirer in advance and, to the extent
permitted by such Governmental Entity, grants Acquirer the opportunity to
attend and lead the discussions at such meeting or (B) proffer, make
proposals, negotiate, execute, carry out or submit to any agreements or Orders
providing for any actions that would constitute an Antitrust Restraint.

5.5.Third-Party Consents; Notices.

(a)During the Pre-Closing Period, the Company shall use its commercially
reasonable efforts to (x) obtain prior to the Closing such consents and
authorizations of third parties and (y) give notices to third parties, in each
case as are listed on Schedule 5.5; provided that the Company shall not be
obligated to (and, without the prior written consent of Acquirer, the Company
shall not) make any payment or any commercial concession to any third party,
or incur any Liability, as a condition to (or in connection with) obtaining
any such consent or authorization. The Company will (i) consult with Acquirer
beforehand regarding the process for seeking such consents and authorizations
and providing such notices, (ii) provide Acquirer with a reasonable
opportunity to review and comment in advance on the forms of such consent and
authorization requests and notices, and (iii) incorporate any reasonable
comments thereto made by Acquirer. (b)The Company shall timely give all notices and other information required to
be given to the employees of the Company or any Subsidiary, any collective
bargaining unit representing any group of employees of the Company or any
Subsidiary, and any applicable Governmental Entity under the WARN Act, the
National Labor Relations Act, as amended, the Code, COBRA and other Applicable
Law in connection with the Transactions. Any such notice shall be subject to
review and advance approval by Acquirer, such approval not to be unreasonably
withheld, delayed or denied.

5.6.Litigation. The Company shall (i) notify Acquirer in writing promptly
after learning of any Legal Proceeding initiated by or against it or any
Subsidiary, or known by the Company to be threatened in writing against the
Company or any Subsidiary, or any of their respective directors, officers or
employees or the Company Stockholders in their capacity as such (a "New
Litigation Claim"), (ii) notify Acquirer of ongoing material developments in
any New Litigation Claim or other ongoing litigation in which the Company or
any of its Subsidiaries is involved, whether as plaintiff, defendant,
intervenor, or otherwise ("Other Litigation Claim") and (iii) consult in good
faith with Acquirer regarding the conduct of the defense of any New Litigation
Claim or Other Litigation Claim.

5.7.Access to Information.

(a)During the Pre-Closing Period, (i) the Company shall use its commercially
reasonable efforts (subject in all cases to (x) Applicable Law and (y) any
applicable logistical restrictions or limitations as a result of the effects
of COVID-19 or "shelter-in-place" requirements; provided that, in such
instance under clause (y), the Company shall reasonably cooperate with
Acquirer to provide such access in a manner (including through virtual
meetings or access to electronic files) that would not be subject to such
logistical restrictions or limitations) to afford Acquirer and its
Representatives reasonable access during business hours to (A) the Company's
and each of the Subsidiaries' properties, personnel, books, Contracts and
records and (B) all other information concerning the business, properties and
personnel of the Company or any Subsidiary as Acquirer may reasonably request
and which is in the possession or under the control of the Company or any of
its Subsidiaries and (ii) the Company shall provide to Acquirer and its
Representatives true, correct and complete copies of the Company's and each
Subsidiary's (A) internal financial statements, (B) Tax Returns, Tax elections
and all other records and workpapers relating to Taxes, (C) a schedule of any
deferred intercompany gain or loss with respect to transactions to which the
Company has been a party, (D) records and information reasonably requested in
writing by Acquirer to allow Acquirer to reasonably assess the compliance
status of the Company and its Subsidiaries, and (E) receipts for any Taxes
paid to foreign Tax Authorities; provided that (1) such access does not
unreasonably interfere with the normal operations of the Company or the
Subsidiaries, (2) all requests for such access shall be directed to the
General Counsel of the Company or such other Person as the Company may
designate in writing from time to time, and (3) nothing herein shall require
the Company to provide access to, or to disclose any information to, Acquirer
or any of its Representatives if such access or disclosure, in the good faith
reasonable belief of the Company, (x) would cause significant competitive harm
to the Company if the Transactions are not consummated, (y) would waive any
legal privilege or (z) would be in violation of Applicable Law or regulations
of any Governmental Entity (including the HSR Act and other Antitrust Laws) or
the confidentiality provisions of any Contract to which the Company is a party
as of the Agreement Date; provided, however, that, in each such instances, the
Company shall inform Acquirer of the general nature of the access or
information being withheld and, upon Acquirer's request, reasonably cooperate
with Acquirer to provide such access or information, in whole or in part, in a
manner that would not result in any of the outcomes described in the foregoing
clauses (x), (y) and (z). (b)Subject to compliance with Applicable Law, for the duration of the Pre-
Closing Period, the Company shall confer from time to time as reasonably
requested by Acquirer with one or more Representatives of Acquirer to discuss
any material changes or developments in the operational matters of the Company
and each Subsidiary and the general status of the ongoing operations of the
Company and each Subsidiary.

(c)No information or knowledge obtained by Acquirer before or after the
execution of this Agreement, including in connection with due diligence, in
connection with any investigation pursuant to this Section 5.7 or as a result
of any notice from the Company or any of its Representatives, shall affect or
be deemed to modify the rights and remedies of Acquirer in connection with any
representation, warranty, covenant, agreement, obligation or condition set
forth herein or in any other Transaction Document (except to the extent
disclosed in the Company Disclosure Letter, subject to any limitations
expressly set forth in the opening paragraph of Article II).

(d)Within five (5) days following the Agreement Date, the Company shall
deliver to Acquirer one or more DVDs or other digital media evidencing the
documents that were made available, which shall indicate, for each document,
the date that such document was first uploaded to the data room.

5.8.Expenses; Company Debt.

(a)Whether or not the Merger is consummated, except as otherwise set forth in
this Agreement, all costs and expenses incurred in connection with this
Agreement and the Transactions (including Transaction Expenses) shall be paid
by the party incurring such expense; provided that (i) at the Closing,
Acquirer shall pay or cause to be paid all Unpaid Transaction Expenses on
behalf of the Company as set forth in clause (c) below and (ii) whether or not
the Merger is consummated, Acquirer shall be solely responsible for all
Audited Interim Financials Expenses.

(b)At, and subject to, the Closing, Acquirer shall repay or cause to be repaid
all Company Debt then outstanding, in accordance with the Funds Flow. The
Company shall deliver to Acquirer, at least four (4) Business Days prior to
the Closing Date, executed payoff letters or similar instruments, in form and
substance reasonably satisfactory to Acquirer, with respect to all Company
Debt outstanding as of the Closing, which letters or instruments (i) provide
for the full payoff and discharge of such Company Debt and the termination and
release of all instruments providing for or related to the Company Debt,
including the related guaranty, Encumbrances and promissory notes, in each
case upon receipt of the applicable payoff amount set forth in such letter or
similar instrument (which amount shall include any premiums above the
principal amount of such Company Debt or any accrued but unpaid interest, fees
and other amounts payable in connection therewith) and (ii) contemplate the
delivery of UCC-3 termination statements and mortgage releases that when filed
or recorded, as the case may be, will be sufficient to release any and all
Encumbrance relating to such Company Debt.

(c)At, and subject to, the Closing, Acquirer shall pay or cause to paid, in
accordance with the Funds Flow, the Unpaid Transaction Expenses payable to
each Person with respect to which the Company has delivered either a written
acknowledgement or a final invoice, bill or statement of services in
accordance with this Section 5.8(c); provided that, after the Closing,
Acquirer shall pay or cause to be paid all Unpaid Transaction Expenses payable
to any other Person in accordance with the Funds Flow within four (4) Business
Days following the receipt by Acquirer of a written acknowledgement or a final
invoice, bill or statement of services relating to such Unpaid Transaction
Expenses from such other Person. The Company shall use commercially reasonable
efforts to deliver to Acquirer, at least two (2) Business Days prior to the
Closing Date, written acknowledgments pursuant to which each Person that is entitled to any Unpaid Transaction Expenses acknowledges (A) the total amount
of Transaction Expenses that has been incurred and remains payable to such
Person as of the Closing and (B) that, upon payment of such remaining payable
amount at the Closing, it shall be paid in full and shall not be owed any
other amount (whether or not then due and payable) by any of Acquirer, the
Company, its Affiliates, the Surviving Corporation or any combination thereof.
With respect to any such Person for which the Company has not delivered the
written acknowledgement pursuant to this Section 5.8(c), the Company shall use
commercially reasonable efforts to deliver, at least two (2) Business Days
prior to the Closing Date, a final invoice, bill or statement of services from
such Person setting forth the total amount of Transaction Expenses that has
been incurred and remain payable to such Person as of the Closing.

5.9.Employees.

(a)With respect to matters described in this Section 5.9, the Company will
consult with Acquirer (and will consider in good faith the advice of Acquirer)
prior to sending any written notices or other written communication materials
to its employees.

(b)Prior to the Effective Time and subject to Applicable Law, the Company
shall use its commercially reasonable efforts to: (i) provide a notice of
termination of employment or of the service relationship to each Non-
Continuing Employee, (ii) obtain a valid and enforceable general release of
claims and (iii) terminate the employment or service relationship of such Non-
Continuing Employee, effective no later than immediately prior to the
Effective Time, including the payment of any severance compensation and/or
benefits, as agreed between the Company and Acquirer.

(c)If David Hughes has not repaid that certain Secured Full Recourse
Promissory Note, dated September 17, 2019, by and between the Company and
David Hughes (the "Hughes Promissory Note") in full prior to the Closing, or
any other employee has not repaid any Option Exercise Note in full prior to
the Closing, the Company shall enter into an agreement with David Hughes or
such employee (each, a "Debt Settlement Agreement"), in a form reasonably
satisfactory to Acquirer, pursuant to which (i) David Hughes or such employee
shall assign to the Company his or her right to receive a portion of the
Closing Payment equal to the aggregate outstanding amount (including principal
amount and interest) under the Hughes Promissory Note or such Option Exercise
Note, as applicable, as of the Closing Date and agree to pay such portion of
the Closing Payment to the Company promptly upon receipt thereof and (ii) in
consideration for such assignment and promise to pay, the Hughes Promissory
Note and any such Option Exercise Note shall be settled in full and terminated
without any further force or effect as of immediately prior to the Closing.

(d)For a period of twelve (12) months following the Effective Time (the
"Benefit Continuation Period"), Acquirer shall provide, or cause the Surviving
Corporation or any of their respective subsidiaries to provide, each
Continuing Employee with (i) a base salary or wage rate that is not less
favorable than the base salary or wage rate (as applicable) provided to such
Continuing Employee as of immediately prior to the Effective Time, and (ii)
cash incentive opportunities (excluding equity-based compensation and change
of control, retention and related incentives) and other benefits (excluding
equity-based compensation and change of control, retention and related
incentives) that are substantially comparable to those provided to similarly
situated employees of Acquirer. Acquirer shall honor in accordance with their
existing terms the severance entitlements in the Company Employee Plans for
those individuals set forth on Schedule 5.9(d), as described opposite such
individual's name on Schedule 5.9(d), subject to any amendment and termination
provisions therein. (e)With respect to each employee benefit plan maintained by Acquirer, the
Surviving Corporation or the relevant subsidiary for the benefit of any
Continuing Employees, subject only to any required approval of the applicable
insurance provider, if any, and applicable plan terms, (i) Acquirer shall
cause to be waived for each Continuing Employee any eligibility waiting
periods, any evidence of insurability requirements and the application of any
pre-existing condition limitations under such plan, to the extent the same
were waived under the corresponding Company Employee Plans in effect
immediately prior to the Closing Date, (ii) each Continuing Employee shall
receive credit for purposes of severance benefits, for purposes of eligibility
for any vacation, sick, and personal time off plans or programs and for
purposes of eligibility and vesting under a US 401(k) plan of Acquirer, the
Surviving Corporation or a relevant subsidiary, in each case for years of
service with the Company prior to the Closing Date, to the extent that (y)
such credit was recognized for the same purposes under the analogous Company
Employee Plan in effect immediately prior to the Closing Date, and (z) such
credit does not result in the duplication of benefits or compensation for the
same period of service, and (iii) Acquirer shall cause each Continuing
Employee to be given credit under such plan for all amounts paid by such
Continuing Employee under any similar Company Employee Plan for the plan year
that includes the Closing Date for purposes of applying deductibles, co-
payments and out-of-pocket maximums as though such amounts had been paid in
accordance with the terms and conditions of the applicable plan maintained by
Acquirer or the Surviving Corporation (or the relevant subsidiary of either
such entity), as applicable, for the plan year in which the Closing Date
occurs.

(f)Prior to the Effective Time, the Company shall adopt the 2014 Plan
Amendment and the Company shall grant Promised Option RSUs from the Company's
2014 Equity Incentive Plan to (x) each individual listed on Schedule 2.2(d) of
the Company Disclosure Letter and (y) any Continuing Employees hired during
the period between the Agreement Date and the Closing Date in accordance with
Section 4.2 and whose offer letters contemplate a grant of equity in
connection the commencement of their employment (any such individuals pursuant
to this clause (y), collectively, the "Permitted New Hires"), with an
aggregate grant-date fair value for each such individual equal to the product
of (i) the excess of (A) the Per Share Consideration Estimate over (B) 3.44,
and (ii) the number of shares of Company Common Stock originally intended to
be subject to the option promised to be granted to such individual, as set
forth adjacent to such individual's name on Schedule 2.2(d) of the Company
Disclosure Letter or, in the case of Permitted New Hires, in such individual's
offer letter. The foregoing grants shall be documented pursuant to restricted
stock unit agreements in the form attached hereto as Exhibit K. Each such
individual's award of Promised Option RSUs shall vest according to the vesting
schedule set forth adjacent to such individual's name on Schedule 2.2(d) of
the Company Disclosure Letter or, in the case of Permitted New Hires, in such
individual's offer letter. Each Promised Option RSU shall be converted into
restricted stock units with respect to Acquiror Common Stock pursuant to
Section 1.3(a)(iv)(B) and shall be settled in Acquirer Common Stock within 30
days following the date on which it vests pursuant to the foregoing schedule.
Each such restricted stock unit award agreement shall provide that the
Promised Option RSU granted pursuant thereto is granted in lieu of and in full
satisfaction of any rights to any options promised by the Company to the
recipient.

(g)Prior to the Effective Time, the Company shall grant the Retention RSUs
(other than the Promised Option RSUs) from the Company's 2014 Equity Incentive
Plan to the Key Employees and certain key Continuing Employees pursuant to
restricted stock unit agreements in the form attached hereto as Exhibit K. The
value of such Retention RSUs granted to each Key Employee shall be set forth
in such Key Employee's Offer Letter. The remainder of the Retention RSUs
(other than the Promised Option RSUs) shall be allocated in its entirety by
Acquirer in mutual agreement with the Company's Chief Executive Officer no
later than ten (10) Business Days prior to the Closing Date. Each award of
Retention RSUs (other than the Promised Option RSUs) shall vest according to
the following schedule, provided that such employee continues in employment with Acquirer or one of
its Subsidiaries through each vesting date: (i) one-third of the Retention
RSUs shall vest upon the one-year anniversary of the Closing Date (the
"Anniversary Date"); and (ii) one-eighth of the remainder of the Retention
RSUs shall vest upon each quarterly anniversary of the Anniversary Date, until
the entire award of Retention RSUs shall have become fully vested by the third
(3rd) anniversary of the Closing Date; provided, however, that the Retention
RSUs for the Holdback Participant shall be subject to the vesting schedule set
forth in his Offer Letter. Each Retention RSU (other than the Promised Option
RSUs) shall be converted into a restricted stock unit with respect to Acquiror
Common Stock pursuant to Section 1.3(b) and shall be settled in Acquirer
Common Stock within 30 days following the date on which it vests pursuant to
the foregoing schedule.

(h)As soon as practicable following the Closing, Acquirer shall grant to
certain key Continuing Employees (i) cash retention awards in an aggregate
amount not to exceed $2,000,000 (the "Post-Closing Cash Retention Awards")
and/or (ii) restricted stock units with respect to Acquirer Common Stock under
any of Acquirer's equity incentive plans with an aggregate grant-date value in
the case of this clause (ii), based on the closing price of Acquirer Common
Stock as reported on NYSE on the date of grant, of the excess of (x) the
Aggregate Retention Award Amount over (y) the sum of (A) the aggregate grant-
date value of the Retention RSUs granted pursuant to Section 5.9(g), (B) the
aggregate grant-date value of the Promised Option RSUs (other than the Excess
Promised Option RSUs) granted pursuant to Section 5.9(f) and (C) the aggregate
value of the Post-Closing Cash Retention Awards (the "Post-Closing Acquiror
RSUs"). The Post-Closing Acquiror RSUs shall be allocated by Acquirer in
consultation with the Company's Chief Executive Officer. Each award of Post-
Closing Acquiror RSUs shall vest according to the following schedule, provided
that such employee continues in employment with Acquirer or one of its
Subsidiaries through each vesting date: (i) one-third of the Post-Closing
Acquiror RSUs shall vest upon the Anniversary Date; and (ii) one-eighth of the
remainder of the Post-Closing Acquiror RSUs shall vest upon each quarterly
anniversary of the Anniversary Date, until the entire award of Post-Closing
Acquiror RSUs shall have become fully vested by the third (3rd) anniversary of
the Closing Date. Each Post-Closing Acquiror RSU shall be settled in Acquirer
Common Stock within 30 days following the date on which it vests pursuant to
the foregoing schedule. The Post-Closing Cash Retention Awards shall vest
according to the same schedule as the Post-Closing Acquiror RSUs or a shorter
schedule as mutually agreed by Acquirer and the Company's Chief Executive
Officer.

(i)Nothing in this Section 5.9 or Section 5.10, whether express or implied,
shall (x) create any rights to continued employment or service, any term or
condition of employment or service with the Acquirer or the Surviving
Corporation or any of their Affiliates or in any way prohibit Acquirer, its
Affiliates, the Surviving Corporation or any of their respective Subsidiaries
of the foregoing from terminating the employment or service of any Continuing
Employee or any other Person at any time and for any or no reason, (y) be
construed as an establishment, termination or amendment of any Company
Employee Plan or any other benefit or compensation plan, program, policy,
contract, agreement or arrangement, or prohibit Acquirer, its Affiliates, the
Surviving Corporation or any of their respective Subsidiaries from
establishing, amending or terminating any Company Employee Plan or any other
benefit or compensation plan, program, policy, contract, agreement or
arrangement or (z) grant any rights or remedies whatsoever, including any
third party beneficiary rights, by reason of this Section 5.9 to any Person
other than the parties.

5.10.Termination of Benefit Plans.

(a)Effective as of the day immediately preceding the Closing Date, the Company
shall terminate any Company Employee Plans intended to include a Section
401(k) arrangement (unless and to the extent that Acquirer provides written notice to the Company no
later than three Business Days prior to the Closing Date that such plans shall
not be terminated). The Company shall provide Acquirer with evidence that such
Company Employee Plan(s) have been terminated (effective no later than the day
immediately preceding the Closing Date) pursuant to resolutions of the Board
or any applicable committee thereof. The form and substance of such
resolutions shall be subject to the reasonable review of Acquirer. The Company
also shall take such other actions in furtherance of terminating such Company
Employee Plan(s) as Acquirer may reasonably require. In the event that
termination of the Company's 401(k) Plan would reasonably be anticipated to
trigger liquidation charges, surrender charges or other fees (not in the
ordinary course of plan termination), then the Company shall reasonably
estimate the amount of such charges and/or fees and provide such estimate in
writing to Acquirer, which charges and/or fees shall be deemed Transaction
Expenses hereunder.

(b)Prior to the Closing Date, the Company will make all required contributions
and pay all premiums required under each Company Benefit Plan which are due on
or before the Closing Date.

5.11.Company Closing Financial Certificate. The Company shall prepare and
deliver to Acquirer a draft of the Company Closing Financial Certificate not
later than six (6) Business Days prior to the Closing Date and a final version
of the Company Closing Financial Certificate to Acquirer not later than four
(4) Business Days prior to the Closing Date. In the event that Acquirer
notifies the Company that there are or may be errors in the drafts of the
Company Closing Financial Certificate, Acquirer and the Company shall discuss
such errors in good faith and the Company shall correct such errors to
Acquirer's reasonable satisfaction prior to delivering the final versions of
the same in accordance with this Section 5.11. Without limiting the foregoing
or Section 5.7, the Company shall provide to Acquirer, together with the
Company Closing Financial Certificate, such supporting documentation,
information and calculations as are reasonably necessary for Acquirer to
verify and determine the calculations, amounts and other matters set forth in
the Company Closing Financial Certificate.

5.12.Tax Matters.

(a)Each of Acquirer, the Stockholders' Agent, the Company Securityholders and
the Company shall cooperate fully, as and to the extent reasonably requested
by any of the others, in connection with the filing of Tax Returns and any
Legal Proceeding with respect to Taxes. Such cooperation shall include the
retention and (upon request therefor) the provision of records and information
reasonably relevant to any such Legal Proceeding and making employees
available on a mutually convenient basis to provide additional information and
explanation of any material provided hereunder. Acquirer, the Company, the
Stockholders' Agent and the Company Securityholders agree to retain all books
and records with respect to Tax matters pertinent to the Company and the
Subsidiaries relating to any taxable period beginning before the Closing Date
until expiration of the statute of limitations of the respective taxable
periods, and to abide by all record retention agreements entered into with any
Tax Authority. Notwithstanding anything to the contrary in this Agreement, the
Stockholders' Agent shall have no obligation to prepare or file any Tax
Returns.

(b)The Company shall cause each Company Securityholder to further agree, upon
request, to use their reasonable best efforts to obtain any certificate or
other document from any Governmental Entity or any other Person as may be
necessary to mitigate, reduce or eliminate any Tax that could be imposed
(including with respect to the Transactions). (c)Acquirer shall prepare and timely file, or cause to be prepared and timely
filed, any Tax Return required to be filed after the Closing Date with respect
to the Company and the Subsidiaries for a Taxable period (or portion thereof)
ending on or prior to the Closing Date (the "Pre-Closing Tax Period"). Such
Tax Returns, to the extent relating to the Pre-Closing Tax Period, shall be
prepared in a manner consistent with the past practice of the Company and the
Subsidiaries, as applicable, except where otherwise required by Applicable Law
or, in respect of transactions between the Company and the Subsidiaries, where
required to conform to any updated transfer pricing analysis completed prior
to the due date of such Tax Return in a manner fully compliant with Applicable
Law relating to transfer pricing; provided that if such transfer pricing
analysis provides a range of margins, Acquirer shall use a margin which is not
higher than the middle of such range. The Company shall prepare and timely
file, or cause to be prepared and timely filed, any Tax Return required to be
filed before the Closing Date with respect to the Company and the
Subsidiaries. Such Tax Returns shall be prepared in a manner consistent with
the past practice of the Company and the Subsidiaries, as applicable, except
where otherwise required by Applicable Law. For the avoidance of doubt, the
Stockholders' Agent shall have no obligation to prepare or file any Tax
Returns of the Company and the Subsidiaries.

(d)Without the prior written consent of the Stockholders' Agent (such consent
not to be unreasonably withheld, conditioned or delayed) or as required by
Applicable Law, Acquirer shall not, and shall cause the Company and the
Subsidiaries not to make or change any Tax election or file an amended Tax
Return, in each case to the extent such Tax election or Tax Return is with
respect to a Pre-Closing Tax Period; provided, that Acquirer may, and may
cause the Company and the Subsidiaries to, file an amended Tax Return in order
to utilize a carryback of an item from a Taxable period (or portion thereof)
beginning on or after the day after the Closing Date (each a "Post-Closing Tax
Period"), to the extent such amended Tax Return would not reasonably be
expected to result in additional Pre-Closing Taxes to the Company, any if its
Subsidiaries or the Company Securityholders. No election under Section 338 or
Section 336 of the Code shall be filed with respect to the Transactions.

(e)Acquirer shall with reasonable promptness notify the Stockholders' Agent
upon the receipt of any notice, or becoming aware, of any audit or other
similar examination with respect to Taxes for which the Converting Holders
would reasonably be expected to be liable pursuant to this Agreement (a "Tax
Contest"). Acquirer shall control, or cause the Surviving Corporation to
control, the conduct of any Tax Contest; provided that if the Converting
Holders may be required to pay for any Indemnifiable Damages resulting from
such Tax Contest, Acquirer shall keep the Stockholders' Agent reasonably
informed of the progress of such Tax Contest to the extent it relates to a
Pre-Closing Tax Period, and shall not settle or compromise any such Tax
Contest without first consulting with the Stockholders' Agent. Acquirer shall
consider the Stockholders' Agent comments to the Tax Contest in good faith.

5.13.280G Stockholder Approval. To the extent any payments made with respect
to, or which arise as a result of, this Agreement or the transactions
contemplated hereby (including in connection with any other event), could be
characterized as an "excess parachute payment" within the meaning of Section
280G(b)(1) of the Code, the Company shall (i) within five (5) Business Days
following the date of this Agreement (and in any event, prior to obtaining the
consent of any recipient of such payment in accordance with (ii) below),
disclose its calculations with respect to such excess parachute payments to
Acquirer, along with the assumptions used to make the calculations and the
data necessary for Acquirer to confirm the accuracy of the calculations, (ii)
promptly seek via a parachute payment waiver, in substantially the form
attached hereto as Exhibit I (the "Parachute Payment Waiver") the consent of
the recipient of any such payment that would otherwise be due and owing that
entitlement to such payment shall be waived, absent 280G Stockholder Approval
(as defined below) and (iii) promptly (and in any case prior to the Closing Date) cause all such payments to be adequately
disclosed to, and obtain the vote (whether of approval or disapproval) of, the
holders of the voting stock of the Company meeting the requirements of the
Code and the applicable treasury regulations ("280G Stockholder Approval"), in
a manner reasonably satisfactory to Acquirer. Acquirer shall have the right to
reasonably review and approve any disclosure required by clause (iii) of the
first sentence of this Section 5.13 before such disclosure is made. Prior to
the Closing, the Company shall deliver to Acquirer notification and
documentation reasonably satisfactory to Acquirer that (i) the 280G
Stockholder Approval was obtained or (ii) the 280G Stockholder Approval was
not obtained and as a consequence, that such payments and/or benefits shall
not be made or provided to the extent they would cause any amounts to
constitute Section 280G Payments, pursuant to the Parachute Payment Waivers.

5.14.Joinder Agreements, Option Cancellation Agreements and Warrantholder
Agreements. The Company shall seek and shall use commercially reasonable
efforts (including through the exercise of all available drag along or similar
rights) to obtain, prior to Closing, a duly executed Joinder Agreement, Option
Cancellation Agreement or Warrantholder Agreement, as applicable, from all
Company Stockholders, Company Optionholders and Company Warrantholders,
respectively (other than those Company Stockholders who have already executed
and delivered a Written Consent).

5.15.Prohibited and Restricted Parties. During the Pre-Closing Period, the
Company shall cooperate in good faith with Acquirer to determine if any of the
Company's or Subsidiary's customers, partners, suppliers or employees are
Prohibited and Restricted Parties and if it is determined that the Company or
any Subsidiary is conducting business with any Prohibited and Restricted
Party, the Company or Subsidiary shall use reasonable best efforts to
terminate such business prior to the Closing.

5.16.Directors' and Officers' Indemnification and Insurance.

(a)If the Merger is consummated, for six years following the Closing, Acquirer
shall cause the Surviving Corporation to fulfill and honor the obligations of
the Company to its officers and directors determined as of immediately prior
to the Effective Time (the "Company Indemnified Parties") pursuant to an
indemnification agreement with the Company (each, a "DandO Indemnification
Agreement") and pursuant to the Certificate of Incorporation or Bylaws (the
"Indemnity Provisions"), in each case, in effect as of the Agreement Date,
with respect to claims arising out of acts or omissions occurring at or prior
to the Effective Time that are asserted after the Effective Time.

(b)Acquirer acknowledges and agrees that the Company intends to, on or prior
to the Closing, purchase tail insurance coverage for the Company Indemnified
Parties (the "DandO Tail Policy"), which shall provide the Company Indemnified
Parties with coverage for six years following the Closing Date in an amount
not less than the existing coverage and that shall have other terms not
materially less favorable to the insured persons than the directors' and
officers' liability insurance coverage maintained by the Company as of the
Agreement Date. Acquirer shall cause the Surviving Corporation to maintain the
DandO Tail Policy in full force and effect and continue to honor the obligations
thereunder until the sixth (6th) anniversary of the Closing Date.

(c)This Section 5.16 (i) shall survive the consummation of the Merger, (ii) is
intended to benefit each Company Indemnified Party and their respective heirs,
(iii) is in addition to, and not in substitution for, any other rights to
indemnification or contribution that any such Person may have against Acquirer
or the Surviving Corporation first arising after the earlier of the Closing
Date and the termination of this Agreement by contract or otherwise, (iv)
shall be binding on all successors and assigns of Acquirer and the Surviving
Corporation, as applicable, (v) shall not be terminated or modified in such a manner as to adversely affect the rights of any Company Indemnified Party
under this Section 5.16 without the written consent of such affected Company
Indemnified Party and (vi) is subject in all respects to Section 8.3(d).

5.17.Termination of Agreements.

(a)The Company shall terminate all those Related Party Contracts set forth on
Schedule 5.17(a) on or prior to the Closing Date, in each case without any
remaining Liability of any kind on the part of the Company, any of its
Subsidiaries or Acquirer as a result of or in connection with such termination
or such Contract.

(b)Any Liabilities of any kind on the part of the Company or any of its
Subsidiaries that arise in connection with the performance or breach by the
Company of this Section 5.17 shall be included in the Transaction Expenses.



5.18.Spreadsheet. The Company shall prepare and deliver to Acquirer the final
version of a spreadsheet (the "Spreadsheet") in form and substance reasonably
satisfactory to Acquirer and the Paying Agent no later than three (3) Business
Days prior to the Closing Date, which Spreadsheet shall (i) be dated as of the
Closing Date, (ii) set forth all of the following information (in addition to
the other required data and information specified therein) as of immediately
prior to the Effective Time, and (iii) be certified as complete, true and
correct as of the Closing Date by the Chief Executive Officer of the Company
(the "Spreadsheet Certificate"); provided that the Company shall deliver to
Acquirer a draft version of the Spreadsheet at least five (5) Business Days
prior to the Closing Date and correct any errors identified by Acquirer to
Acquirer's reasonable satisfaction prior to delivering the final version of
the same in accordance with this Section 5.18:

(a)the names of all of the Company Securityholders (other than a Company
Securityholder that holds only Retention RSUs) and, as shown on the books and
records of the Company, their respective addresses, e-mail addresses, country
of employment and whether such persons were employees or independent
contractors;

(b)the number and type of shares of Company Capital Stock held by, or subject
to the Company Options, Company Warrants, Company RSUs or other forms(s) of
equity compensation award held by, such Company Securityholders and, in the
case of outstanding shares, the respective certificate numbers;

(c)the number of shares of Company Capital Stock subject to and, to the extent
applicable, the exercise price per share in effect for, each Company Option,
Company RSU and Company Warrant;

(d)the grant date and vesting status and schedule with respect to Company
Options, Company Warrants and Company RSUs;

(e)for each Company Option that was early exercised, the Tax status of each
such Company Option under Section 422 of the Code, the date of such exercise
and the applicable exercise price;

(f)the calculation of Fully-Diluted Common Stock (including specification of
the securities that will be excluded pursuant to the proviso to the definition
of Per Share Consideration); (g)the calculation of Total Consideration, Aggregate Exercise Price, Per Share
Consideration, Closing Per Share Consideration, Total Converting Holders
Consideration and the Closing Payment;

(h)the calculation of aggregate cash amounts from the Closing Payment payable
to each Converting Holder pursuant to Section 1.3(a);

(i)the calculation of the Unvested Company Options to be assumed by Acquirer
pursuant to Section 1.3(a)(ii), including corresponding calculations of the
Exchange Ratio and Acquirer Stock Price; and

(j)the calculation of each Converting Holder's Pro Rata Share (expressed as a
percentage) and the aggregate amount of each Converting Holder's contribution
to the Escrow Fund and the Expense Fund, respectively.



5.19.Audited Interim Financials. The Company shall use its reasonable best
efforts to deliver to Acquirer the Audited Interim Financials as soon as
reasonably practicable after the date hereof but in no event later than seven
(7) days prior to the Closing Date. The Company shall use its commercially
reasonable efforts to take the actions described in Schedule 5.19 in relation
to the Audited Interim Financials.

5.20.Specified Actions. The Company and the Holdback Participant shall use
their respective reasonable best efforts to complete the actions described in
Schedule 5.20 as soon as reasonably practicable following the Agreement Date.

ARTICLE VI.

Conditions to the Merger

6.1.Conditions to Obligations of Each Party to Effect the Merger. The
respective obligations of each party hereto to consummate the Transactions
shall be subject to the satisfaction or waiver in writing at or prior to the
Closing of each of the following conditions:

(a)Company Stockholder Approval. The Company Stockholder Approval shall have
been duly and validly obtained.

(b)Illegality. No Order issued by any court of competent jurisdiction or other
legal or regulatory restraint or prohibition preventing the consummation of
the Merger shall be in effect, and no action shall be pending by any
Governmental Entity seeking any of the foregoing, and no Applicable Law or
Order shall have been enacted, entered, enforced or deemed applicable to the
Merger that makes the consummation of the Merger illegal.

(c)Governmental Approvals. All filings with and approvals of any Governmental
Entity required by any Applicable Law to be made or obtained in connection
with the Transactions and that are set forth on Schedule 6.1(c) shall have
been made or obtained and shall be in full force and effect and any applicable
waiting period under (i) the HSR Act (or extension thereof) or (ii) the other
applicable Antitrust Laws listed in Schedule 6.1(c) shall have expired or
early termination of such waiting period shall have been granted by the
applicable Governmental Entity, and there shall be no agreement in effect
between Acquirer, Merger Sub or the Company with any Governmental Entity
preventing the parties from consummating the Transactions. 6.2.Additional Conditions to Obligations of the Company. The obligations of
the Company to consummate the Transactions shall be subject to the
satisfaction or waiver at or prior to the Closing of each of the following
conditions (it being understood and agreed that each such condition is solely
for the benefit of the Company and may be waived by the Company in writing in
its sole discretion without notice or Liability to any Person):

(a)Representations, Warranties and Covenants. The representations and
warranties made by Acquirer herein shall be true and correct in all material
respects (except for such representations and warranties that are qualified by
their terms by a reference to materiality, which representations and
warranties as so qualified shall be true and correct in all respects) on and
as of the Agreement Date and on and as of the Closing Date as though such
representations and warranties were made on and as of such dates (except for
representations and warranties that address matters only as to a specified
date or dates, which representations and warranties shall be true and correct
with respect to such specified date or dates). Acquirer shall have performed
and complied in all material respects with all covenants, agreements and
obligations herein required to be performed and complied with by Acquirer at
or prior to the Closing.

(b)Receipt of Closing Deliveries. The Company shall have received each of the
agreements, instruments, certificates and other documents set forth in Section
1.2(a).

6.3.Additional Conditions to the Obligations of Acquirer. The obligations of
Acquirer and Merger Sub to consummate the Transactions shall be subject to the
satisfaction or waiver at or prior to the Closing of each of the following
conditions (it being understood and agreed that each such condition is solely
for the benefit of Acquirer and Merger Sub and may be waived by Acquirer (on
behalf of itself and/or Merger Sub) in writing in its sole discretion without
notice or Liability to any Person):

(a)Representations, Warranties and Covenants. (i) The representations and
warranties made by the Company in the first sentence of Section 2.1(a)
(Organization), Section 2.3(a) (Authority and Enforceability) and Section
2.5(b) (No Material Adverse Effect) shall be true and correct in all respects,
(ii) the representations and warranties made by the Company in Section 2.2
(Capital Structure) and Section 2.3(d) (State Takeover Statutes) shall be true
and correct in all material respects (except for such representations and
warranties that are qualified by their terms by a reference to materiality or
Material Adverse Effect, which representations and warranties as qualified
shall be true and correct in all respects), and (iii) all other
representations and warranties made by the Company herein shall be true and
correct in all respects (except to the extent that, after disregarding all
references to materiality and Material Adverse Effect in such representations
and warranties, all inaccuracies in and breaches of such representations and
warranties, taken together, do not constitute a Material Adverse Effect with
respect to the Company), in each case, on and as of the Agreement Date and on
and as of the Closing Date as though such representations and warranties were
made on and as of such dates (except for representations and warranties that
address matters only as to a specified date or dates, which representations
and warranties shall be so true and correct with respect to such specified
date or dates). The Company shall have performed and complied in all material
respects with all covenants, agreements and obligations herein required to be
performed and complied with by the Company at or prior to the Closing.

(b)Receipt of Closing Deliveries. Acquirer shall have received each of the
agreements, instruments, certificates and other documents set forth in Section
1.2(b). (c)Restraints on Conduct of Business. No Antitrust Restraint shall be in
effect, and no Legal Proceeding seeking any Antitrust Restraint shall be
pending or threatened in writing.

(d)No Legal Proceedings. No Governmental Entity shall have then commenced or
threatened in writing to commence any Legal Proceeding challenging or seeking
the recovery of a material amount of damages in connection with the Merger or
the other Transactions or seeking to prohibit or limit the exercise by
Acquirer of any material right pertaining to ownership of Equity Interests of
the Surviving Corporation.

(e)No Material Adverse Effect. There shall not have occurred a Material
Adverse Effect with respect to the Company after the Agreement Date that is
continuing.

(f)Key Employees. The Offer Letter with each Key Employee shall be in full
force and effect and each Key Employee shall (i) have remained actively
employed by the Company through the Closing and not have repudiated his Offer
Letter, (ii) not be unable to perform in all material respects his obligations
under the applicable Offer Letter by reason of any fact or circumstance that,
if such fact or circumstance remained in existence, would constitute a
"disability" within the meaning of Section 22(e)(3) of the Code and (iii) not
have committed an act or omission that would permit his termination for
"cause" under the applicable offer letter; provided that, in the case of each
of the individuals identified on Schedule I-2, the foregoing conditions in
clauses (i) and (ii) shall be deemed to be satisfied with respect to such
individual in the event his employment with the Company terminates between the
Agreement Date and the Closing Date by reason of his death or "disability".

(g)Section 280G Matters. The Company shall have delivered to Acquirer the
notification and evidence required by Section 5.13.

ARTICLE VII.

Termination

7.1.Termination. At any time prior to the Closing, this Agreement may be
terminated and the Merger abandoned by authorized action taken by the
terminating party, whether before or after the Company Stockholder Approval is
obtained:

(a)by mutual written consent duly authorized by Acquirer and the Board;

(b)by either Acquirer or the Company, by written notice to the other, if the
Closing shall not have occurred on or before January 7, 2021, or such other
date that Acquirer and the Company may agree upon in writing (the "Termination
Date"); provided that (i) the right to terminate this Agreement under this
Section 7.1(b) shall not be available to any party whose breach of any
covenant, agreement or obligation hereunder will have been the principal cause
of, or will have directly resulted in, the failure of the Closing to occur on
or before the Termination Date and (ii) either Party shall have the right to
extend, by advance written notice to the other on or prior to the initial
Termination Date, the initial Termination Date by up to 90 days if, by the
initial Termination Date, both (x) the condition to Closing in Section 6.1(c)
has not been satisfied or waived by both Parties or the condition to Closing
in Section 6.3(c) has not been satisfied or waived by Acquirer and (y) at the
time of such extension such Party is not precluded from exercising its right
to terminate this Agreement under clause (i) of this proviso; (c)by either Acquirer or the Company, by written notice to the other, if any
Order of a Governmental Entity of competent authority preventing the
consummation of the Merger shall have become final and non-appealable;

(d)by Acquirer, by written notice to the Company, if (i) there shall have been
an inaccuracy in any representation or warranty made by, or a breach of any
covenant, agreement or obligation of, the Company herein and such inaccuracy
or breach shall not have been cured within 10 Business Days after receipt by
the Company of written notice of such inaccuracy or breach and, if not cured
within such period and at or prior to the Closing, such inaccuracy or breach
would result in the failure of any of the conditions set forth in Section 6.1
or Section 6.3 to be satisfied (provided that no such cure period shall be
available or applicable to any such breach that by its nature cannot be
cured), or (ii) the Written Consent is not delivered to Acquirer within 24
hours following the execution of this Agreement, provided that Acquirer shall
be deemed to have waived its right to terminate pursuant to this clause (ii)
if it does not so terminate within 15 days following the Company's failure to
deliver the Written Consent within such 24-hour period; or

(e)by the Company, by written notice to Acquirer, if there shall have been an
inaccuracy in any representation or warranty made by, or a breach of any
covenant, agreement or obligation of, Acquirer herein and such inaccuracy or
breach shall not have been cured within 10 Business Days after receipt by
Acquirer of written notice of such inaccuracy or breach and, if not cured
within such period and at or prior to the Closing, such breach would result in
the failure of any of the conditions set forth in Section 6.1 or Section 6.2
to be satisfied (provided that no such cure period shall be available or
applicable to any such inaccuracy or breach that by its nature cannot be
cured).

7.2.Effect of Termination. In the event of termination of this Agreement as
provided in Section 7.1, this Agreement shall forthwith become void and there
shall be no Liability on the part of Acquirer, Merger Sub, the Company or
their respective officers, directors, stockholders or Affiliates; provided
that (i) Section 5.3 (Confidentiality; Public Disclosure), Section 5.8(a)
(Expenses), this Section 7.2 (Effect of Termination), Article IX (General
Provisions) and any related definition provisions in or referenced in Exhibit
A and the Confidentiality Agreement shall remain in full force and effect and
survive any termination of this Agreement and (ii) nothing herein shall
relieve any party hereto from liability in connection with any material and
willful breach by such party herein.

ARTICLE VIII.

Escrow Fund and Indemnification

8.1.Escrow Fund and Release of Escrow Fund

(a)At or promptly (and in any event within one (1) Business Day) following the
Effective Time, Acquirer shall deposit the Escrow Amount with Citibank N.A.
(or another institution selected by Acquirer and reasonably satisfactory to
the Company) as escrow agent (the "Escrow Agent") (the aggregate amount of
cash so held by the Escrow Agent from time to time, the "Escrow Fund"), which
Escrow Fund shall be governed by this Agreement and the escrow agreement in
substantially the form attached hereto as Exhibit J with such changes as
Acquirer and the Stockholders' Agent may agree in writing (the "Escrow
Agreement"). The Escrow Fund shall constitute partial security for the benefit
of Acquirer (on behalf of itself or any other Indemnified Person) with respect
to any indemnification obligations of the Converting Holders under this
Article VIII. (b)Subject to Section 8.4, the Escrow Agent shall hold the Escrow Fund until
11:59 p.m. Pacific time on the date that is 15 months after the Effective Time
(the "Escrow Release Date"); provided that an amount equal to that portion of
the Escrow Fund that is determined in good faith, in the reasonable judgment
of Acquirer, to be reasonably necessary to satisfy all unsatisfied or disputed
claims for indemnification specified in any Claim Certificate properly
delivered to the Stockholders' Agent on or prior to the Escrow Release Date
(collectively, the "Escrow Reserved Amounts") shall remain in the Escrow Fund
and shall not be released on the Escrow Release Date. From and following the
Escrow Release Date, the Escrow Fund shall only be available to satisfy any
unsatisfied or disputed claims for indemnification specified in any Claim
Certificate properly delivered to the Stockholders' Agent on or prior to the
Escrow Release Date. None of the Escrow Fund or any portion of the Escrow Fund
or any beneficial interest therein may be pledged, subjected to any
Encumbrance, sold, assigned or transferred by any Converting Holder or be
taken or reached by any legal or equitable process in satisfaction of any debt
or other Liability of any Converting Holder, in each case prior to the
distribution of the Escrow Fund, as applicable, to any Converting Holder in
accordance with Sections 8.1(c) and 8.1(d), except that each Converting Holder
shall be entitled to assign such Converting Holder's rights to such Converting
Holder's Pro Rata Share of the Escrow Fund (if any) by will, by the laws of
intestacy or by other operation of law.

(c)Within five (5) Business Days following the Escrow Release Date, the
Acquirer and the Stockholders' Agent shall issue written instruction to the
Escrow Agent in accordance with the Escrow Agreement to cause the Escrow Agent
to distribute to the Paying Agent for further distribution to the Converting
Holders (or, in the case of Company Optionholders that are subject to income
or employment Tax withholding by Acquirer or the Surviving Corporation,
through Acquirer's or the Surviving Corporation's payroll system) and in
accordance with each such Converting Holder's Pro Rata Share, as applied to
such portion of the Escrow Fund, the portion of the Escrow Amount remaining in
the Escrow Fund at such time less the Escrow Reserved Amounts, assuming the
foregoing amount is greater than zero.

(d)From and after the Escrow Release Date until the full release or depletion
of the Escrow Fund in accordance with this Agreement, promptly following the
resolution of any unsatisfied or disputed claim for indemnification for which
amounts are reserved in the Escrow Reserved Amounts, (i) if and to the extent
such claim has been resolved as a claim payable by the Converting Holders,
Acquirer and the Stockholders' Agent shall cause the Escrow Agent to release
from the Escrow Fund an amount equal to the Indemnifiable Damages payable by
the Converting Holders under such claim to Acquirer, and (B) if and to the
extent such claim has been resolved as a claim not payable by the Converting
Holders, Acquirer and the Stockholders' Agent shall cause the Escrow Agent to
release from the Escrow Fund an amount determined not to be payable by the
Converting Holders to the Paying Agent for further distribution to the
Converting Holders (or, in the case of Company Optionholders who are subject
to income or employment Tax withholding by Acquirer or the Surviving
Corporation, through Acquirer's or the Surviving Corporation's payroll system)
and in accordance with each such Converting Holder's Pro Rata Share, as
applied to such portion of the Escrow Fund.

8.2.Indemnification.

(a)Subject to the limitations set forth in this Article VIII, from and after
the Closing, each of Acquirer, Merger Sub and the Surviving Corporation and
their respective officers, directors, agents and employees and each Person, if
any, who controls or may control Acquirer within the meaning of the Securities
Act (each, an "Indemnified Person") shall be indemnified and held harmless
from and shall be compensated and reimbursed by each Converting Holder from
the then available portion of the Escrow Fund, and shall be further indemnified and held harmless, from and
after the earlier of the Escrow Release Date and the full depletion of the
Escrow Fund, by each Converting Holder, severally but not jointly, based on
each Converting Holder's Pro Rata Share, against any and all losses,
liabilities, damages (excluding any consequential or punitive damages or
losses, except (x) to the extent any such damages or losses are actually
awarded by a Governmental Entity in a Legal Proceeding to a third party with
respect to a matter for which Indemnified Person is entitled to
indemnification hereunder or (y) solely with respect to consequential damages
or losses, to the extent any such damages or losses are a reasonably
foreseeable result of the event or facts based on the particular circumstances
known to the Company that pertain to such Indemnified Person and his, her or
its Affiliates that gave rise thereto for which indemnification is sought
under this Agreement), fees, Taxes, out-of-pocket costs and expenses,
including costs of investigation, enforcement and defense and reasonable fees
and expenses of counsel, experts and other professionals (collectively,
"Indemnifiable Damages"), directly or indirectly, whether or not due to a
direct claim or Third-Party Claim, if and to the extent resulting, directly or
indirectly, from:

i.any failure of any representation or warranty made by the Company in this
Agreement (other than the Specified Tax Representations) or any Company
Transaction Document to be true and correct as of the date hereof or thereof
or as of the Closing Date (except in the case of representations and
warranties that by their terms speak only as of a specific date or dates,
which representations and warranties shall be true and correct as of such date
or dates);

ii.any breach prior to the Closing by the Company of any of the covenants,
agreements or obligations made by the Company herein or in any other Company
Transaction Document;

iii.any inaccuracies in the Spreadsheet or the Company Closing Financial
Certificate (including any Taxes described in Section 1.8);

iv.(A) all payments made with respect to Dissenting Shares to the extent that
such payments, in the aggregate, exceed the value of the consideration that
otherwise would have been payable pursuant to Section 1.3(a)(i) upon the
exchange of such Dissenting Shares or (B) all interest, costs, expenses and
fees (including reasonable legal fees incurred by any Indemnified Person) in
connection with the exercise of any appraisal rights or dissenters' rights by
any Company Stockholders;

v.any overstatement of the Total Consideration, whether because of an
overstatement of the amount of the Company Cash as of the Closing, or an
understatement of the amount of the Company Debt as of the Closing or Unpaid
Transaction Expenses;

vi.any Pre-Closing Taxes;

vii.(A) any claim by any current or former holder or alleged current or former
holder of any Equity Interests of the Company, in each case in their capacity
as such, arising out of, resulting from or in connection with (1) any alleged
inaccuracies in any communication by the Company to such party relating to any
actual or projected financial results of the Company or other accounting
related matter or (2) the allocation of the Total Consideration or any portion
thereof that differs from that specified on the Spreadsheet, (B) all claims
that any directors or officers of the Company breached their fiduciary duties
in connection with this Agreement, any Company Transaction Document or any of
the Transactions or (C) any inaccuracies in the Spreadsheet other than as a
result of an inaccuracies in the Company Closing Financial Certificate or any overstatement
of the Total Consideration;

viii.any claim relating to any agreement between one or more Converting
Holders, on the one hand, and the Stockholders' Agent, on the other hand, or
by any actual or purported Company Securityholder relating to any alleged
action or failure to act on its behalf by the Stockholders' Agent; and

ix.any Fraud by the Company under this Agreement or any Company Transaction
Document or with respect to any of the Transactions ("Company Fraud").

(b)Materiality standards or qualifications, and qualifications by reference to
the defined term "Material Adverse Effect" in any representation, warranty,
covenant, agreement or obligation and numerical thresholds in the
representations and warranties set forth in Section 2.4(b) shall be taken into
account in determining whether an inaccuracy or breach occurred, but shall not
be taken into account in determining the amount of any Indemnifiable Damages
with respect to such inaccuracy or breach.

8.3.Indemnifiable Damage Threshold; Other Limitations.

(a)Notwithstanding anything to the contrary contained herein but subject to
the last sentence of this Section 8.3(a), no Converting Holder shall be
required to make any indemnification payment for Indemnifiable Damages if and
to the extent resulting, directly or indirectly, from the matters listed in
Section 8.2(a)(i) unless and until the total amount of all Indemnifiable
Damages to which the Threshold applies exceeds an amount equal to $3,500,000
(the "Threshold") in the aggregate. If such Indemnifiable Damages exceed the
Threshold, then the Indemnified Person may make claims for indemnification for
such matters and may receive cash from the Escrow Fund for all Indemnifiable
Damages with respect to such matters without regard to the Threshold, subject
in all cases to the limitations set forth in this Article VIII.
Notwithstanding the foregoing, this Section 8.3(a) shall in no way limit, and
the Threshold shall not apply to, an Indemnified Person's right to
indemnification for Indemnifiable Damages if and to the extent resulting,
directly or indirectly, from (i) Company Fraud or (ii) any failure of any of
the Special Representations to be true and correct.

(b)If the Merger is consummated, recovery from the cash held in the Escrow
Fund shall constitute the sole and exclusive remedy for the indemnification
obligations of each Converting Holder under this Article VIII for
Indemnifiable Damages (and not specific performance or other non-monetary
equitable remedies) if and to the extent resulting, directly or indirectly,
from the matters listed in Section 8.2(a)(i), except, solely with respect to
each Converting Holder, (i) in the case of Company Fraud or Fraud actually
committed by such Converting Holder under this Agreement or any other
Transaction Document to which such Converting Holder is a party, and (ii) any
failure of any of the representations and warranties made by (A) the Company
in the first two sentences of Section 2.1(a) (Organization), Section 2.2
(Capital Structure), Section 2.3(a) (Authority and Enforceability), Section
2.12 (Taxes) (other than the Specified Tax Representations), the last sentence
of Section 2.13(g) (Employee Benefits) and the first sentence of Section 2.19
(Transaction Fees), or (B) the Company in any certificate delivered to
Acquirer pursuant to this Agreement that are within the scope of those covered
by the foregoing Sections (collectively, the "Special Representations") to be
true and correct as aforesaid.

(c)In the case of any claims for Indemnifiable Damages if and to the extent
resulting, directly or indirectly, from the failure of any of the Special
Representations to be true and correct as aforesaid or the matters listed in clauses (ii) through (viii) of
Section 8.2(a) (collectively, "Special Claims"), after Indemnified Persons
have exhausted or made claims upon all amounts of cash held in the Escrow Fund
(after taking into account all other claims for indemnification, compensation
and reimbursement from the Escrow Fund made by Indemnified Persons) which will
be the first source of recovery for all Indemnifiable Damages hereunder, or
following the applicable Escrow Release Date or the depletion of the Escrow
Fund, each Converting Holder shall have liability pursuant to the terms and
conditions of this Article VIII for such Converting Holder's Pro Rata Share of
the amount of any Indemnifiable Damages if and to the extent resulting,
directly or indirectly, therefrom. Notwithstanding anything to the contrary
contained herein, (i) the total liability of a Converting Holder for Special
Claims (in addition to claims that were otherwise made against the Escrow
Fund) shall be limited to the aggregate amount of cash received by such
Converting Holder pursuant to this Agreement and the Merger (it being
understood that amounts deposited into the Escrow Fund and the Expense Fund
shall be deemed received by the Converting Holders for purposes of calculation
of the total liability hereunder) and (ii) any limitation of liability with
respect to an Converting Holder in this Section 8.3(c) shall not apply in the
case of Fraud actually committed by such Converting Holder under this
Agreement or any other Transaction Document to which such Converting Holder is
a party.

(d)Notwithstanding anything to the contrary contained herein:

i.no Converting Holder (based upon such Converting Holder's position as an
officer, director, employee or agent of the Company or otherwise) shall have
(a) any right of indemnification, contribution or right of advancement from
Acquirer, the Surviving Corporation or any other Indemnified Person or (b) any
right of subrogation against the Company or the Surviving Corporation, in the
case of both (a) and (b), with respect to its Pro Rata Share of the
Indemnifiable Damages claimed by an Indemnified Person by reason of any of the
matters set forth in Section 8.2(a);

ii.the rights and remedies of the Indemnified Persons after the Effective Time
shall not be limited by (A) any investigation by or on behalf of, or
disclosure to (other than any disclosure in the Company Disclosure Letter with
respect to clause (i) of Section 8.2(a), subject to any limitations expressly
set forth in the opening paragraph of Article II), any Indemnified Person at
or prior to the Effective Time regarding any failure, breach or other event or
circumstance or (B) any waiver of any condition to the Closing related
thereto;

iii.if an Indemnified Person's claim under this Article VIII may be properly
characterized in multiple ways in accordance with this Article VIII such that
such claim may or may not be subject to different limitations depending on
such characterization, then such Indemnified Person shall have the right to
characterize such claim in a manner that maximizes the recovery and time to
assert such claim permitted in accordance with this Article VIII; provided
that an Indemnified Person shall not be entitled to double recovery for any
Indemnifiable Damages even though such Indemnifiable Damages may have resulted
from the breach of one or more representations, warranties or covenants in
this Agreement;

iv.no Converting Holder shall be liable for any Indemnifiable Damages
resulting from any reduction in amount or unavailability of any net operating
loss, tax credit or other tax attribute of the Company arising from (A) a
breach by Acquirer or Merger Sub of a provision in this Agreement or (B) any
action taken after the Effective Time by the Acquirer or any of its Affiliates
(including the Surviving Corporation); and v.no amount of Taxes (other than income, franchise or other similar Taxes
imposed on net or gross income, profits or gains of the Company or its
Subsidiaries) shall be subject to indemnification under clauses (i) and (vi)
of Section 8.2(a) unless and until the total amount of all such Taxes exceeds
an amount equal the Pre-Closing Operating Tax Amount; provided that there will
be no indemnification under this Agreement for Taxes that could have been
reduced (to the extent of such reduction) or avoided by utilizing the
Company's net operating losses, capital losses or any other of its tax
attributes (for clarity, not including any net operating losses, capital
losses or any other of its tax attributes arising in a Post-Closing Tax
Period).

(e)All Indemnifiable Damages shall be calculated net of the amount of any
actual recoveries actually received by an Indemnified Person from an unrelated
third party insurer prior to the Escrow Release Date under any existing
insurance policies and contractual indemnification or contribution provisions
(in each case, calculated net of any actual collection costs and reserves,
expenses, deductibles or premium adjustments or retrospectively rated premiums
(as determined in good faith by an Indemnified Person) incurred or paid to
procure such recoveries) in respect of any Indemnifiable Damages suffered,
paid, sustained or incurred by any Indemnified Person; provided that no
Indemnified Person shall have any obligation to seek to obtain or continue to
pursue any such recoveries. If an Indemnified Person actually receives any
amounts under applicable insurance policies or third party indemnification or
reimbursement payments subsequent to its receipt of an indemnification payment
by the Converting Holders (including via the Escrow Fund), then such
Indemnified Person will, without duplication, promptly reimburse the
Converting Holders (including via the Escrow Fund) for any payment made by
such Converting Holders (including via the Escrow Fund) up to the amount
actually received by the Indemnified Person (net of any actual collection
costs and reserves, expenses, deductibles or premium adjustments or
retrospectively rated premiums (as determined in good faith by an Indemnified
Person) incurred or paid to procure such recoveries).

8.4.Period for Claims. Except as otherwise set forth in this Section 8.4, the
period (the "Claims Period") during which claims may be made for Indemnifiable
Damages if and to the extent resulting, directly or indirectly, from:

(a)the matters listed in Section 8.2(a)(i) (other than with respect to any of
the Special Representations), Section 8.2(a)(ii), Section 8.2(a)(iii), Section
8.2(a)(iv) and/or Section 8.2(a)(v) shall commence at the Closing and
terminate at 11:59 p.m. Pacific time on the Escrow Release Date;

(b)the matter listed in Section 8.2(a)(viii) shall commence at the Closing and
terminate at such time as the Stockholders' Agent has fully satisfied its
obligations in its capacity as such;

(c)the matters listed in Section 8.2(a)(i) (solely with respect to any of the
Special Representations), Section 8.2(a)(vi), Section 8.2(a)(vii) and/or
Section 8.2(a)(ix) shall commence at the Closing and terminate at 11:59 p.m.
Pacific time on the date that is 30 days following the expiration of the
statute of limitations applicable to the underlying matter for which recovery
of Indemnifiable Damages is being sought pursuant to this Article VIII.

Notwithstanding the foregoing, if an indemnification claim is properly
asserted in writing pursuant to this Article VIII prior to the expiration date
of the applicable Claims Period (as provided in this Section 8.4), the right
to bring such claim shall survive beyond expiration of the applicable Claims
Period provided for above, but only for the purpose of the resolution of such
claim pursuant to Article VIII, in accordance with Title 10, Section 8106(c)
of the Delaware Code. 8.5.Claims.

(a)From time to time during the Claims Period, Acquirer may deliver to the
Stockholders' Agent one or more certificates signed by any officer of Acquirer
(each, a "Claim Certificate"):

i.stating that an Indemnified Person has incurred, paid, reserved or accrued
(in accordance with GAAP), or in good faith believes that it is reasonably
likely to incur, pay, reserve or accrue (in accordance with GAAP),
Indemnifiable Damages (or that with respect to any Tax matters, that any Tax
Authority is reasonably likely to raise such matter in audit of Acquirer or
its subsidiaries, that could give rise to Indemnifiable Damages);

ii.stating the amount of such Indemnifiable Damages (which, in the case of
Indemnifiable Damages not yet incurred, paid, reserved or accrued, may be the
maximum amount believed by Acquirer in good faith to be incurred, paid,
reserved, accrued or demanded by a third party); and (iii) specifying in
reasonable detail (based upon the information then possessed by Acquirer) the
individual items of such Indemnifiable Damages included in the amount so
stated and the nature of the claim to which such Indemnifiable Damages are
related.

(b)Such Claim Certificate (i) need only specify such information to the
knowledge of such officer of Acquirer as of the date thereof, (ii) shall not
limit any of the rights or remedies of any Indemnified Person with respect to
the underlying facts and circumstances specifically set forth in such Claim
Certificate and (iii) may be updated and amended from time to time by Acquirer
by delivering any updated or amended Claim Certificate, so long as the
delivery of the original Claim Certificate and any update or amendment thereto
that expands the nature of the claims is made within the applicable Claims
Period and in all cases such update or amendment relates to the underlying
facts and circumstances specifically set forth in such original Claims
Certificate; provided that all claims for Indemnifiable Damages properly set
forth in a Claim Certificate or any update or amendment thereto shall remain
outstanding until such claims have been resolved or satisfied pursuant to this
Article VIII, notwithstanding the expiration of such Claims Period. No delay
in providing such Claim Certificate within the applicable Claims Period shall
affect an Indemnified Person's rights hereunder, unless (and then only to the
extent that) the Stockholders' Agent or the Converting Holders are materially
prejudiced thereby.

8.6.Resolution of Objections to Claims.

(a)If the Stockholders' Agent does not contest, by written notice to Acquirer,
any claim or claims by Acquirer made in any Claim Certificate within the
30-day period following receipt of such Claim Certificate, then the Escrow
Agent shall, upon Acquirer's direction, distribute to Acquirer an amount of
cash from the Escrow Fund having a total value equal to the amount of any
Indemnifiable Damages corresponding to such claim or claims as set forth in
such Claim Certificate.

(b)If the Stockholders' Agent objects in writing to any claim or claims by
Acquirer made in any Claim Certificate within the 30-day period set forth in
Section 8.6(a), Acquirer and the Stockholders' Agent shall attempt in good
faith for 45 days after Acquirer's receipt of such written objection to
resolve such objection. If Acquirer and the Stockholders' Agent shall so
agree, a joint written instruction setting forth such agreement shall be
prepared, signed by both parties and delivered to the Escrow Agent. Upon receipt of such instruction, the Escrow Agent shall
distribute to Acquirer an amount of cash from the Escrow Fund in accordance
with the terms of such joint written instruction.

(c)If no such agreement can be reached during the 45-day period for good faith
negotiation set forth in Section 8.6(b), but in any event upon the expiration
of such 45-day period, either Acquirer or the Stockholders' Agent may bring
suit in accordance with the terms of Section 9.12 to resolve the matter.

(d)Any portion of the Escrow Fund held by the Escrow Agent following the
Escrow Release Date shall be paid by the Escrow Agent to the Paying Agent for
further distribution to the Acquirer or the Converting Holders (or, in the
case of Company Optionholders who are subject to income or employment Tax
withholding by Acquirer or the Surviving Corporation, through Acquirer's or
the Surviving Corporation's payroll system) in accordance with each such
Converting Holder's Pro Rata Share of the Escrow Amount, as applied to such
portion of the Escrow Fund, in each case, within five (5) Business Days
following resolution of such claims in accordance with Section 8.1(d).

8.7.Stockholders' Agent.

(a)At the Closing, and by virtue of the approval of the Merger and this
Agreement by the Converting Holders and without any further action of any of
the Converting Holders or the Company, Fortis Advisors LLC shall be
constituted and appointed as the Stockholders' Agent. The Stockholders' Agent
shall be the exclusive agent and attorney-in-fact for and on behalf of the
Converting Holders to: (i) execute, as the Stockholders' Agent, this Agreement
and any agreement or instrument entered into or delivered in connection with
the Transactions, (ii) give and receive notices, instructions and
communications permitted or required under this Agreement, or any other
agreement, document or instrument entered into or executed in connection
herewith, for and on behalf of any Converting Holder, to or from Acquirer (on
behalf of itself or any other Indemnified Person) relating to this Agreement
or any of the Transactions and any other matters contemplated by this
Agreement or by such other agreement, document or instrument (except to the
extent that this Agreement expressly contemplates that any such notice or
communication shall be given or received by each Converting Holder
individually), (iii) review, negotiate and agree to and authorize Acquirer to
reclaim an amount of cash from the Escrow Fund in satisfaction of claims
asserted by Acquirer (on behalf of itself or any other Indemnified Person,
including by not objecting to such claims) pursuant to this Article VIII, (iv)
object to such claims pursuant to Section 8.6, (v) consent or agree to,
negotiate, enter into, or, if applicable, contest, prosecute or defend,
settlements and compromises of, and comply with Orders of courts with respect
to, such claims, resolve any such claims, take any actions in connection with
the resolution of any dispute relating hereto or to the Transactions by
settlement or otherwise, and take or forego any or all actions permitted or
required of any Converting Holder or necessary in the judgment of the
Stockholders' Agent for the accomplishment of the foregoing and all of the
other terms, conditions and limitations of this Agreement, (vi) consult with
legal counsel, independent public accountants and other experts selected by
it, solely at the cost and expense of the Converting Holders, (vii) consent or
agree to any amendment to this Agreement or to waive any terms and conditions
of this Agreement providing rights or benefits to the Converting Holders
(other than with respect to the payment of the Closing Payment) in accordance
with the terms hereof and in the manner provided herein, and (viii) take all
actions necessary or appropriate in the judgment of the Stockholders' Agent
relating to the subject matter of this Agreement, the Escrow Agreement and the
Stockholders' Agent Engagement Agreement, in each case without having to seek
or obtain the consent of any Person under any circumstance. Notwithstanding
the foregoing, the Stockholders' Agent shall have no obligation to act on
behalf of the Converting Holders, except as expressly provided herein, in the
Escrow Agreement and in the Stockholders' Agent Engagement Agreement, and for
purposes of clarity, there are no obligations of the Stockholders' Agent in any ancillary
agreement, schedule, exhibit or the Company Disclosure Letter. Acquirer,
Merger Sub and their respective Affiliates (including after the Effective
Time, the Surviving Corporation) shall be entitled to rely on the appointment
of Fortis Advisors LLC as the Stockholders' Agent and treat such Stockholders'
Agent as the duly appointed attorney-in-fact and exclusive agent of each
Converting Holder and has having the duties, power and authority provided for
in this Section 8.7. The powers, immunities and rights to indemnification
granted to the Stockholders' Agent Group hereunder: (i) are coupled with an
interest and shall be irrevocable and survive the death, incompetence,
bankruptcy or liquidation of any Converting Holder and shall be binding on any
successor thereto, and (ii) shall survive the delivery of an assignment by any
Converting Holder of the whole or any fraction of his, her or its interest in
the Escrow Fund. The Converting Holders shall be bound by all actions taken
and documents executed by the Stockholders' Agent in connection with this
Article VIII, and Acquirer and other Indemnified Persons shall be entitled to
rely exclusively on any action or decision of the Stockholders' Agent. The
Person serving as the Stockholders' Agent may be removed or replaced from time
to time, or if such Person resigns from its position as the Stockholders'
Agent, then a successor may be appointed, by the holders of a majority in
interest of the aggregate amount of cash then held in the Escrow Fund (or, in
the event that there is no cash then held in the Escrow Fund by the Converting
Holders collectively having an Pro Rata Share greater than 50%) upon not less
than 30 days' prior written notice to Acquirer. The immunities and rights to
indemnification shall survive the resignation or removal of the Stockholders'
Agent or any member of the Advisory Group and the Closing and/or any
termination of this Agreement and the Escrow Agreement. No bond shall be
required of the Stockholders' Agent.

(b)Certain Converting Holders have entered into an engagement agreement (the
"Stockholders' Agent Engagement Agreement") with the Stockholders' Agent to
provide direction to the Stockholders' Agent in connection with its services
under this Agreement, the Escrow Agreement and the Stockholders' Agent
Engagement Agreement (such Converting Holders, including their individual
representatives, collectively hereinafter referred to as the "Advisory
Group"). Neither the Stockholders' Agent nor its members, managers, directors,
officers, contractors, agents and employees nor any member of the Advisory
Group (collectively, the "Stockholders' Agent Group"), shall be liable to any
Converting Holder for any act done or omitted hereunder, under the Escrow
Agreement or under the Stockholders' Agent Engagement Agreement as the
Stockholders' Agent while acting in good faith (and any act done or omitted
pursuant to the advice of counsel shall be conclusive evidence of such good
faith) and without gross negligence or willful misconduct. The Converting
Holders shall severally but not jointly indemnify and defend the Stockholders'
Agent Group and hold it harmless against any loss, Liability, claim, damage,
fee, cost, judgment, fine, amount paid in settlement or expense incurred
without gross negligence, willful misconduct or bad faith on the part of the
Stockholders' Agent and arising out of, resulting from or in connection with
the acceptance or administration of its duties hereunder, under the Escrow
Agreement or under the Stockholders' Agent Engagement Agreement, including all
reasonable out-of-pocket costs and expenses and legal fees and other legal
costs, costs of skilled professionals and in connection with seeking recovery
from insurers reasonably incurred by the Stockholders' Agent (collectively,
the "Stockholders' Agent Expenses"). If not paid directly to the Stockholders'
Agent by the Converting Holders, such Stockholders' Agent Expenses may be
recovered by the Stockholders' Agent, first, from the Expense Fund, and
second, from the portion of the Escrow Fund otherwise distributable to the
Converting Holders (and not distributed or distributable to an Indemnified
Person or subject to a pending indemnification claim of an Indemnified Person)
on or after the Escrow Release Date pursuant to the terms hereof, at the time
of distribution, and such recovery will be made from the Converting Holders
according to their respective Pro Rata Shares of such losses, Liabilities or
expenses. The Converting Holders acknowledge that the Stockholders' Agent
shall not be required to expend or risk its own funds or otherwise incur any
financial liability in the exercise or performance of any of its powers,
rights, duties or privileges or pursuant to this Agreement, the Escrow
Agreement, the Stockholders' Agent Engagement Agreement or the transactions contemplated hereby or thereby. Furthermore, the
Stockholders' Agent shall not be required to take any action unless the
Stockholders' Agent has been provided with funds, security or indemnities
which, in its determination, are sufficient to protect the Stockholders' Agent
against the costs, expenses and liabilities which may be incurred by the
Stockholders' Agent in performing such actions.

(c)After the Closing, any notice or communication given or received by, and
any decision, action, failure to act within a designated period of time,
agreement, consent, settlement, resolution or instruction of, the
Stockholders' Agent that is within the scope of the Stockholders' Agent's
authority under this Agreement, the Escrow Agreement or the Stockholders'
Agent Engagement Agreement shall constitute a notice or communication to or
by, or a decision, action, failure to act within a designated period of time,
agreement, consent, settlement, resolution or instruction of all the
Converting Holders and shall be final, binding and conclusive upon each such
Converting Holder and their successors as if expressly confirmed and ratified
in writing by each such Converting Holder, and all defenses which may be
available to any Converting Holder to contest, negate or disaffirm the action
of the Stockholders' Agent taken in good faith under this Agreement, the
Escrow Agreement or the Stockholders' Agent Engagement Agreement are waived.
Each Indemnified Person shall be entitled to rely exclusively upon any such
notice, communication, decision, action, failure to act within a designated
period of time, agreement, consent, settlement, resolution or instruction as
being a notice or communication to or by, or a decision, action, failure to
act within a designated period of time, agreement, consent, settlement,
resolution or instruction of, each and every such Converting Holder. Acquirer,
Merger Sub, the Surviving Corporation and the Indemnified Persons are hereby
relieved from any Liability to any Person for any acts done by them in
accordance with such notice, communication, decision, action, failure to act
within a designated period of time, agreement, consent, settlement, resolution
or instruction of the Stockholders' Agent. The Stockholders' Agent shall be
entitled to: (i) rely upon the Spreadsheet, (ii) rely upon any signature
believed by it to be genuine, and (iii) reasonably assume that a signatory has
proper authorization to sign on behalf of the applicable Converting Holder or
other party.

(d)At or promptly following the Effective Time, the Acquirer will wire to the
Stockholders' Agent $500,000 (the "Expense Fund"), which will be used (i) for
the purposes of paying directly, or reimbursing the Stockholders' Agent for,
any Stockholders' Agent Expenses incurred pursuant to this Agreement and the
Escrow Agreement or (ii) as otherwise determined by the Advisory Group. The
Stockholders' Agent is not providing any investment supervision,
recommendations or advice and shall have no responsibility or liability for
any loss of principal of the Expense Fund other than as a result of its gross
negligence or willful misconduct. The Stockholders' Agent is not acting as a
withholding agent or in any similar capacity in connection with the Expense
Fund, and has no Tax reporting or income distribution obligations. The
Converting Holders will not receive any interest on the Expense Fund and
assign to the Stockholders' Agent any such interest. Subject to Advisory Group
approval, the Stockholders' Agent may contribute funds to the Expense Fund
from any consideration otherwise distributable to the Converting Holders. In
any event no later than contemporaneously with or as soon as practicable
following the earlier of the Escrow Release Date and the completion of the
Stockholders' Agent's responsibilities, the Stockholders' Agent will deliver
the balance of the Expense Fund (the "Expense Fund Surplus") to the Paying
Agent or the Surviving Corporation, as applicable, for further distribution to
the Converting Holders in accordance with each such Converting Holder's Pro
Rata Share, as applied to such portion of the Expense Fund. For Tax purposes,
the Expense Fund will be treated as having been received and voluntarily set
aside by the Converting Holders at the time of Closing. 8.8.Third-Party Claims. In the event an Indemnified Person becomes aware of a
claim by a third party (a "Third-Party Claim") that such Indemnified Person in
good faith believes may result in a claim for Indemnifiable Damages by or on
behalf of an Indemnified Person, Acquirer (on behalf of such Indemnified
Person) shall promptly notify the Stockholders' Agent of such Third-Party
Claim (provided that any delay or failure in so notifying the Stockholders'
Agent of such Third-Party Claim shall not limit or relieve the Converting
Holders of their obligations under this Article VIII, except to the extent, if
at all, that the defense of such Third-Party Claim is materially prejudiced by
reason of such delay or failure), and shall use its commercially reasonable
efforts to provide copies of any notice or documentation submitted by the
third party making such Third-Party Claim, if any, as soon as reasonably
practicable after receipt of such documentation or notice. Acquirer shall, in
its sole discretion, conduct and control the defense of such Third-Party
Claim; provided that the Stockholders' Agent, at the expense of the Converting
Holders, shall be entitled to participate in (but not to determine the conduct
of) the defense of such Third-Party Claim and engage separate counsel, and
Acquirer shall keep Stockholders' Agent reasonably informed concerning the
progress of such Third-Party Claim. If permitted by the relevant tribunal, the
Stockholders' Agent shall have the right to receive copies of all pleadings,
notices and material communications with respect to such Third-Party Claim to
the extent that receipt of such documents does not affect any privilege
relating to any Indemnified Person, subject to execution by the Stockholders'
Agent of a customary non-disclosure agreement with Acquirer (and, if required,
such third party) to the extent that such materials contain confidential or
proprietary information. The applicable Indemnified Person shall not be
entitled to be indemnified or held harmless under Section 8.2(a) for such
Third-Party Claim if it shall settle such Third-Party Claim without the prior
written consent of the Stockholders' Agent, unless the Indemnified Person has
sought such consent and such consent has been unreasonably withheld or
delayed, it being agreed that the Stockholders' Agent shall not unreasonably
withhold or delay such consent.

8.9.Treatment of Indemnification Payments. Acquirer, the Stockholders' Agent
and the Converting Holders agree to treat (and cause their respective
Affiliates to treat) any payment received by the Indemnified Persons pursuant
to this Article VIII as adjustments to the Total Consideration for all Tax
purposes to the extent permitted by Applicable Law.

8.10.Sole and Exclusive Remedy. From and after the Closing, other than with
respect to claims for Fraud (subject to Sections 8.3(a), (b) and (c) and
Section 8.4 of this Agreement), non-monetary specific performance or other
non-monetary equitable relief: (a) this Article VIII shall constitute the sole
and exclusive recourse and remedy of the Indemnified Persons for recovery of
Indemnifiable Damages arising under or in connection with this Agreement, the
Merger or the other Transactions against the Converting Holders, (b) the only
legal action that may be asserted by or on behalf of any Indemnified Person
with respect to this Agreement and the Transactions shall be a contract action
to recover Indemnifiable Damages pursuant to a claim made under this Article
VIII and (c) no legal action based upon predecessor or successor liability,
contribution, tort, strict liability or any statute, regulation or ordinance
may be maintained by or on behalf of any Indemnified Person with respect to
any matter that is the subject of this Article VIII; provided, that,
notwithstanding anything herein to the contrary, nothing in this Agreement
shall limit the rights or remedies of Acquirer or any other Indemnified Person
in connection with any breach or misrepresentation by any Company
Securityholder in any Transaction Document to which such Company
Securityholder is a party, but only to the extent that the applicable
Indemnified Person does not otherwise have recourse for the underlying subject
matter of such breach or misrepresentation as an indemnified matter under this
Article VIII. ARTICLE IX.

General Provisions

9.1.Survival of Representations, Warranties and Covenants. If the Merger is
consummated, the representations and warranties made by the Company herein
(other than the Special Representations and the Specified Tax
Representations), as qualified by the Company Disclosure Letter (subject to
the limitations expressly set forth in the opening paragraph of Article II),
and in the other certificates contemplated by this Agreement shall survive the
Closing and remain in full force and effect, regardless of any investigation
or disclosure made by or on behalf of any of the parties hereto, until the
date that is 15 months following the Closing Date; provided that, regardless
of any investigation or disclosure made by or on behalf of any of the parties
hereto, the Special Representations (including any portion of the Company
Disclosure Letter related thereto) will remain operative and in full force and
effect until expiration of the statute of limitations applicable to the
underlying matter for which recovery of Indemnifiable Damages is being sought
pursuant to Article VIII; provided, further, that (x) no right to
indemnification pursuant to Article VIII in respect of any claim that is set
forth in a Claim Certificate delivered to the Stockholders' Agent on or prior
to the expiration of the applicable Claims Period shall be affected by such
expiration until such claim is resolved pursuant to Article VIII, and (y) such
expiration shall not affect the rights of any Indemnified Person under Article
VIII or otherwise to seek recovery of Indemnifiable Damages if and to the
extent resulting, directly or indirectly, from any Special Claims by the
Company until the expiration of the applicable Claims Period as set forth
herein. If the Merger is consummated, the Specified Tax Representations and
the representations and warranties made by Acquirer herein and in the other
certificates contemplated by this Agreement shall expire and be of no further
force or effect as of the Closing. If the Merger is consummated, all
covenants, agreements and obligations of the parties hereto shall expire and
be of no further force or effect as of the Closing, except to the extent such
covenants, agreements and obligations provide that they are to be performed
after the Closing; provided that no right to indemnification pursuant to
Article VIII in respect of any claim based upon any breach of a covenant,
agreement or obligation shall be affected by the expiration of such covenant,
agreement or obligation.

9.2.Notices. All notices, requests, consents, claims, demands, waivers and
other communications hereunder shall be in writing and shall be deemed given
if delivered personally or by commercial delivery service, or mailed by
registered or certified mail (return receipt requested) or sent via facsimile
(with automated confirmation of receipt) or e-mail to the parties hereto at
the following address (or at such other address for a party as shall be
specified by like notice); provided that with respect to notices deliverable
to the Stockholders' Agent, such notices shall be delivered solely via email
or facsimile:

i.if to Acquirer or Merger Sub, to:

Hewlett Packard Enterprise Company

6280 America Center Drive

San Jose, CA 95002

Attention: General Counsel

Facsimile No.: (650) 857-4837

 with a copy (which shall not constitute notice) to:

Freshfields Bruckhaus Deringer US LLP

31st Floor

601 Lexington Avenue

New York, NY 10022

Attention: Ethan A. Klingsberg; Zheng Zhou

Facsimile No.: (212) 277 4001

Email: Ethan.Klingsberg@freshfields.com

Zheng.Zhou@freshfields.com

ii.if to the Company (prior to the Closing), to:

Silver Peak Systems, Inc.

2860 De La Cruz Blvd.

Santa Clara, California 95050

Attention: General Counsel

Email: legal@silver-peak.com



with a copy (which shall not constitute notice) to:

Fenwick and West LLP

801 California Street

Mountain View, CA 94041

Attention: Kris S. Withrow; Dawn Belt

Facsimile No.: (650) 938-5200

Telephone No.: (650) 988-8500

Email: kwithrow@fenwick.com;

dbelt@fenwick.com



iii.If to the Stockholders' Agent, to:

Fortis Advisors LLC

Attention: Notices Department (Project Santorini)

Facsimile No.: (858) 408-1843

Telephone No.: notices@fortisrep.com

Any notice given as specified in this Section 9.2 (i) if delivered personally
or sent by facsimile transmission or e-mail shall conclusively deemed to have
been given or served at the time of dispatch if sent or delivered on a
Business Day or, if not sent or delivered on a Business Day, on the next
following Business Day and (ii) if sent by commercial delivery service or
mailed by registered or certified mail (return receipt requested) shall
conclusively be deemed to have been received on the third Business Day after
the post of the same.

9.3.Interpretation. When a reference is made herein to Articles, Sections,
subsections, Schedules or Exhibits, such reference shall be to an Article,
Section or subsection of, or a Schedule or an Exhibit to this Agreement unless
otherwise indicated. The headings contained herein are for reference purposes
only and shall not affect in any way the meaning or interpretation of this
Agreement. The words "include," "includes" and "including" when used herein
shall be deemed in each case to be followed by the words "without limitation." Where a reference is made to a Contract,
instrument or Applicable Law, such reference is to such Contract, instrument
or Applicable Law as amended, modified or supplemented, including (in the case
of Contracts or instruments) by waiver or consent and (in the case of
Applicable Law) by succession of comparable successor law and references to
all attachments thereto and instruments incorporated therein. Unless the
context of this Agreement otherwise requires: (i) words of any gender include
each other gender and neutral forms of such words, (ii) words using the
singular or plural number also include the plural or singular number,
respectively, (iii) the terms "hereof," "herein," "hereto," "hereunder" and
derivative or similar words refer to this entire Agreement, (iv) references to
clauses without a cross-reference to a Section or subsection are references to
clauses within the same Section or, if more specific, subsection, (v)
references to any Person include the successors and permitted assigns of that
person, (vi) references from or through any date shall mean, unless otherwise
specified, from and including or through and including, respectively, (vii)
the phrases "provided to" and "delivered to" and phrases of similar import
mean that a true, correct and complete paper or electronic copy of the
information or material referred to has been delivered to the party to whom
such information or material is to be provided, (viii) the phrase "made
available to" and phrases of similar import means, with respect to any
information, document or other material of Acquirer or the Company, that such
information, document or material was made available for review in the virtual
data room established by Acquirer or the Company, respectively, in connection
with this Agreement at least 48 hours prior to the execution of this Agreement
or actually delivered (whether by physical or electronic delivery) to the
Company or Acquirer, respectively, or its Representatives at least 48 hours
prior to the execution of this Agreement and (ix) a sentence containing
"and/or" shall be construed to read as if the sentence is included twice, once
with "and" construction and once with an "or" construction. The symbol "$"
refers to United States Dollars. The word "extent" in the phrase "to the
extent" means the degree to which a subject or other thing extends and such
phrase shall not mean simply "if." All references to "days" shall be to
calendar days unless otherwise indicated as a "Business Day." Any action
otherwise required to be taken on a day that is not a Business Day shall
instead be taken on the next succeeding Business Day, and if the last day of
such period is a non-Business Day, the period in question shall end on the
next succeeding Business Day. Unless indicated otherwise, all mathematical
calculations contemplated by this Agreement shall be rounded to the tenth
decimal place, except in respect of payments, which shall be rounded to the
nearest whole United States cent.

9.4.Amendment. Subject to Applicable Law, the parties hereto may amend this
Agreement by authorized action at any time pursuant to an instrument in
writing signed on behalf of each of the parties hereto; provided that after
the Company Stockholder Approval is obtained, no amendment shall be made to
this Agreement that by Applicable Law requires further approval by the Company
Stockholders without such further approval. To the extent permitted by
Applicable Law, Acquirer and the Stockholders' Agent may cause this Agreement
to be amended at any time after the Closing by execution of an instrument in
writing signed on behalf of Acquirer and the Stockholders' Agent.

9.5.Extension; Waiver. At any time at or prior to the Closing, any party
hereto may, to the extent legally allowed, (i) extend the time for the
performance of any of the obligations or other acts of the other parties
hereto owed to such party, (ii) waive any inaccuracies in the representations
and warranties made to such party contained herein or in any document
delivered pursuant hereto and (iii) waive any breaches of any of the
covenants, agreements, obligations or conditions for the benefit of such party
contained herein. At any time after the Closing, Acquirer and the
Stockholders' Agent may, to the extent legally allowed, (A) extend the time
for the performance of any of the obligations of the other owed to such party,
(B) waive any inaccuracies in the representations and warranties made to such
party contained herein or in any document delivered pursuant hereto or (C)
waive any breaches of any of the covenants, agreements, obligations or
conditions for the benefit of such party contained herein; provided, however, that after the Company Stockholder Approval has been obtained, no
waiver may be made that pursuant to Applicable Law requires further approval
or adoption by the Company Stockholders without such further approval or
adoption. Any such extension or waiver shall be valid only if set forth in an
instrument in writing that is (I) prior to the Closing with respect to the
Company and/or the Company Securityholders, signed by the Company, (II) after
the Closing with respect to the Converting Holders and/or the Stockholders'
Agent, signed by the Stockholders' Agent and (III) with respect to Acquirer
and/or Merger Sub, signed by Acquirer. Without limiting the generality or
effect of the preceding sentence, no failure to exercise or delay in
exercising any right under this Agreement shall constitute a waiver of such
right, and no waiver of any breach or default shall be deemed a waiver of any
other breach or default of the same or any other provision herein.

9.6.Counterparts. This Agreement may be executed in two or more counterparts,
all of which shall be considered one and the same instrument and shall become
effective when one or more counterparts have been signed by each of the
parties hereto and delivered to the other parties hereto; it being understood
and agreed that all parties hereto need not sign the same counterpart. The
delivery by facsimile or by electronic delivery in PDF format of this
Agreement with all executed signature pages (in counterparts or otherwise)
shall be sufficient to bind the parties hereto to the terms and conditions set
forth herein. All of the counterparts will together constitute one and the
same instrument and each counterpart will constitute an original of this
Agreement.

9.7.Entire Agreement; Parties in Interest.

(a)This Agreement and the documents and instruments and other agreements
specifically referred to herein or delivered pursuant hereto, including all
the exhibits attached hereto, the Schedules, including the Company Disclosure
Letter, (i) constitute the entire agreement among the parties hereto with
respect to the subject matter hereof and supersede all prior agreements and
understandings, both written and oral, among the parties hereto with respect
to the subject matter hereof, except for the Confidentiality Agreement, which
shall continue in full force and effect, and shall survive any termination of
this Agreement, in accordance with its terms and (ii) are not intended to
confer, and shall not be construed as conferring, upon any Person other than
the parties hereto any rights or remedies hereunder (except that Section 5.16
is intended to benefit the Company Indemnified Parties and Article VIII is
intended to benefit the Indemnified Persons).

(b)Each of the Company, on the one hand, and Acquirer and Merger Sub, on the
other hand, acknowledges and agrees that none of the other Party or any of its
Affiliates or representatives, or any other Person acting on behalf of the
other Party or any of their respective Affiliates or representatives has made,
and such Party has not relied upon, any representation or warranty, express or
implied, as to the other Party or its Subsidiaries or their respective
businesses or assets, except as expressly set forth in this Agreement or, in
the case of the Company, as and to the extent required by this Agreement to be
set forth in the Company Disclosure Letter; provided that none of the
foregoing in this Section 9.2(b) shall limit Acquirer's rights or remedies in
the case of a Company Fraud or Fraud actually committed by a Converting Holder
under this Agreement or any other Transaction Document to which such
Converting Holder is a party (in each case, subject to Sections 8.3(a), (b)
and (c) and Section 8.4 of this Agreement).

9.8.Assignment. Neither this Agreement nor any of the rights and obligations
under this Agreement may be assigned or delegated, in whole or in part, by
operation of law or otherwise by any of the parties hereto without the prior
written consent of the other parties hereto, and any such assignment without
such prior written consent shall be null and void, except that Acquirer and/or
Merger Sub may assign its rights and delegate its obligations under this Agreement to any
direct or indirect wholly owned subsidiary of Acquirer without the prior
consent of any other party hereto; provided that notwithstanding any such
assignment, Acquirer and/or Merger Sub, as applicable, shall remain liable for
all of its obligations under this Agreement. Subject to the preceding
sentence, this Agreement shall be binding upon, inure to the benefit of, and
be enforceable by, the parties hereto and their respective successors and
assigns.

9.9.Severability. In the event that any provision of this Agreement, or the
application thereof, becomes or is declared by a court of competent
jurisdiction to be illegal, void or unenforceable, the remainder of this
Agreement shall continue in full force and effect and shall be interpreted so
as reasonably necessary to effect the intent of the parties hereto. The
parties hereto shall use all reasonable efforts to replace such void or
unenforceable provision of this Agreement with a valid and enforceable
provision that shall achieve, to the greatest extent possible, the economic,
business and other purposes of such void or unenforceable provision.

9.10.Remedies Cumulative; Specific Performance. Except as otherwise provided
herein, including Section 8.10 and Section 7.2, any and all remedies herein
expressly conferred upon a party hereto shall be deemed cumulative with and
not exclusive of any other remedy conferred hereby, or by law or equity upon
such party, and the exercise by a party hereto of any one remedy shall not
preclude the exercise of any other remedy and nothing herein shall be deemed a
waiver by any party hereto of any right to specific performance or injunctive
relief. It is accordingly agreed that, subject to Section 8.3(b), the parties
hereto shall be entitled to an injunction or injunctions to prevent breaches
of this Agreement and to enforce specifically the terms and provisions hereof,
this being in addition to any other remedy to which they are entitled at law
or in equity, and the parties hereto hereby waive the requirement of any
posting of a bond in connection with the remedies described herein.

9.11.Governing Law. This Agreement and all claims arising out of this
Agreement shall be governed by, and construed in accordance with, the internal
laws of the State of Delaware (whether arising in contract, tort, equity or
otherwise), without regard to any conflicts of law principles that would
result in the application of any law other than the law of the State of
Delaware.

9.12.Jurisdiction and Venue; Consent to Service of Process. The parties hereby
irrevocably and unconditionally submit to the exclusive jurisdiction of the
Court of Chancery of the State of Delaware or, if such court shall not have
jurisdiction, any federal court of the United States of America located within
the State of Delaware, solely in respect of the interpretation and enforcement
of the provisions of this Agreement and of the documents referred to in this
Agreement, and in respect of the transactions contemplated hereby and thereby,
and, to the fullest extent permitted by Applicable Law, hereby waive, and
agree not to assert, as a defense in any action, suit or other Legal
Proceeding for the interpretation or enforcement hereof or thereof, that it is
not subject thereto or that such action, suit or other Legal Proceeding may
not be brought or is not maintainable in said courts or that the venue thereof
may not be appropriate or that this Agreement or any such document may not be
enforced in or by such courts, and the parties irrevocably and unconditionally
agree that all claims with respect to such action, suit or other Legal
Proceeding shall be heard and determined in the Delaware Court of Chancery or,
to the extent required by Applicable Law, the federal court located within the
State of Delaware. The parties hereby consent to and grant any such court
jurisdiction over such parties and over the subject matter of such dispute and
agree that mailing of process or other papers in connection with any such
action, suit or Proceeding in the manner provided for notices in Section 9.2
or in such other manner as may be permitted by Applicable Law, shall be valid
and sufficient service thereof. With respect to any particular action, suit or other Proceeding, venue shall lie solely in the Court of Chancery of the
State of Delaware or such federal court located within the State of Delaware.

9.13.WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY
WAIVES ALL RIGHT TO TRIAL BY JURY AND ANY ACTION, PROCEEDING OR COUNTERCLAIM
(WHETHER BASED ON CONTRACT, TORT, OR OTHERWISE) ARISING OUT OF OR RELATING TO
THIS AGREEMENT OR THE ACTIONS OF ANY PARTY HERETO IN NEGOTIATION,
ADMINISTRATION, PERFORMANCE OR ENFORCEMENT HEREOF.

9.14.Rules of Construction. The parties hereto have been represented by
counsel during the negotiation, preparation and execution of this Agreement
and, therefore, hereby waive, with respect to this Agreement, each Schedule
and each Exhibit attached hereto, the application of any Applicable Law or
rule of construction providing that ambiguities in an agreement or other
document shall be construed against the party drafting such agreement or
document.

9.15.Waiver of Conflicts; Privilege. If the Stockholders' Agent so desires,
acting on behalf of the Converting Holders and without the need for any
consent or waiver by the Company, Acquirer (provided Fenwick is not then
actively representing Acquirer (and for this purpose Fenwick's representation
of the Company prior to Closing shall not (by virtue of the Company being a
subsidiary of the Acquirer post-Closing) be deemed to be representing Acquirer
post-Closing)), or Merger Sub, Fenwick and West LLP ("Fenwick") shall be
permitted to represent the Converting Holders (through the Stockholders'
Agent) after the Closing in connection with any dispute relating to this
Agreement and/or any of the Transactions. Acquirer, Merger Sub and the Company
further agree that, as to all communications among Fenwick and the
Stockholders' Agent and the Converting Holders and their respective Affiliates
(individually and collectively, the "Seller Group") to the extent relating to
the negotiation, preparation, execution and delivery of this Agreement and the
consummation of the Transactions (but not communications between the Company
and Fenwick relating to the general business matters of the Company), the
attorney-client privilege and the expectation of client confidence belongs
solely to the Seller Group and may be controlled only by the Seller Group and
shall not pass to or be claimed, or deemed waived, by Acquirer, Merger Sub or
the Company. This right to the attorney-client privilege shall exist even if
such communications may exist on the Company's computer system or in documents
in the Company's possession. Notwithstanding the foregoing, in the event that
a dispute arises between Acquirer and its subsidiaries (including the
Surviving Corporation), and a Person other than a party to this Agreement
after the Closing, Acquirer and its subsidiaries (including the Surviving
Corporation), shall be entitled to access such materials and assert (but not
waive) the attorney-client privilege.

[Signature Page Next]

 IN WITNESS WHEREOF, Acquirer, Merger Sub, the Company, the Stockholders' Agent
and the Holdback Participant have caused this Agreement and Plan of Merger to
be executed and delivered by their respective officers thereunto duly
authorized (or with respect to the Holdback Participant, personally), all as
of the date first written above.

HEWLETT PACKARD ENTERPRISE COMPANY

By: /s/ Sergio E. Letelier

Name: Sergio E. Letelier

Title: Vice President and Deputy General Counsel



[Signature Page to Agreement and Plan of Merger]



US3653629/60 166756-0017 IN WITNESS WHEREOF, Acquirer, Merger Sub, the Company, the Stockholders' Agent
and the Holdback Participant have caused this Agreement and Plan of Merger to
be executed and delivered by their respective officers thereunto duly
authorized (or with respect to the Holdback Participant, personally), all as
of the date first written above.

SANTORINI MERGER SUB, INC.

By: /s/ Sergio E. Letelier

Name: Sergio E. Letelier

Title: President and Secretary



[Signature Page to Agreement and Plan of Merger]



US3653629/60 166756-0017 IN WITNESS WHEREOF, Acquirer, Merger Sub, the Company, the Stockholders' Agent
and the Holdback Participant have caused this Agreement and Plan of Merger to
be executed and delivered by their respective officers thereunto duly
authorized (or with respect to the Holdback Participant, personally), all as
of the date first written above.

SILVER PEAK SYSTEMS, INC.

By: /s/ David Hughes

Name: David Hughes

Title: Chief Executive Officer



[Signature Page to Agreement and Plan of Merger]



US3653629/60 166756-0017 IN WITNESS WHEREOF, Acquirer, Merger Sub, the Company, the Stockholders' Agent
and the Holdback Participant have caused this Agreement and Plan of Merger to
be executed and delivered by their respective officers thereunto duly
authorized (or with respect to the Holdback Participant, personally), all as
of the date first written above.

STOCKHOLDERS\' AGENT

By: /s/ Ryan Simkin

Name: Ryan Simkin

Title: Managing Director





[Signature Page to Agreement and Plan of Merger]



US3653629/60 166756-0017 IN WITNESS WHEREOF, Acquirer, Merger Sub, the Company, the Stockholders' Agent
and the Holdback Participant have caused this Agreement and Plan of Merger to
be executed and delivered by their respective officers thereunto duly
authorized (or with respect to the Holdback Participant, personally), all as
of the date first written above.

HOLDBACK PARTICIPANT

/s/ David Hughes

Name: David Hughes



[Signature Page to Agreement and Plan of Merger]



US3653629/60 166756-0017 EXHIBIT A

Definitions

As used herein, the following terms shall have the meanings indicated below:

"Acquirer Authorized Representatives" means those individuals set forth on
Schedule A-1.

"Acquirer Common Stock" means the Common Stock, par value $0.01 per share, of
Acquirer.

"Acquirer Stock Price" means the average daily closing price of Acquirer
Common Stock as reported on NYSE for the five consecutive trading days ending
five (5) Business Days prior to the Closing Date.

"Acquisition Proposal" means, with respect to the Company, any agreement,
offer, proposal or bona fide indication of interest (other than this Agreement
or any other offer, proposal or indication of interest by Acquirer), or any
public announcement of intention to enter into any such agreement or of (or
intention to make) any offer, proposal or bona fide indication of interest,
relating to, or involving: (a) any acquisition or purchase from the Company,
or from the Company Stockholders, by any Person or Group of more than a 10%
interest in the total outstanding voting securities of the Company or any
tender offer or exchange offer that if consummated would result in any Person
or Group beneficially owning 10% or more of the total outstanding voting
securities of the Company or any merger, consolidation, business combination
or similar transaction involving the Company, (b) any sale, lease, mortgage,
pledge, exchange, transfer, license (other than in the ordinary course of
business consistent with past practice), acquisition, or disposition of more
than 10% of the assets of the Company in any single transaction or series of
related transactions, (c) any liquidation, dissolution, recapitalization or
other similar significant corporate reorganization of the Company or (d) any
merger, consolidation, business combination or similar transaction involving
the Company or any of its Subsidiaries, in each case other than with Acquirer
or its Affiliates.

"Affiliate" means, with respect to any Person, any other Person that directly
or indirectly through one or more intermediaries controls, or is controlled
by, or is under common control with, such Person. For purposes of this
definition, the term "control" (including the correlative meanings of the
terms "controlled by" and "under common control with"), as used with respect
to any Person, means the possession, directly or indirectly, of the power to
direct or cause the direction of the management policies of such Person,
whether through the ownership of voting securities or by Contract or
otherwise.

"Aggregate Exercise Price" means the sum of the exercise prices of all Company
Options (other than any Unvested Company Options held by Non-Continuing
Employees and Performance Options) and Company Warrants, in each case
outstanding as of immediately prior to the Effective Time, but excluding the
exercise prices to the extent excluded pursuant to the proviso to the
definition of "Per Share Consideration".

"Aggregate Retention Award Amount" means the amount set forth on Schedule A-3.

"Anti-Corruption Law" means any Applicable Law relating to anti-bribery or
anti-corruption (governmental or commercial), including the Foreign Corrupt
Practices Act of 1977, as amended, The Bribery Act of 2010 and any other
Applicable Law that prohibits the payment, offer, promise or

A-1

US3653629/60 166756-0017 authorization of the payment or transfer of anything of value (including gifts
or entertainment), directly or indirectly, to improperly influence any Person,
including any Government Official.

"Antitrust Laws" means the Sherman Act, the Clayton Act, the HSR Act and all
foreign Applicable Law designed to prohibit, restrict or regulate actions
having the purpose or effect of monopolization, restraint of trade or foreign
investment.

"Applicable Law" means, with respect to any Person, any federal, state,
foreign, local, municipal or other law, statute, constitution, legislation,
principle of common law, resolution, ordinance, code, edict, decree, rule,
directive, license, permit, regulation, ruling or requirement issued, enacted,
adopted, promulgated, implemented or otherwise put into effect by or under the
authority of any Governmental Entity and any Orders applicable to such Person
or such Person's Affiliates or to any of their respective assets, properties
or businesses.

"Audited Interim Financials Expenses" means the following fees, costs,
expenses, payments and expenditures actually paid by the Company prior to the
Closing in connection with the preparation of the Audited Interim Financials:
(i) out-of-pocket audit fees to the outside auditor (in an amount not to
exceed $500,000), (ii) out-of-pocket incremental consulting fees to one or
more consultants, including for the provision of tax services (in an aggregate
amount not to exceed $100,000) and (iii) spot bonuses to each of three members
of the Company's finance team (in an aggregate amount not to exceed $150,000)
(including the employer portion of any payroll, social security, unemployment
or similar Tax imposed on such amounts). For the avoidance of doubt, Audited
Interim Financials Expenses shall exclude any fees or expenses relating to the
preparation of financial data or statements other than the Audited Interim
Financials.

"Bid" means any bid, quotation or proposal by the Company or any Subsidiary.

"Business" means the business of the Company and the Subsidiaries, as
currently conducted and as currently proposed to be conducted by the Company
and the Subsidiaries (absent and apart from the Merger).

"Business Day" means a day (i) other than Saturday or Sunday and (ii) on which
commercial banks are open for business in San Francisco, California.

"Closing Payment" means the Total Converting Holders Consideration less (i)
the Expense Fund, less (ii) the Escrow Amount.

"Closing Per Option Consideration" means in respect of each share of Company
Common Stock subject to a Vested Company Option (after giving effect to
Section 1.6), an amount in cash equal to the product obtained by multiplying
(i) the applicable Per Option Consideration in respect of such Vested Company
Option by (ii) the Closing Percentage.

"Closing Per Share Consideration" means in respect of a share of Company
Capital Stock (in each case on an as-converted to Company Common Stock basis
and after giving effect to any exercise of Company Options or Company Warrants
and settlement of Company RSUs prior to the Effective Time, including any such
settlement pursuant to Section 1.3(a)(iv)) that is held by a Company
Stockholder as of the Effective Time, an amount in cash equal to the product
obtained by multiplying (i) the Per Share Consideration and (ii) the Closing
Percentage.

A-2

US3653629/60 166756-0017 "Closing Per Warrant Consideration" means, in respect of each share of Company
Capital Stock subject to the Company Warrant, an amount in cash equal to the
product obtained by multiplying (i) the applicable Per Warrant Consideration
in respect of such Company Warrant by (ii) the Closing Percentage.

"Closing Percentage" means one hundred percent (100%) minus the sum of the
Escrow Percentage and the Expense Percentage.

"Company Accounting Principles" means GAAP applied on a basis consistent with
the methodologies, practices, estimation techniques, assumption and principles
used in the preparation of the Company's audited financial statements for the
fiscal years ending July 31, 2019 (including balance sheets, statements of
operations and statements of cash flows); provided that, in the event of any
conflict between such methodologies, practices, estimation techniques,
assumption and principles and GAAP, GAAP shall control.

"Company Capital Stock" means, collectively, the Company Common Stock and the
Company Preferred Stock.

"Company Cash" means cash and cash equivalents of the Company and the
Subsidiaries, calculated in accordance with the Company Accounting Principles
as of immediately prior to the Closing (except with respect to foreign cash,
which shall be calculated as set forth in the succeeding sentence).
Notwithstanding the foregoing, Company Cash shall (i) be increased by any
deposits, or incoming wires or electronic fund transfers, made but not yet
cleared, (ii) be decreased by any outstanding checks, or outgoing wires or
electronic fund transfers not yet cleared, (iii) exclude any restricted cash
(as determined under the Company Accounting Principles); provided that (A) up
to $800,000 of restricted cash held by Silicon Valley Bank as security for the
Company's credit card with such lender and (B) all foreign cash and cash
equivalents (which shall be calculated based on the Designated Exchange Rate
three (3) Business Days prior to the Closing) shall be included in the
calculation of the Company Cash and (iv) be increased by the amount of any
Audited Interim Financials Expenses and the aggregate outstanding amount of
indebtedness, if any, owed by Company employees or members of the Board to the
Company under any Option Exercise Notes as of the Closing.

"Company Closing Balance Sheet" means the Company's unaudited balance sheet as
of the Closing prepared in a manner consistent basis with the Company Balance
Sheet.

"Company Closing Financial Certificate" means a certificate executed by the
chief executive officer and chief financial officer of the Company dated as of
the Closing Date, certifying, as of the Closing: (i) an itemized list of
Company Debt with a description of the nature of such Company Debt and the
Person to whom such Company Debt is owed, (ii) an itemized list of Unpaid
Transaction Expenses with a description of the nature of each such Unpaid
Transaction Expenses and the Person to whom such Unpaid Transaction Expense is
owed, (iii) the Company's calculation of Company Cash, (iv) the Company's
calculation of the Aggregate Exercise Price, each of which shall be attached
as an exhibit to the Company Closing Financial Certificate. The Company
Closing Financial Certificate shall also include, solely for informational
purposes, the Company Closing Balance Sheet.

"Company Common Stock" means the common stock, par value of $0.0005 per share,
of the Company.

"Company Data" means all data collected, generated, or received in connection
with the development, marketing, offering, selling, delivery, or use of any
Company Product, including Company-Licensed Data, Company-Owned Data and
Personal Data.

A-3

US3653629/60 166756-0017 "Company Data Agreement" means any Contract involving Company Data to which
the Company or any Subsidiary is a party or is bound by, except for the
standard terms of service entered into by users of the Company Products
(copies of which have been made available to Acquirer).

"Company Debt" means, as of a specified date or time, without duplication and
whether or not then due and payable as of such date or time: (i) all
obligations (including the principal amount thereof or, if applicable, the
accreted amount thereof and the amount of accrued and unpaid interest thereon)
of the Company and the Subsidiaries, whether or not represented by bonds,
debentures, notes or other securities (whether or not convertible into any
other security), for the repayment of money borrowed (other than employee
expenses under corporate credit cards incurred in the ordinary course of
business in the thirty (30) days prior to the Closing in an amount up to
$600,000), (ii) all obligations for the deferred purchase price of property or
assets purchased (other than accounts payable incurred in the ordinary course
of business and deferred revenue), (iii) all obligations of the Company and
the Subsidiaries to pay amounts under a lease which is required to be
classified as a capital lease in accordance with GAAP (other than, for the
avoidance of doubt, leases real estate leases), (iv) all outstanding
reimbursement obligations of the Company and the Subsidiaries with respect to
letters of credit (other than under real estate leases), bankers' acceptances
or similar facilities issued for the account of the Company, (v) all
obligations of the Company and the Subsidiaries under any interest rate swap
agreement, forward rate agreement, interest rate cap or collar agreement or
other financial agreement or agreement entered into for the purpose of
limiting or managing interest rate risks, (vi) all obligations secured by any
Encumbrance existing on property owned by the Company and the Subsidiaries,
whether or not indebtedness secured thereby will have been assumed, (vii) all
premiums, penalties, fees, expenses, breakage costs and change of control
payments required to be paid or offered in respect of any of the foregoing on
prepayment or settlement, as a result of the consummation of the Transactions,
(viii) all guaranties, endorsements, assumptions and other contingent
obligations of the Company or the Subsidiaries in respect of, or to purchase
or to otherwise acquire, any of the obligations and other matters of the kind
described in any of the clauses (i) through (vii) appertaining to third
parties, and (ix) all obligations set forth on Schedule A-2.

"Company Equity Plans" means, collectively, (i) the Company 2004 Stock Plan,
as amended from time to time and, (ii) the Company 2014 Equity Incentive Plan,
as amended from time to time.

"Company Government Subcontract" means any Contract with any Contractor that
relates to a Contract between such Contractor and any Governmental Entity for
the provision of Company Products to such Governmental Entity, and each Bid
that if accepted or awarded could lead to a Contract between the Company or
any Subsidiary and a Contractor that relates to a Contract between such
Contractor and any Governmental Entity for the provision of Company Products
to such Governmental Entity.

"Company Intellectual Property" means any and all Company-Owned Intellectual
Property and any and all Third-Party Intellectual Property that is licensed to
the Company or any Subsidiary.

"Company Intellectual Property Agreements" means any Contract governing any
Company Intellectual Property to which the Company or any Subsidiary is a
party or bound by, except for Standard Inbound Licenses.

"Company Optionholders" means (i) with respect to any time before the
Effective Time, collectively, the holders of record of Company Options
outstanding as of such time and (ii) with respect to any time at or after the
Effective Time, collectively, the holders of record of Company Options
outstanding as of immediately prior to the Effective Time.

A-4

US3653629/60 166756-0017 "Company Options" means options to purchase shares of Company Common Stock
awarded under the Company Equity Plans. For the avoidance of doubt, the
options promised to be granted as set forth on Schedule 2.2(d) of the Company
Disclosure Letter or, with respect to any Permitted New Hires, in such
individuals' offer letters shall not constitute Company Options.

"Company-Owned Intellectual Property" means any and all Intellectual Property
that is owned or purported to be owned by the Company or any Subsidiary.

"Company Preferred Stock" means the Company Series A Stock, Company Series B
Stock, Company Series C Stock, Company Series D Stock and Company Series F
Stock.

"Company Privacy Policies" means, collectively, any and all (i) of the
Company's or any Subsidiaries' data privacy and security policies relating to
Personal Data, whether applicable internally, or published on Company Websites
or otherwise made available by the Company or any Subsidiary to any Person,
(ii) public representations (including representations on Company Websites) of
adherence to industry self-regulatory obligations and commitments and
Contracts with third parties relating to the Processing of Personal Data and
(iii) policies and obligations applicable to the Company or any Subsidiary
relating to transfers of Personal Data, including pursuant to the GDPR or as a
result of the Company's certification under the U.S.-EU Privacy Shield or
Swiss-U.S. Privacy Shield.

"Company Products" means all products or services currently produced,
marketed, offered, licensed, sold, distributed or performed by or on behalf of
the Company or any Subsidiary and all products or services currently under
development by the Company or any Subsidiary and scheduled for commercial
release within ninety (90) days following the Agreement Date.

"Company Registered Intellectual Property" means the United States,
international and foreign: (i) patents and patent applications (including
provisional applications and utility models), (ii) registered trademarks,
applications to register trademarks, intent-to-use applications, or other
registrations or applications related to trademarks, (iii) registered Internet
domain names and (iv) registered copyrights and applications for copyright
registration, in each case registered or filed in the name of, or owned by,
the Company or any Subsidiary.

"Company RSUs" means restricted stock units awarded under the Company Equity
Plans with respect to shares of Company Common Stock (whether or not vested),
including the Excess Promised Option RSUs (if any), but excluding the
Retention RSUs.

"Company RSU Holders" means (i) with respect to any time before the Effective
Time, collectively, the holders of record of Company RSUs outstanding as of
such time and (ii) with respect to any time at or after the Effective Time,
collectively, the holders of record of Company RSUs outstanding as of
immediately prior to the Effective Time

"Company Securityholders" means, collectively, the Company Stockholders,
Company Optionholders, Company RSU Holders, Retention RSU Holders and Company
Warrantholders.

"Company Series A Stock" means the Series A Preferred Stock, par value $0.0005
per share, of the Company.

"Company Series B Stock" means the Series B Preferred Stock, par value $0.0005
per share, of the Company.

A-5

US3653629/60 166756-0017 "Company Series C Stock" means the Series C Preferred Stock, par value $0.0005
per share, of the Company.

"Company Series D Stock" means the Series D Preferred Stock, par value $0.0005
per share, of the Company.

"Company Series F Stock" means the Series F Preferred Stock, par value $0.0005
per share, of the Company.

"Company Source Code" means, collectively, any software source code or
database specifications or designs, or any material proprietary information or
algorithm contained in or relating to any software source code or database
specifications or designs, of any Company-Owned Intellectual Property or
Company Products.

"Company Stockholders" means (i) with respect to any time before the Effective
Time, collectively, the holders of record of shares of Company Capital Stock
outstanding as of such time and (ii) with respect to any time at or after the
Effective Time, collectively, the holders of record of shares of Company
Capital Stock outstanding as of immediately prior to the Effective Time.

"Company Transaction Documents" means this Agreement and each other
Transaction Document to which the Company is or will be a party.

"Company Warrantholders" means (i) with respect to any time before the
Effective Time, collectively, the holders of record of Company Warrants
outstanding as of such time and (ii) with respect to any time at or after the
Effective Time, collectively, the holders of record of Company Warrants
outstanding as of immediately prior to the Effective Time.

"Company Warrants" means warrants to purchase shares of Company Capital Stock.

"Company Websites" means all web sites owned, operated or hosted by the
Company or any Subsidiary or through which the Company or any Subsidiary
conducts their respective Businesses (including those web sites operated using
the domain names listed in Schedule 2.9(c) of the Company Disclosure Letter),
and the underlying platforms for such web sites.

"Continuing Employees" means the employees of the Company or a Subsidiary as
of immediately prior to the Effective Time who are employed with Acquirer, the
Surviving Corporation or one of their respective subsidiaries as of
immediately after the Effective Time, excluding (unless determined otherwise
by Acquirer) any employees who are presented with an Offer Letter and fail to
execute such agreement prior to the Effective Time.

"Contract" means any written or oral legally binding contract, agreement,
instrument, commitment or undertaking of any nature (including leases,
subleases, licenses, mortgages, notes, guarantees, sublicenses, subcontracts,
letters of intent and purchase orders) as of the Agreement Date or as may
hereafter be in effect, including all amendments, supplements, exhibits and
schedules thereto.

"Contractor" means any prime contractor or upper-tier subcontractor.

"Converting Holders" means (i) Company Stockholders, (ii) Company
Optionholders holding Vested Company Options (after giving effect to Section
1.6) and (c) the Company Warrantholders, in each case as of immediately prior
to the Effective Time.

A-6

US3653629/60 166756-0017 "COVID-19" means the novel coronavirus disease 2019, known as COVID-19.

"Designated Exchange Rate" means, in respect of any date, the rate of exchange
from the applicable foreign currency to Dollars as published by the Wall
Street Journal at http://online.wsj.com/mdc/public/page/2_3021-forex.html for
the end of the trading day prior to such date.

"DGCL" means the General Corporation Law of the State of Delaware.

"Direct Government Contract" means any Contract with any Governmental Entity
and any Bid that if accepted or awarded could lead to a Contract between
Company or any Subsidiary and any Governmental Entity, including any
indefinite delivery/indefinite quantity contract, firm-fixed-price contract,
schedule contract, blanket purchase agreement, or task or delivery order;

"Dissenting Shares" means any shares of Company Capital Stock that are issued
and outstanding immediately prior to the Effective Time and in respect of
which appraisal or dissenters' rights shall have been perfected, and not
waived, withdrawn or lost, in accordance with the DGCL or CCC, to the extent
applicable, in connection with the Merger.

"Encumbrance" means, with respect to any asset, any mortgage, easement,
encroachment, equitable interest, right of way, deed of trust, lien (statutory
or other), pledge, charge, security interest, title retention device,
conditional sale or other security arrangement, collateral assignment, claim,
community property interest, adverse claim of title, ownership or right to
use, right of first refusal, restriction or other encumbrance of any kind in
respect of such asset (including any restriction on (i) the voting of any
security or the transfer of any security or other asset, (ii) the receipt of
any income derived from any asset, (iii) the use of any asset and (iv) the
possession, exercise or transfer of any other attribute of ownership of any
asset).

"Environmental, Health and Safety Requirements" means all Applicable Laws
concerning or relating to worker/occupational health and safety, or pollution
or protection of the environment, including those relating to the use,
generation, handling, treatment, storage, or disposal of any Materials of
Environmental Concern, or relating to the importation, sale, transport or
labeling of chemical substances or products, articles or goods containing
chemical substances, and the reuse, recycling, or disposal of chemical
substances or products, including without limitation, the U.S. Comprehensive
Environmental Response, Compensation and Liability Act ("CERCLA"), U.S.
Resource Conservation and Recovery Act ("RCRA"), U.S. Clean Water Act, U.S.
Clean Air Act, EU RoHS, EU REACH and EU WEEE, U.S. Toxic Substances Control
Act, California Proposition 65, California Supply Chain Transparency Act,
Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act
pertaining to Conflict Minerals, Technical Regulations, and all analogous,
similar or related Applicable Laws each as amended and as now in effect.

"Equity Interests" means, with respect to any Person, any capital stock of, or
other ownership, membership, partnership, joint venture or equity interest in,
such Person or any indebtedness, securities, options, warrants, call,
subscription or other rights or entitlements of, or granted by, such Person or
any of its Affiliates that are convertible into, or are exercisable or
exchangeable for, or giving any Person any right or entitlement to acquire any
such capital stock or other ownership, partnership, joint venture or equity
interest, in all cases, whether vested or unvested.

"Escrow Amount" means an amount in cash equal to $75,000,000.

A-7

US3653629/60 166756-0017 "Escrow Percentage" means the quotient obtained by dividing (i) the Escrow
Amount by (ii) the Total Converting Holders Consideration.

"Excess Promised Option RSUs" means Promised Option RSUs, if any, that exceed
the Promised Option Cap and are not included in the definition of Retention
RSUs.

"Exchange Act" means the Securities Exchange Act of 1934, as amended.

"Exchange Ratio" means with respect to Unvested Company Options the fraction
having (i) a numerator equal to the Per Share Consideration and (ii) a
denominator equal to the Acquirer Stock Price.

"Expense Percentage" means the quotient obtained by dividing (i) the Expense
Fund by (ii) the Total Converting Holders Consideration.

"Fraud" means Delaware common law fraud with the element of scienter.

"Fully-Diluted Common Stock" means, as of immediately prior to the Effective
Time, the sum of the following: (i) the aggregate number of shares of Company
Capital Stock issued and outstanding (excluding any shares of Company Series D
Stock), (ii) the aggregate number of shares of Company Common Stock issuable
upon the conversion of the shares of Company Series D Stock and (iii) the
aggregate number of shares of Company Common Stock issuable upon the exercise
or settlement of the Vested Company Options (after giving effect to Section
1.6), Unvested Company Options (after giving effect to Section 1.6) (other
than any Unvested Company Options held by Persons who are Non-Continuing
Employees and any Performance Options), Company RSUs and Company Warrants (in
the case of clause (i) and (ii) after giving effect to any exercise of Company
Options or Company Warrants and settlement of Company RSUs prior to the
Effective Time, including any such settlement pursuant to Section1.3(a)(iv)).
For the avoidance of doubt, the Fully-Diluted Common Stock shall exclude all
Retention RSUs and all shares of Company Capital Stock that are owned by the
Company as treasury stock.

"Future Per Option Consideration" means, with respect to each Vested Company
Option (after giving effect to Section 1.6) that a Converting Holder owned
immediately prior to the Effective Time, a non-transferable contingent right
to the amount in cash to be released from the Escrow Fund and the Expense Fund
in respect of such Vested Company Option, in each case pursuant to Article
VIII.

"Future Per Share Consideration" means, with respect to each share of Company
Capital Stock (in each case, on an as-converted to Company Common Stock basis
and after giving effect to any exercise of Company Options or Company Warrants
and settlement of Company RSUs prior to the Effective Time, including any such
settlement pursuant to Section 1.3(a)(iv)) that a Converting Holder owned
immediately prior to the Effective Time, a non-transferable contingent right
to the amount in cash to be released from the Escrow Fund and the Expense Fund
in respect of such share of Company Capital Stock, in each case pursuant to
Article VIII.

"Future Per Warrant Consideration" means, with respect to each Company Warrant
that a Converting Holder owned immediately prior to the Effective Time, a non-
transferable contingent right to the amount in cash to be released from the
Escrow Fund and the Expense Fund in respect of such Company Warrant, in each
case pursuant to Article VIII.

"GAAP" means United States generally accepted accounting principles set forth
in the opinions and pronouncements of the Accounting Principles Board and the
American Institute of Certified Public

A-8

US3653629/60 166756-0017 Accountants and statements and pronouncements of the Financial Accounting
Standards Board, that are applicable to the circumstances of the date of
determination, consistently applied.

"Government Contracts" means, collectively, the Company Government
Subcontracts and Direct Government Contracts.

"Government Official" means (i) any official, employee, agent or
representative of, or any Person acting in an official capacity for or on
behalf of, any Governmental Entity, (ii) any political party, political party
official or candidate for political office, (iii) any official, employee,
agent or representative of, or any Person acting in an official capacity for
or on behalf of, a company, business, enterprise or other entity owned, in
whole or in part, or controlled by any Governmental Entity or (iv) any
official, employee, agent or representative of, or any Person acting in an
official capacity for or on behalf of, a royal family or public international
organization.

"Governmental Entity" means any supranational, national, state, municipal,
local or foreign government, any court, tribunal, arbitrator, administrative
agency, commission or other Government Official, authority or instrumentality
(including, but not limited to, any entity that is partially or wholly
government owned or government controlled), in each case whether domestic or
foreign, any stock exchange or similar self-regulatory organization or any
quasi-governmental or private body exercising any executive, legislative,
judicial, regulatory, Tax Authority or other functions of, or pertaining to,
government authority (including any governmental or political division,
department, agency, commission, instrumentality, official, organization, unit,
body or entity and any court or other tribunal).

"Group" has the meaning ascribed to such term under Section 13(d) of the
Exchange Act, the rules and regulations thereunder and related case law.

"HSR Act" means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as
amended, and the rules and regulations promulgated thereunder.

"Intellectual Property" means (i) Intellectual Property Rights and (ii)
Proprietary Information and Technology.

"Intellectual Property Rights" means any and all of the following and all
rights in, arising out of, or associated therewith, throughout the world:
patents, utility models, and applications therefor and all reissues,
divisions, re-examinations, renewals, extensions, provisionals, continuations
and continuations-in-part thereof and equivalent or similar rights in
inventions and discoveries anywhere in the world, including invention
disclosures, common law and statutory rights associated with trade secrets,
confidential and proprietary information and know-how, industrial designs and
any registrations and applications therefor, trade names, logos, trade dress,
trademarks and service marks, trademark and service mark registrations,
trademark and service mark applications and any and all goodwill associated
with and symbolized by the foregoing items, Internet domain name applications
and registrations, Internet and World Wide Web URLs or addresses, copyrights,
copyright registrations and applications therefor and all other rights
corresponding thereto, database rights, mask works, mask work registrations
and applications therefor and any equivalent or similar rights in
semiconductor masks, layouts, architectures or topology, moral and economic
rights of authors and inventors, however denominated and any similar or
equivalent rights to any of the foregoing.

"IRS" means the United States Internal Revenue Service.

A-9

US3653629/60 166756-0017 "knowledge" means, with respect to any fact, circumstance, event or other
matter in question, the knowledge of such fact, circumstance, event or other
matter after reasonable inquiry of (i) an individual, if used in reference to
an individual or (ii) with respect to any Person that is not an individual
(other than the Company), the executive officers of such Person, and with
respect to the Company, the individuals listed on Schedule I-3 (the foregoing
individuals with respect to the Company, collectively the "Company knowledge
persons"); provided that any executive officer or Company knowledge persons,
as applicable, will be deemed to have knowledge of a particular fact,
circumstance, event or other matter if such knowledge could be obtained from
reasonable inquiry, including of such executive officer's or Company knowledge
person's direct subordinates or reports with knowledge of the subject matter
in question.

"Legal Proceeding" means any private or governmental action, written inquiry,
formal investigation, claim, counterclaim, proceeding, suit, arbitration,
hearing, litigation or audit, in each case whether civil, criminal,
administrative, judicial or investigative, or any appeal therefrom.

"Liabilities" (and, with correlative meaning, "Liability") means all debts,
liabilities, commitments and obligations, whether accrued or fixed, absolute
or contingent, matured or unmatured, determined or determinable, liquidated or
unliquidated, asserted or unasserted, known or unknown, whenever or however
arising, including those arising under Applicable Law or any Legal Proceeding
or Order of a Governmental Entity and those arising under any Contract,
regardless of whether such debt, liability, commitment or obligation would be
required to be reflected on a balance sheet prepared in accordance with GAAP
or disclosed in the notes thereto.

"Material Adverse Effect" with respect to any Person means any change, event,
violation, inaccuracy, circumstance or effect (each, an "Effect") that,
individually or taken together with all other Effects, and regardless of
whether such Effect constitutes an inaccuracy in the representations or
warranties made by, or a breach of the covenants, agreements or obligations
of, such Person herein, is, or would reasonably be likely to be or become,
materially adverse in relation to the financial condition, assets (including
intangible assets), liabilities, business, operations or results of operations
of such Person and its subsidiaries, taken as a whole, except to the extent
that any such Effect directly results from: (i) changes in general economic
conditions, (ii) changes affecting the industry generally in which such Person
operates, (iii) changes in GAAP, (iv) the outbreak or escalation of war,
hostilities, or terrorist activities, either in the United States or any other
jurisdiction in which such Person operates, (v) earthquakes, hurricanes,
tornadoes, floods, epidemics/pandemics or other natural disasters (including
COVID-19), (vi) changes in Applicable Law after the Agreement Date, (vii) the
announcement of entry into this Agreement (including the identity of
Acquirer), (viii) any failure by such Person to meet any projections,
forecasts or estimates in and of itself (provided that any facts or
occurrences giving rise to or contributing to such failure to meet any
projections, forecasts or estimates shall not be excluded under this clause
(viii)), or (ix) with respect to the Company only, the taking of any specific
action, or refraining from taking any specific action, in each case at the
specific written request of Acquirer or that is specifically required to be
taken or prohibited under this Agreement (other than actions taken or
refrained from taking by the Company in compliance with, or pursuant to
consent granted under, Section 4.1 or Section 4.2, except to the extent that
any such inaction is as a result of Acquirer's unreasonably withholding,
delaying or conditioning its consent therefor); unless, in the case of each of
the foregoing clauses (i) through (vi) only, such changes or events
disproportionately affect such Person as compared to other Persons or
businesses that operate in the industry in which such Person operates.

"Materials of Environmental Concern" means chemicals, pollutants,
contaminants, including emerging contaminants such as PFAS, emissions, wastes,
substances, petroleum and petroleum products, radioactive materials, asbestos,
polychlorinated biphenyls, lead or lead-based paints or materials, radon,

A-10

US3653629/60 166756-0017 mold, chlorofluorocarbons and all other ozone-depleting substances, and any
other substance that is now or hereafter regulated by, or gives rise to
Liability under, any Applicable Law or that is otherwise a danger to health,
reproduction or the environment.

"Non-Continuing Employees" means any employee of the Company or its
Subsidiaries who is not a Continuing Employee.

"NYSE" means The New York Stock Exchange.

"Open Source Materials" means software or other material that is distributed
as "free software," "open source software" or under similar licensing or
distribution terms (including the GNU General Public License (GPL), GNU Lesser
General Public License (LGPL), Mozilla Public License (MPL), BSD licenses, the
Artistic License, the Netscape Public License, the Sun Community Source
License (SCSL) the Sun Industry Standards License (SISL) and the Apache
License).

"Order" means any judgment, writ, decree, stipulation, determination,
decision, award, rule, preliminary or permanent injunction, temporary
restraining order or other order.

"Per Option Consideration" means, in respect of each share of Company Common
Stock subject to a Company Option (other than any Unvested Company Options
held by Persons who are Non-Continuing Employees and any Performance Options),
an amount equal to the excess, if any, of the Per Share Consideration over the
applicable per share exercise price.

"Per Share Consideration" means an amount equal to the quotient obtained by
dividing (i) the Total Consideration plus the Aggregate Exercise Price by (ii)
the Fully-Diluted Common Stock; provided, that if the Per Share Consideration
calculated is less than the exercise price per share of any Company Options or
Company Warrants, the calculation shall be repeated by excluding such Company
Options and/or Company Warrants with the highest exercise price per share from
the Fully-Diluted Common Stock in clause (ii) and the Aggregate Exercise Price
with respect to such Company Options and/or Company Warrants from clause (i),
until the resulting Per Share Consideration equals or exceeds the exercise
price per share of all Company Options and Company Warrants included in such
calculation, and such Per Share Consideration shall be the Per Share
Consideration for purposes of this Agreement.

"Per Share Consideration Estimate" means an estimated amount of the Per Share
Consideration determined by Acquiror in consultation with the Company's Chief
Executive Officer for purposes of granting the Promised Option RSUs and the
Retention RSUs pursuant to Section 5.9(f) and 5.9(g).

"Per Warrant Consideration" shall mean, in respect of each share of Company
Capital Stock subject to an unexercised Company Warrant, an amount equal to
the excess, if any, of the Per Share Consideration over the applicable per
share exercise price.

"Performance Options" means the Company Options granted on December 2, 2019 to
each of David Hughes and Ian Whiting that are subject to a performance-based
vesting component.

"Permitted Encumbrances" means: (i) statutory liens for Taxes that are not yet
due and payable or liens for Taxes being contested in good faith by any
appropriate proceedings for which adequate reserves have been established in
accordance with the Company Accounting Principles, (ii) statutory liens to
secure obligations to landlords, lessors or renters under leases or rental
agreements, (iii) deposits or pledges made in connection with, or to secure
payment of, workers' compensation, unemployment insurance or similar programs
mandated by Applicable Law, (iv) statutory liens in favor of carriers,

A-11

US3653629/60 166756-0017 warehousemen, mechanics and materialmen, to secure claims for labor, materials
or supplies and other like liens, (v) liens in favor of customs and revenue
authorities arising as a matter of Applicable Law to secure payments of
customs duties in connection with the importation of goods, and (vi) non-
exclusive object code licenses of software and of related documentation by the
Company or a Subsidiary in the ordinary course of business consistent with
past practice.

"Person" means any natural person, company, corporation, limited liability
company, general partnership, limited partnership, limited liability
partnership, trust, estate, proprietorship, joint venture, business
organization or Governmental Entity.

"Personal Data" means a natural Person's (including an end user's, an
employee's or other individual's) name, street address, telephone number,
e-mail address, photograph, social security number, driver's license number,
passport number or user or account number, or any other piece of information
that allows the identification of a natural Person or is otherwise considered
personally identifiable information or personal data under Applicable Law.

"Pre-Closing Operating Tax Amount" means an amount equal to the average of the
month end balance of all Taxes payable by the Company and the Subsidiaries in
the ordinary course of business (other than (a) income or franchise or similar
Taxes on net or gross income, profits or gains and (b) any employment Taxes
attributable to bonus or severance payments) for the three months in 2019 that
correspond to the three months ending immediately prior to the Closing Date.
For illustration, if the Closing Date were December 10, 2020, then the Pre-
Closing Operating Tax Amount would be an amount equal to the average of the
month end balance of all Taxes payable by the Company and the Subsidiaries in
the ordinary course of business (other than income or franchise or similar
Taxes on net or gross income, profits or gains) for September, October and
November of 2019.

"Pre-Closing Tax" means, without duplication, any (i) Taxes in respect of the
Company and the Subsidiaries for a Taxable period (or portion thereof) ending
on or prior to the Closing Date, (ii) any Taxes of any other Person for which
the Company is or becomes liable if the agreement, event or occurrence giving
rise to such Liability occurred on or before the Closing Date, including any
Liability for the payment of any amounts of Taxes as a result of being a
member of an affiliated, consolidated, combined, unitary or aggregate group
for any Taxable period, of being a transferee of or successor to any Person,
or as a result of any express or implied obligation to assume such Taxes or to
indemnify any other Person, and (iii) any Transfer Taxes. In the case of any
Taxes of the Company or any Subsidiary that are imposed on a periodic basis
and that are payable for a Taxable period that includes (but does not end on)
the Closing Date, such Taxes shall (A) in the case of property, ad valorem or
other Taxes that accrue based upon the passage of time, be deemed to be Pre-
Closing Taxes in an amount equal to the amount of such Taxes for the entire
Taxable period multiplied by a fraction, the numerator of which is the number
of days in the Taxable period through and including the Closing Date and the
denominator of which is the number of days in the entire Taxable period, and
(B) in the case of any other Taxes, be deemed to be Pre-Closing Taxes in an
amount equal to the amount of Taxes that would be payable if the relevant
Taxable period ended on the Closing Date. Any credits relating to a Taxable
period that includes (but does not end on) the Closing Date shall be taken
into account as though the relevant Taxable period ended on the Closing Date.
Notwithstanding the foregoing, Pre-Closing Taxes, shall not include any costs
incurred in connection with amounts deposited in the Escrow Fund for Vested
Company Options, the Company Options assumed by Acquirer, Promised Option
RSUs, Retention RSUs or any retention bonus or similar amount payable to any
Continuing Employee in connection with his or her employment agreement
(including any employment or payroll Taxes or other withholding obligations
associated therewith).

A-12

US3653629/60 166756-0017 "Privacy Laws" means (i) each Applicable Law applicable to the protection or
Processing or both of Personal Data, including, without limitation, the EU
General Data Protection Regulation ("GDPR") and rules relating to the EU-U.S.
Privacy Shield or Swiss-U.S. Privacy Shield, the California Consumer Privacy
Act and Section 5 of the FTC Act, and direct marketing, e-mails, text messages
or telemarketing, (ii) applicable guidance and regulations issued by a
Governmental Entity that pertains to one of the laws, rules or standards
outlined in clause (i), and (iii) industry self-regulatory principles to which
the Company publicly subscribes and that are applicable to the protection or
the Processing of Personal Data, by the Company or any Subsidiary in relation
to direct marketing, e-mails, text messages or telemarketing

"Pro Rata Share" means, with respect to a particular Converting Holder, a
fraction, (i) the numerator of which is the sum of (A) the aggregate Per
Option Consideration in respect of all Vested Company Options outstanding as
of the Effective Time held by such Converting Holder (after giving effect to
Section 1.6), plus (B) the aggregate Per Share Consideration in respect of all
shares of Company Capital Stock that are issued and outstanding as of the
Effective Time (in the case of each of clause (A) and (B), after giving effect
to any exercise of Company Options or Company Warrants and settlement of
Company RSUs prior to the Effective Time, including any such settlement
pursuant to Section1.3(a)(iv), and in the case of clause (B), in each case on
an as-converted to Company Common Stock basis) held by such Converting Holder
plus (C) the aggregate Per Warrant Consideration in respect to all Company
Warrants outstanding as of the Effective Time held by such Converting Holder,
and (ii) the denominator of which is the Total Converting Holders
Consideration.

"Process" or "Processing" means, with respect to data (including Personal
Data), the use, collection, processing, storage, recording, organization,
adaption, alteration, transfer (including cross-border transfer), retrieval,
consultation, disclosure, dissemination or combination of such data.

"Promised Option RSUs" means the Company RSUs awarded pursuant to Section
5.9(f) under the Company's 2014 Equity Incentive Plan in lieu of the options
promised by the Company to be granted as set forth on Schedule 2.2(d) of the
Company Disclosure letter or, in the case of any Permitted New Hires, such
individuals' offer letters with the Company.

"Proprietary Information and Technology" means any and all of the following:
works of authorship, computer programs, source code and executable code,
whether embodied in software, firmware or otherwise, assemblers, applets,
compilers, user interfaces, application programming interfaces, protocols,
architectures, documentation, annotations, comments, designs, files, records,
schematics, test methodologies, test vectors, emulation and simulation tools
and reports, hardware development tools, models, tooling, prototypes,
breadboards and other devices, circuits, hardware systems and subsystems,
data, data structures, databases, data compilations and collections,
inventions (whether or not patentable), invention disclosures, discoveries,
improvements, technology, proprietary and confidential ideas and information,
know-how and information maintained as trade secrets, tools, concepts,
techniques, methods, processes, formulae, patterns, algorithms and
specifications, customer lists and supplier lists, of (A) the foregoing or (B)
any Intellectual Property Rights in any form and embodied in any media.

"Representatives" means, with respect to a Person, such Person's officers,
directors, Affiliates, stockholders or employees, or any investment banker,
attorney, accountant, auditor or other advisor or representative retained by
any of them.

"Retention RSUs" means (i) the restricted stock units awarded pursuant to
Section 5.9(f) under the Company's 2014 Equity Incentive Plan with respect to
shares of Company Common Stock and (ii) Promised Option RSUs with an aggregate
grant-date value of up to $1,000,000 (the "Promised Option

A-13

US3653629/60 166756-0017 Cap"), with a combined aggregate grant-date value of up to the Aggregate
Retention Award Amount, the grant-date value in each case based on the Per
Share Consideration Estimate, with the actual aggregate grant-date value to be
as instructed by Acquiror no later than ten (10) Business Days prior to the
Closing.

"Retention RSU Holders" means (i) with respect to any time before the
Effective Time, collectively, the holders of record of Retention RSUs
outstanding as of such time and (ii) with respect to any time at or after the
Effective Time, collectively, the holders of record of Retention RSUs
outstanding as of immediately prior to the Effective Time.

"Securities Act" means the Securities Act of 1933, as amended.

"Specified Tax Representations" means those representations and warranties of
the Company contained in Sections 2.12(a), (b), (c), (g), (r), (t), (u), (w),
(x), (z) and (bb).

"Standard Inbound Licenses" means (i) "shrink wrap" and similar generally
available standard form of non-negotiated commercial end-user licenses to
software that have an enterprise-level acquisition cost of $10,000 or less on
a fully paid-up basis; (ii) Open Source Materials; (iii) Standard Non-
Disclosure Agreements; and (iv) employment and consulting agreements, in each
case of clauses (i) - (iv) excluding any licenses to material Intellectual
Property Rights necessary for the functioning of the Company Products.

"Standard Non-Disclosure Agreements" means any Contract relating to the
disclosure of confidential information that (i) is entered into in the
ordinary course of business or (ii) is not providing any express rights to
Intellectual Property.

"Standard Outbound Licenses" means (i) standard terms of service entered into
by end users of the Company Products in the ordinary course of business
consistent with past practice; (ii) consulting agreements; and (iii) Standard
Non-Disclosure Agreements.

"subsidiary" means, with respect to any Person, any corporation, partnership,
limited liability company or other Person of which such Person, either alone
or together with one or more subsidiaries or by one or more other subsidiaries
(i) directly or indirectly owns or purports to own, beneficially or of record
securities or other interests representing more than 50% of the outstanding
equity, voting power, or financial interests of such other Person or (ii) is
entitled, by Contract or otherwise, to elect, appoint or designate directors
constituting a majority of the members of such other Person's board of
directors or other governing body.

"Subsidiary" means any subsidiary of the Company and Silver Peak Systems Pte.
Ltd.

"Tax" (and, with correlative meaning, "Taxes" and "Taxable") means (i) any net
income, alternative or add-on minimum tax, gross income, estimated, gross
receipts, sales, use, ad valorem, value added, transfer, franchise, fringe
benefit, capital stock, profits, license, registration, withholding, payroll,
social security (or equivalent), employment, unemployment, disability, excise,
escheat, severance, stamp, occupation, premium, property (real, tangible or
intangible), environmental or windfall profit tax, custom duty or other tax,
governmental fee or other like assessment or charge of any kind whatsoever,
together with any interest or any penalty, addition to tax or additional
amount (whether disputed or not) imposed by any Governmental Entity
responsible for the imposition of any such tax (domestic or foreign) (each, a
"Tax Authority"), and (ii) any penalties (including any interest thereon and
additional amounts thereto) imposed for a failure to file, or a failure to
file any Tax Returns in a timely, correct or complete manner.

A-14

US3653629/60 166756-0017 "Tax Return" means any return, statement, report or form (including estimated
Tax returns and reports, withholding Tax returns and reports, any schedule or
attachment, and information returns and reports) filed or required to be filed
with respect to Taxes.

"Technical Regulations" means any Applicable Law pertaining to electromagnetic
compatibility, product safety, electrical safety, radio communications,
telecommunications, consumer protection, radiation emitting devices,
electrical appliances, energy efficiency, CE Mark and any Applicable Law
issued by or regulated by the Federal Communications Commission or similar
organization.

"Third-Party Intellectual Property" means any and all Intellectual Property
owned by a third party.

"Total Converting Holders Consideration" means the sum of (i) the aggregate
Per Option Consideration in respect of all Vested Company Options outstanding
as of the Effective Time (after giving effect to Section 1.6) plus (ii) the
product of (A) the Per Share Consideration multiplied by (B) the aggregate
number of shares of Company Capital Stock that are issued and outstanding as
of the Effective Time (in the case of each of clause (i) and (ii), after
giving effect to any exercise of Company Options or Company Warrants and
settlement of Company RSUs prior to the Effective Time, including any such
settlement pursuant to Section 1.3(a)(iv), and in the case of clause (ii) in
each case on an as-converted to Company Common Stock basis) plus (iii) the
aggregate Per Warrant Consideration in respect to all Company Warrants
outstanding as of the Effective Time.

"Total Consideration" means $925,000,000 in cash less (i) all Unpaid
Transaction Expenses, plus (ii) the aggregate amount of Company Cash, less
(iii) the aggregate amount of Company Debt as of the Closing, in each case of
clauses (i), (ii) and (iii), as set forth in the Company Closing Financial
Certificate.

"Transaction Document" means, collectively, (i) this Agreement, (ii) the
Escrow Agreement, Written Consents, Joinder Agreements, Option Cancellation
Agreements, Warrantholder Agreements, Letters of Transmittal and (iii) the
Company Closing Financial Certificate, the Spreadsheet Certificate and the
other certificates expressly required to be delivered by either Acquirer or
the Company pursuant to Sections 1.2.

"Transaction Expenses" means all third-party fees, costs, expenses, payments
and expenditures incurred by or on behalf of the Company in connection with
the Merger, this Agreement, the other Transaction Documents and the
Transactions or the process of the sale of the Company, or, to the extent such
fees or expenses are incurred by or on behalf of the Company before the
Closing, any other extraordinary actual or contemplated transaction, including
any actual or contemplated underwriting, equity or debt financing,
recapitalization, change in control transaction, business combination
transaction, or sale, lease or licensing of all or substantially all of the
assets (all of the foregoing, "Extraordinary Matters"), in each case, whether
or not incurred, billed or accrued (including (i) any fees, costs expenses,
payments and expenditures of legal counsel and accountants, (ii) the maximum
amount of fees costs, expenses, payments and expenditures payable to brokers,
finders, financial advisors, investment bankers or similar Persons
notwithstanding any earn-outs, escrows or other contingencies, (iii) all sale,
change-in-control, retention or similar bonuses or severance obligations owed
by the Company to the Company's current or former directors, employees,
consultants and/or other service providers solely as a result of the
consummation of the Merger and that are unpaid as of the Closing, including
the employer portion of any payroll, social security, unemployment or similar
Tax imposed on such amounts, (iv) the employer portion of any payroll or
similar withholding Tax attributable to the portion of the Closing Payment to
be made with respect to Vested Company Options pursuant to Section
1.3(a)(ii)(A) and Section 1.4(c), (v)

A-15

US3653629/60 166756-0017 one half of the costs, fees and expenses of the Paying Agent (not to exceed
$25,000), (vi) fees, costs, expenses, payments and expenditures, if any,
payable to any Person by the Company in connection with Section 5.5(a), (vii)
any such fees, costs, expenses, payments and expenditures incurred by Company
Securityholders paid for or to be paid for by the Company, (viii) the cost of
the DandO Tail Policy and (ix) if and to the extent (A) the Company fails to
comply with the terms of Section 5.13 and (B) as a result of which the Company
is unable to obtain a deduction by reason of Section 280G of the Code, the
value of such lost deduction. Notwithstanding the foregoing, Transaction
Expenses shall in no event include any Audited Interim Financials Expenses.

"Transfer Taxes" means any and all transfer, documentary, stamp, registration,
recording, sales, use, value added, good and services, and other similar Taxes
and fees, together with any interest, penalties, or additions thereto,
incurred in connection with the Merger.

"Unpaid Transaction Expenses" means any Transaction Expenses that are incurred
but unpaid as of the Closing.

"Unvested Company Option" means any Company Option that is not vested under
the terms of any Contract between the holder of such Company Option and the
Company (including any Company Equity Plan) as of immediately prior to the
Effective Time.

"Vested Company Option" means any Company Option that is vested under the
terms of any Contract between the holder of such Company Option and the
Company (including any Company Equity Plan) as of immediately prior to the
Effective Time.

"willful breach" means a breach by a Person that is both the product of an
intentional (i.e., not inadvertent) act or omission of such Person and that,
at the time of such act or omission was actually known by such Person to, or
known by such Person to be reasonably likely to, constitute or give rise to
such breach.

Other capitalized terms used herein and not defined in this Exhibit A shall
have the meanings assigned to such terms in the following Sections:

"2014 Plan Amendment" 1.2(b)(viii)

"280G Stockholder Approval" 5.13

"401(k) Plan" 1.2(b)(viii)

"Accounts Receivable" 2.4(f)

"Acquirer" Preamble

"Advisory Group" 8.7(b)

"Agreement" Preamble

"Agreement Date" Preamble

"Anniversary Date" 5.9(f)

"Antitrust Restraint" 5.4(c)

"Audited Interim Financials" 1.2(b)(xv)

"Audited Interim Financials Expenses" 5.8(a)

"Author" 2.9(f)(i)

"ASC" 2.4(c)

"Benefit Continuation Period" 5.9(d)

"BIS" 2.23(e)

"Board" Recitals

"Book-Entry Shares" 1.4(b)(i)

"Bylaws" 1.2(b)(ii)

"CCC" 1.3(f)

"Certificate of Incorporation" 1.2(b)(ii)

"Certificate of Merger" 1.1(d)

A-16

US3653629/60 166756-0017 "Certificates" 1.4(b)(i)

"Claim Certificate" 8.5(a)

"Claims Period" 8.4

"Closing" 1.1(c)

"Closing Date" 1.1(c)

"Closing Payment Fund" 1.4(a)

"COBRA" 2.13(c)

"Company" Preamble

"Company Authorizations" 2.7(b)

"Company Balance Sheet" 2.4(b)

"Company Balance Sheet Date" 2.4(b)

"Company Databases" 2.11(i)

"Company Disclosure Letter" Article II

"Company Employee Plans" 2.13(a)

"Company Fraud" 8.2(a)(viii)

"Company Indemnified Parties" 5.16(a)

"Company-Licensed Data" 2.11(j)

"Company-Owned Data" 2.11(k)

"Company Privacy Commitments" 2.11(a)

"Company Stockholder Approval" 2.3(a)

"Company Voting Debt" 2.2(e)

"Confidential Information" 2.9(h)

"Confidentiality Agreement" 5.3(a)

"Consenting Stockholders" Recitals

"Contaminant" 2.10(b)

"DAC 6 Directive" 2.12(h)

"DandO Indemnification Agreement" 5.16(a)

"DandO Tail Policy" 5.16(b)

"Debt Settlement Agreement" 5.9(c)

"Disabling Code" 2.10(b)

"EAR" 2.23(e)

"Effective Time" 1.1(d)

"ERISA" 2.13(a)

"ERISA Affiliate" 2.13(a)

"Escrow Agent" 8.1(a)

"Escrow Agreement" 8.1(a)

"Escrow Fund" 8.1(a)

"Escrow Release Date" 8.1(b)

"Escrow Reserved Amounts" 8.1(b)

"Expense Fund" 8.7(d)

"Expense Fund Surplus" 8.7(d)

"False Claims Act" 2.24(a)(vii)

"FAR" 2.24(a)(vii)

"Fenwick" 9.15

"Financial Statements" 2.4(a)

"Foreign Plan" 2.13(h)

"Former Government Employee" 2.24(d)

"Funds Flow" 1.2(b)(x)

"Holdback Participant" Preamble

"Hughes Promissory Note" 5.9(c)

"ICT Infrastructure" 2.10(a)

"Import and Export Approvals" 2.23(a)

"Import and Export Laws" 2.23

"Indemnifiable Damages" 8.2(a)

"Indemnified Person" 8.2(a)

"Indemnity Provisions" 5.16(a)

"Infringement" 2.9(i)

"Joinder Agreement" 1.2(b)(iv)

"Key Employee" Recitals

"Material Contracts" 2.18(a)

"Merger" Recitals

"Merger Sub" Preamble

A-17

US3653629/60 166756-0017 "New Litigation Claim" 5.6

"OFAC" 2.23

"Option Exercise Note" 4.2(f)

"Offer Letter" Recitals

"Option Cancellation Agreement" 1.2(b)(iv)

"Other Litigation Claim" 5.6

"Parachute Payment Waiver" 5.13

"Paying Agent" 1.4(a)

"Permitted Issuance" 4.2(e)

"Permitted New Hires" 5.9(f)

"Post-Closing Acquiror RSUs" 5.12(c)

"Post-Closing Cash Retention Awards" 5.9(h)

"Post-Closing Tax Period" 5.12(c)

"Pre-Closing Period" 4.1

"Pre-Closing Tax Period" 5.12(c)

"Prohibited and Restricted Parties" 2.23(g)

"Related Party Contract" 2.155

"Seller Group" 9.15

"Significant Customer" 2.25(a)

"Significant Supplier" 2.25(b)

"Special Claims" 8.3(c)

"Special Representations" 8.3(b)

"Spreadsheet" 5.18(a)

"Spreadsheet Certificate" 5.18(a)

"Letter of Transmittal" 1.4(b)(i)

"Stockholder Notice" 5.1(c)

"Stockholders' Agent" Preamble

" Stockholders' Agent Engagement Agreement" 8.7(b)

" Stockholders' Agent Expenses" 8.7(b)

" Stockholders' Agent Group" 8.7(b)

"Surviving Corporation" 1.1(a)

"Tax Contest" 5.12(e)

"Termination Date" 7.1(b)

"Third-Party Claim" 8.8

"Threshold" 8.3(a)

"Transactions" Recitals

"WARN Act" 2.14(g)

"Warrantholder Agreement" 1.2(b)(iv)

"Written Consent" Recitals



A-18

US3653629/60 166756-0017



   '

